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ABSTRACT
A genome editing revolution of unprecedented magnitude—
spearheaded by a scientific breakthrough called CRISPR—is
underway. This powerful technology has enabled scientists to
precisely edit genes and is challenging long-held conventions of
how humans view life. The incipient power to control and alter the
genetic destiny of living organisms, including plants and animals
intended for human consumption, raises complex legal issues that
our legal system will soon be forced to address. Against a
backdrop of limited natural resources to meet demands for global
food security and fervid opposition to genetically modified
organisms (“GMOs”) by many groups worldwide, the future of
genetically modified (“GM”) crops developed using CRISPR
technologies is uncertain.
This Article explores the legal status of genome-edited crops. It
provides a succinct resource that aims to dissect, demystify, and
render primary scientific literature on GMOs accessible to law
and policy makers. The Article also examines the intricacies and
limitations associated with the current regulatory scheme under
the Coordinated Framework for the Regulation of Biotechnology,
and how it discriminates among GM products on the basis of risk
and process depending on the method through which the products
∗ J.D., LL.M., Ph.D. Candidate, Structural and Molecular Biochemistry. I am
grateful to Anna Stepanova, Fred Gould, Steve Spiker, and John Conley for their
generous comments on earlier versions of the manuscript, and the Journal’s
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are derived. The Article analyzes the dissonance in the current
regulatory framework governing GMOs and argues that, in the
near future, it will likely be increasingly difficult to make
meaningful and enforceable regulatory distinctions between
genome-edited and naturally occurring crops. Lastly, the Article
identifies several obstacles to developing scientific-based public
policy in the realm of GMOs and proposes a set of policy
recommendations to facilitate the rational regulation of genomeedited crops.

TABLE OF CONTENTS
ABSTRACT....................................................................................432
INTRODUCTION ............................................................................435
I. GENETICALLY MODIFIED ORGANISMS ...................................445
A. From Domestication . . . ................................................447
B . . . . To Molecular Manipulation ....................................453
II. MAKING A GMO ....................................................................458
A. Non-Recombinant DNA Methods .................................459
1. Interspecific and Intergeneric Hybridization ...........460
2. Embryo Rescue .........................................................461
3. Chromosome Engineering ........................................462
4. Induced Mutagenesis ................................................463
5. Somaclonal Variation ...............................................464
B. Genetic Engineering Methods........................................465
1. Agrobacterium tumefaciens-Based Plant
Transformation .......................................................465
2. Particle Bombardment Transformation....................469
3. Polyethylene Glycol- and Electroporation-Based
Protoplast Transformation .....................................470
4. Microinjection ..........................................................471
5. Other Methods ..........................................................471
III. HEALTH AND ENVIRONMENTAL GMO SAFETY
CONCERNS ..........................................................................472
A. Human and Animal Health ............................................473
1. Institutional Authorities and International
Organizations .........................................................473

434

N.C. J.L. & TECH.

[VOL. 18: 432

2. Scientific Literature ..................................................476
3. Dissenting Voices—Opposition to the Scientific
Consensus ...............................................................481
B. The Environment ...........................................................487
1. Crop Yield and Economics .......................................488
2. Pest Management .....................................................490
3. Pesticide Use, Acquired Resistance, and
Controversies ..........................................................490
4. Non-Target Species and Biodiversity .......................493
IV. THE REGULATORY LANDSCAPE—A COORDINATED
FRAMEWORK ......................................................................497
A. The United States Department of Agriculture ...............500
B. The Food and Drug Administration ...............................503
C. The Environmental Protection Agency..........................506
V. CRISPR GMOS—NEW FOOD OR JUST GMOS 2.0?............508
A. CRISPR-Based, Targeted Genome Editing—A Brief
Overview ......................................................................509
B. CRISPR-Based Genome Editing and the Coordinated
Framework....................................................................510
VI. A REGULATORY PATH FOR GENOME-EDITED CROPS IN THE
TWENTY-FIRST CENTURY .................................................513
A. Banana vs. Fungus—A Hypothetical ............................516
B. Applying the Coordinated Framework to Reveal
Regulatory Gaps ...........................................................519
C. Regulatory Outlook and Policy Perspectives.................521
1. The Worlds of Science and Policy ............................522
2. Promoting Research- and Scientific-Based Policy
Development ...........................................................525
2.1 Facilitate Transparency in the Regulatory
Process............................................................525
2.2 Disclose Conflicts of Interest............................527
2.3 Develop Policies to Promote Dedicated
Grants .............................................................529
2.4. Incorporate Modern Technologies, When
Feasible, and Promote Technology
Development ...................................................531
CONCLUSION ...............................................................................536

MAY 2017]

CRISPR GMOs

435

TABLE OF FIGURES
FIGURE 1. Crop evolution depicted by juxtaposition of select
popular crops genetically modified through artificial selection
and their unmodified wild progenitors..................................452
FIGURE 2. The molecular basis for insecticide resistance in GM
crops—A Bt insecticidal Cry protein.....................................494
FIGURE 3. The molecular basis for herbicide resistance in GM
crops—A glyphosate-resistant EPSPS (5-enolpyruvylshikimate3-phosphate synthase) enzyme...............................................517

INTRODUCTION
A genome editing1 revolution of unprecedented magnitude—
spearheaded by a scientific breakthrough called “CRISPR”
(Clustered, Regularly Interspaced, Short Palindromic Repeats)—is
underway. At its core, this scientific revolution concerns the
rational and deliberate manipulation of the genetic composition—
genotype2—of myriad living organisms.
1

Genome editing is an umbrella term that refers to “scientific technological
advances that enable rational genetic engineering—at a local (gene) or global
(genome) level—to facilitate precise insertion, removal, or substitution of
fragments of Deoxyribonucleic acid (“DNA”) molecules, comprising one or
more nucleotides . . . into the cell(s) of an organism’s genome.” Paul Enríquez,
Genome Editing and the Jurisprudence of Scientific Empiricism, 19 VAND. J.
ENT. & TECH. L. 603, 617 (2017) (internal citations omitted). Genome editing is
frequently used interchangeably with other terms including, but not limited to,
gene editing and genetic engineering. Id. at 617 n.53.
2
The term “genotype” refers broadly to the overall genetic composition of a
living organism and narrowly to the variant forms of genes—alleles—carried by
the
organism
in
its
cells.
See
Genotype,
SCITABLE,
https://www.nature.com/scitable/definition/genotype-234 (last visited Mar. 16,
2016). The discussion of rational manipulation of genetic material frequently
concerns the alteration of specific DNA sequences known as genes, which
encode biochemical information to synthesize functional Ribonucleic acid
(“RNA”) or protein molecules. However, it is important to note that genome
editing can not only encompass deliberate manipulation of coding regions of
DNA, but also the alteration of other non-coding DNA regions throughout an
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Millions of years ago, world history changed course when our
hominid ancestors concocted the Oldowan toolkit. Now, for the
first time in the history of civilization, humans have developed
another set of specialized tools. Only this time, the tools bring the
previously unimaginable prospect of changing the very essence of
life—by making intended modifications at specific sites of any
organism’s genome—within the realm of possibility. The
discovery of highly precise and programmable enzymes that
function as macromolecular machines to shear DNA has made that
feat possible and is democratizing scientists’ access to new tools
requisite for uncovering future significant medical and scientific
advances.3 At the same time, the emerging technology in the realm
of gene editing is challenging long-held conventions of how
humans view life and the incipient power to control and alter the
genetic destiny of every living creature.
More than four decades have passed since the era of
recombinant DNA gave rise to modern biotechnology.4 During that
time, humans have innovated ways to address complex challenges
in fields ranging from synthetic biology to medicine and
agriculture. The impact of biotechnology on agriculture, for
example, has been remarkable. Today, agrobiotechnology is
tackling broad issues such as improving human health and
nutrition,5 as well as feeding an ever-increasing world population.6
Feeding the world and achieving food security has become a
major goal of biotechnology, and with good reason. The United
Nations estimates that the world population will rise from nearly
organism’s genome, including intergenic (between genes) and intragenic (within
genes) DNA sequences.
3
Enríquez, supra note 1, at 614–15, 632.
4
Id. at 621–22.
5
E.g., Xudong Ye et al., Engineering the Provitamin A (β-Carotene)
Biosynthetic Pathway into (Carotenoid-Free) Rice Endosperm, 287 SCIENCE
303 (2000) (engineering rice enriched in levels of a Vitamin A precursor).
6
See generally, e.g., NORMAN E. BORLAUG & CHRISTOPHER R. DOWSWELL,
FEEDING A WORLD OF TEN BILLION PEOPLE: A 21ST CENTURY CHALLENGE, IN
PROCEEDINGS OF THE INTERNATIONAL CONGRESS IN THE WAKE OF THE DOUBLE
HELIX: FROM THE GREEN REVOLUTION TO THE GENE REVOLUTION (2003),
http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.462.3105&rep=rep1&
type=pdf.
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seven billion to approximately ten billion in the next thirty years.7
Global crop demand is set to increase more than 100% during that
same timeframe.8 Limited resources in the form of arable land and
water available for irrigation will pose great impediments in global
efforts to foster food security.9
To confront the challenges of transforming global agriculture
and improving crop yields, scientists have devised ways of using
biotechnology to manipulate the genetic material of crop plants to
engineer pest, chemical, and drought resistance, improve
nutritional content, optimize yields, and minimize the impact of
suboptimal environmental conditions.10
Unfortunately, good intentions and finite scientific knowledge
often translate into imperfect technologies. Early attempts to
address modern agricultural problems involved the use of
traditional breeding coupled with artificial selection11—an often
tedious and laborious combination of methods—and what is now
known as transgenesis, a process that refers to the artificial

7

United Nations Department of Economic and Social Affairs, World
Population Projected to Reach 9.6 Billion by 2050, UNITED NATIONS (June 13,
2013),
https://www.un.org/development/desa/en/news/population/un-reportworld-population-projected-to-reach-9-6-billion-by-2050.html.
8
David Tilman et al., Global Food Demand and the Sustainable
Intensification of Agriculture, 108 PROC. NAT’L ACAD. SCI. U.S. 20260, 20261
(2011).
9
Elliot M. Berry et al., Food Security and Sustainability: Can One Exist
Without the Other?, 18 PUBLIC HEALTH NUTRITION 2293, 2300 (2015).
10
It bears noting that genetic modification of plants, including crops, has also
been used for other non-food agricultural purposes beyond the scope of this
Article, such as bioremediation and the production of biofuels and
pharmaceutical compounds. See, e.g., Ute Krämer & Agnes N. Chardonnes, The
Use of Transgenic Plants in the Bioremediation of Soils Contaminated with
Trace Elements, 55 APPLIED MICROBIOLOGY & BIOTECHNOLOGY 661 (2001)
(bioremediation); Bryan R. Moser, Camelina (Camelina sativa L.) Oil as a
Biofuels Feedstock: Golden Opportunity or False Hope?, 22 LIPID
TECHNOLOGY 270, 273 (2010) (biofuels); Hugh S. Mason et al., Expression of
Hepatitis B Surface Antigen in Transgenic Plants, 89 PROC. NAT’L ACAD. SCI.
U.S. 11745 (1992) (pharmaceuticals).
11
See infra Part I and Section II.A.
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introduction of genetic material—namely, transgenic 12 DNA—
from one organism into the genome of another unrelated organism.
Remarkably, scientists proved that the latter approach could be
used to create pest-resistant, 13 drought-tolerant, 14 herbicideresistant,15 and other varieties of plants to ameliorate agricultural
challenges through biotechnological innovation.
Notwithstanding the scientific progress, the practice of
adjoining native and foreign DNAs generated controversy and
opposition to genetic engineering. A primary objection has been
that genetic modification of living organisms is “unnatural” and,
therefore, in some sense, wrong. 16 Some opponents of modern
genetic modification techniques have conjured up parallels to
Frankenstein; or, the Modern Prometheus, 17 the famed fictional
novel. 18 Despite the lack of logical resemblance, such flawed
comparisons have permeated social discourse surrounding genetic
engineering. Public perceptions of genetically modified organisms

12

See,
Transgene,
SCITABLE,
http://www.nature.com/scitable/definition/transgene-223 (last visited Dec. 1,
2016).
13
See, e.g., Ronald L. Meeusen & Gregory Warren, Insect Control with
Genetically Engineered Crops, 34 ANN. REV. ENTOMOLOGY 373, 373 (1989).
14
See, e.g., Jiyul Chang et al., Water Stress Impacts on Transgenic DroughtTolerant Corn in the Northern Great Plains, 106 AGRONOMY J. 125 (2013).
15
See, e.g., Barbara J. Mazur & S. Carl Falco, The Development of Herbicide
Resistant Crops, 40 ANN. REV. PLANT PHYSIOLOGY & PLANT MOLECULAR
BIOLOGY 441 (1989).
16
See, e.g., 10 Scary Facts About GMOs, ONE GREEN PLANET (Mar. 18,
2013), http://www.onegreenplanet.org/vegan-health/10-scary-facts-about-gmos/.
17
MARY SHELLEY, FRANKENSTEIN; OR, THE MODERN PROMETHEUS VOL. I
(1818). The novel’s first edition was published anonymously in 1818, but Mary
Shelley's name appeared on the second edition, which was published in 1823.
See Frankenstein, WIKIPEDIA, https://en.wikipedia.org/wiki/Frankenstein (last
visited May 10, 2017).
18
See, e.g., Jill Ettinger, Everything You Absolutely Need to Know About
GMOs,
ORGANIC
AUTHORITY
(Feb.
20,
2012),
http://www.organicauthority.com/foodie-buzz/what-are-gmos-geneticallymodified-crops-foods.html (“The practice of introducing new DNA and
chemicals to seeds or animals . . . is similar to how Mary Shelly’s Frankenstein
created his monster—through piecing together lots of different organisms.”).
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(“GMOs”) 19 have become so distorted that foods derived from
genetically modified (“GM”) crops are frequently referred to as
“Frankenfoods.”20 Some opponents of genetic engineering “have
[even] likened [an] inevitable backlash of GMO technology to the
destruction and muderous [sic] rampage of Frankenstein’s
monster.”21 It is no surprise that the use of genetically modified
organisms in agriculture has become one of the most controversial
and impassioned topics in modern times.
While the use of biotechnology for agricultural purposes has
been the subject of scientific research for decades, CRISPR
biotechnologies mark a new turning point in the current GMO
narrative. CRISPR-based genome editing technologies and their
progeny are poised to raise challenging problems that our legal
system will be forced to address sooner rather than later. The
current GM crop regulatory scheme in the United Stated—namely,
the 1986 Coordinated Framework for the Regulation of
Biotechnology (“Coordinated Framework”)22—is largely limited in
scope by older genetic engineering methods that rely on
recombinant DNA technology. 23 Specifically, the regulatory
calculus focuses heavily on the introduction of transgenic DNA,
from foreign organisms—e.g., viruses or bacteria that may be
considered plant pests under current law—into GM crops by virtue
of human intervention.24
At the time the Coordinated Framework went into effect, it
would have been impossible for scientists—let alone law and
19

See definition infra Part I; see also infra notes 51–59 and accompanying

text.
20

See, e.g., Watch Out New Frankenfood Arriving Soon: GMO Potatoes, THE
ALTERNATIVE
DAILY,
(http://www.thealternativedaily.com/watch-newfrankenfood-arriving-soon-gmo-potatoes/ (last visited May 10, 2017); Ettinger,
supra note 18; Catherine Guthrie, Frankenfood = Genetically Modified Food,
EXPERIENCE LIFE (June 2013), https://experiencelife.com/article/frankenfoodgenetically-modified-foods/.
21
Ettinger, supra note 18.
22
Coordinated Framework for the Regulation of Biotechnology, 51 Fed. Reg.
23,302 (June 26, 1986).
23
See infra Section II.B.
24
See generally Coordinated Framework for the Regulation of Biotechnology,
51 Fed. Reg. 23,302.
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policy makers—to predict all of the technologies by which humans
are now able to alter the genetic composition of whole organisms
at will. The scientific research and industry communities have, for
some time, expressed discontent with the status quo, and calls for
the modernization of the Coordinated Framework are growing
louder each day. To answer those calls, the Obama Administration
launched an initiative to modernize the Coordinated Framework.25
The Executive Branch’s 26 directive to modernize the U.S.
regulatory system for biotechnology aims to improve transparency,
efficiency, predictability, and public confidence in the federal
government’s ability to develop sound health and environmental
policy.27
To understand the need for an overhaul of the current
regulatory scheme, an understanding of how the system
discriminates between products in terms of risk and process is
essential. A high degree of dissonance exists between the ways in
which GM crops derived through recombinant DNA technology
are regulated relative to those derived through conventional
hybridization and plant breeding methods.28
On one hand, GM crops developed through non-recombinant
DNA techniques—e.g., intergeneric hybridization, induced
mutagenesis, etc.29—for cross-breeding non-related30 crop species
25

See Memorandum for Heads of Food and Drug Administration,
Environmental Protection Agency, and Department of Agriculture: Modernizing
the Regulatory System for Biotechnology Products, (July 2, 2015),
https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/moderni
zing_the_reg_system_for_biotech_products_memo_final.pdf
[hereinafter
Modernizing the Regulatory System for Biotechnology Products].
26
As of the time of this writing, the author is not aware of any reports or
statements by the Trump Administration that undermine efforts to modernize the
Coordinated Framework.
27
See Modernizing the Regulatory System for Biotechnology Products, supra
note 25.
28
See infra Parts IV and V.
29
See infra Section II.A (discussing techniques).
30
It is important to distinguish cross-breeding of non-related and related plant
species. Although both types are deemed not to fall under the regulatory
oversight of the Coordinated Framework, crosses between plants of the same
species are less likely to lead to unexpected phenotypic or compositional
changes in crops.
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or exposing crops to mutagens are largely overlooked under the
Coordinated Framework. This lack of regulatory oversight exists
despite the fact that genetic modifications in many nonrecombinant DNA crops are, in theory, more likely to result in
significant reshuffling of parental genes, 31 which can lead to
unexpected phenotypic or compositional changes in GM food.32
On the other hand, GM crops developed with recombinant
DNA technology, using either non-related or related crop species,
trigger immediate regulatory scrutiny because, despite being more
precise than non-recombinant methods, the techniques used to
introduce DNA could, in theory, also lead to unexpected
phenotypic or compositional changes in GM food.33
Three decades of scientific research suggest that present-day
controversies surrounding GM crops and food are not grounded in
scientific fact. A scientific consensus has now formed to support
that proposition.34 From a strict risk-based standpoint, it seems
logical that some level of deregulation of GM crops should
proceed. Indeed, many in the scientific community have recently
argued on behalf of a risk-based approach to replace the current
process-based approach to biotechnology.35
The Executive Branch’s directive to modernize the U.S.
regulatory system for biotechnology coupled with findings in the
most recent report by the National Academies of Sciences,
Engineering, and Medicine (“NASEM”) on the status of GM
crops36 suggest that the future regulatory landscape for GM crops
will be less restrictive than its current incarnation. However, if the
new approach to biotechnology is risk-based, how will CRISPRmediated genome-edited crops be regulated? In the near future, it
will likely be increasingly cumbersome to make meaningful and
enforceable regulatory distinctions between genome-edited and
31

See Irving W. Knobloch, Intergeneric Hybridization in Flowering Plants,
21 TAXON 97 (1972).
32
See infra Section II.A.
33
See infra Section II.B.
34
See discussion and studies cited infra Section III.A.2.
35
See, e.g., Gregory Conko et al., A Risk-Based Approach to the Regulation of
Genetically Engineered Organisms, 34 NATURE BIOTECHNOLOGY 493 (2016).
36
See infra Section III.A.1.
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naturally occurring crops. Blurring the lines that mark what is
natural or not is likely to challenge the very essence of what
constitutes a GMO. And, if that is the effect of technological
advances in genome editing, should the law regulate CRISPR GM
crops at all?
This Article explores the complex issues raised by new genome
editing technologies—particularly CRISPR genome editing—on
the legal status of GMOs.
Part I provides an overview of GMOs and how humans have
manipulated living organisms to fit their needs since the dawn of
civilization. It introduces evidence of domestication-induced crop
genetic modification over the past few millennia to point out that
arguments that humans ought not to interfere with nature’s course
have little merit. 37 This Part also introduces the reader to key
scientific discoveries that ushered in the age of evolutionary and
molecular biology, which together sparked an agricultural
transformation that led to global commercialization of the first GM
crops.38
Part II provides a detailed account of numerous techniques
used by scientists to make a GMO. It intentionally divides methods
to produce GMOs in two categories: non-recombinant DNA
methods,39 which often rely on artificial selection of desirable plant
traits, and genetic engineering methods, 40 which depend on
recombinant DNA technologies. Importantly, this Part discusses
the advantages, limitations, and potential risks associated with the
techniques, and airs common misperceptions concerning the false
natural status often ascribed to non-recombinant DNA methods.
Part III examines the controversies generated by GMOs over
the past two decades and anchors the discussion under the
framework of a Jurisprudence of Scientific Empiricism. 41 This
theoretical foundation is critical to properly address rising legal
and policy questions related to GMOs that are firmly grounded in
37

See infra Section I.A.
See infra Section I.B.
39
See infra Section II.A.
40
See infra Section II.B.
41
See Enríquez, supra note 1, at 603, 611–14.
38
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reason and scientific facts. This Part provides a comprehensive
examination of the current state of the primary scientific literature
related to the potential health 42 and environmental 43 concerns
surrounding GMO biotechnology. The primary goal is to deliver a
succinct resource to render dense scientific information accessible
to law and policy makers.
In addition, Part III analyzes distinct rationales behind fervid
opposition to GMOs, which have contributed to making regulation
of GMO biotechnologies a “global problem.”44 Evidence suggests
that opposition to GMOs is not exclusively related to technological
aversion on ethical, health, or environmental grounds, but centers
on economic, financial, and political concerns instead. 45 As a
result, many opponents of GMO technologies have been criticized
as hypocritical.46 For instance, although a majority of European
42

See infra Section III.A.
See infra Section III.B.
44
Paul Enríquez, Deconstructing Transnationalism: Conceptualizing
Metanationalism as a Putative Model of Evolving Jurisprudence, 43 VAND. J.
TRANSNAT’L L. 1265, 1269, 1336 (2010). For instance, several European
countries have banned GMOs in recent years. See infra note 217 and
accompanying text. The bans raise complex legal issues concerning international
trade, intellectual property rights, and the future regulation of genome-edited
crops in the European Union and around the world.
45
See, e.g., GM Crop Ban, SCOTTISH GOV’T RIAGHALTAS NA H-ALBA
GOV.SCOT (Aug. 9, 2015), http://news.gov.scot/news/gm-crop-ban (announcing
Scotland’s recent ban of GMOs in order to “protect and further enhance [its]
clean, green status.”); Laurence A. Kogan, Trade Protectionism: Ducking the
Truth About Europe’s GMO Policy, N.Y. TIMES (Nov. 27, 2004),
http://www.nytimes.com/2004/11/27/opinion/trade-protectionism-ducking-thetruth-about-europes-gmo-policy.html?_r=0 (arguing that the European
Commission’s opposition to GMOs in previous years was based on “blatant
trade protectionism,” and that EU policies have influenced developing countries
in Africa to oppose GMOs for fear of trade restrictions to EU markets.); Natasha
Geiling, Scotland Bans Genetically Modified Crops, THINKPROGRESS (Aug. 10,
2015),
https://thinkprogress.org/scotland-bans-genetically-modified-crops8d6ac8849259 (citing potential consumer backlash and a desire to preserve an
image of producing high-quality goods as a driving factor behind Scotland's
decision to ban GMOs).
46
See Mark Lynas, With G.M.O. Policies, Europe Turns Against Science, N.Y.
TIMES
(Oct.
24,
2015),
https://www.nytimes.com/2015/10/25/opinion/sunday/with-gmo-policieseurope-turns-against-science.html (arguing that European policies on GM crops
43
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countries currently ban production of GM crops, Europe “imports
over 30 million tons” of corn and soy-based animal feeds every
year—mostly derived from GM crops—for its livestock industry
because they are cheaper than non-GM crops.47
Part IV examines the jurisdictional power that regulatory
agencies use to implement the Coordinated Framework. It
discusses key statutory provisions that give the United States
Department of Agriculture, the Food and Drug Administration, and
the Environmental Protection Agency shared power to promulgate
rules for GM crop oversight.48 This Part also examines how the
Coordinated Framework, which was intended to enact policies that
would primarily follow a products-based approach to the
regulation of biotechnology, has not lived up to that goal.
Part V introduces CRISPR-Cas9 and modern genome editing
technologies. It provides a brief overview of CRISPR-based
genome editing and the pressure the technology is exerting on the
Coordinated Framework.49 This Part highlights shortcomings of the
are hypocritical because Europe imports large amounts of GM crops for animal
feed).
Along this point, it is interesting to note the geographical dissonance between
the United States and the European Union (“EU”) when it comes to GM crops
and global climate change. Although a scientific consensus has formed to
support the safety of GM crops and the anthropogenic contributions to global
climate change, the US and the EU have different general approaches to these
issues. See, e.g., Brian Kennedy & Cary Funk, Many Americans are Skeptical
About Scientific Research on Climate and GM Foods, PEW RESEARCH CTR.
(Dec. 5, 2016), http://www.pewresearch.org/fact-tank/2016/12/05/manyamericans-are-skeptical-about-scientific-research-on-climate-and-gm-foods/;
CINNAMON PIÑON CARLARNE, CLIMATE CHANGE LAW AND POLICY: EU AND US
APPROACHES 348–49, 359–60 (2010).
The EU has chosen to embrace scientific evidence and lead the world in
progressive climate policies, but blatantly ignores scientific evidence vis-à-vis
GM crops. Id.; Lynas, supra note 46. In contrast, the US takes a progressive
approach to cultivation and consumption of GM crops, but frequently ignores
the scientific consensus on the dangers posed by global climate change, and has
failed to address global climate change at the federal level. PIÑON CARLARNE,
supra; Lynas, supra note 46.
47
Lynas, supra note 46.
48
See infra Part IV.
49
See infra Part V.
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methods of plant transformation discussed in Part II, which are
limited by the inability to control where, and with what frequency,
insertion of foreign DNA occurs into a target plant species. The
discussion then compares those limitations to the advantages of
modern genome editing technologies, which are precise and need
not rely on the insertion of foreign DNA sequences at all to carry
out intended genetic manipulations.
Finally, part VI paves a path for the regulation of genome
editing technologies in the twenty-first century. It illustrates
regulatory gaps in the Coordinated Framework vis-à-vis genome
editing technologies using a hypothetical, identifies several
obstacles to developing scientific-based public policy in the realm
of GMOs, and proposes a set of policy recommendations to
facilitate the rational regulation of genome-edited crops.50
I. GENETICALLY MODIFIED ORGANISMS
The term genetically modified organism, colloquially known as
GMO, refers broadly to any living organism comprising artificially
altered genetic material, which is intended to produce a desired
phenotype (trait). 51 On occasion, other terms, such as living
modified organism (“LMO”)52 or genetically engineered organism
(“GEO”),53 have been used to refer to the same concept, but none
50

See infra Part VI.
See, e.g., Frequently Asked Questions on Genetically Modified Food,
WORLD HEALTH ORG., http://www.who.int/foodsafety/areas_work/foodtechnology/faq-genetically-modified-food/en/ (last visited Dec. 1, 2016);
Genetically
Modified,
OXFORD
ONLINE
DICTIONARY,
https://en.oxforddictionaries.com/definition/genetically_modified (last visited
Dec. 1, 2016); Julia M. Diaz & Judith L. Fridovich-Keil, Genetically Modified
Organism,
ENCYCLOPEDIA
BRITANNICA
(Nov.
28,
2016),
https://www.britannica.com/science/genetically-modified-organism.
52
See SECRETARIAT OF THE CONVENTION ON BIOLOGICAL DIVERSITY, THE
CARTAGENA PROTOCOL ON BIOSAFETY TO THE CONVENTION ON BIOLOGICAL
DIVERSITY, Art. 3(g) (2000) (“‘Living modified organism’ means any living
organism that possesses a novel combination of genetic material obtained
through the use of modern biotechnology.”).
53
See, e.g., Glossary of Agricultural Biotechnology Terms, U.S.D.A. (Feb. 27,
2013),
51
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have become as pervasive as GMO.54 Although many definitions
do not specify the type of species encompassed by GMO, the term
is applicable to microbes, fungi, plants, and animals, but not
human beings.55
The striking diversity of microbes, 56 fungi, 57 plants, 58 and
animals 59 amenable to genetic manipulation has facilitated the
evolution of a wide range of connotations elicited by the term
GMO in different biotechnological contexts. A common thread,
however, is the notion that GMOs can be used in the production of
genetically modified food 60 intended for human consumption. 61
Accordingly, it is no surprise that many GMOs have collectively

https://www.usda.gov/wps/portal/usda/usdahome?contentid=biotech_glossary.ht
ml.
54
As articulated earlier, in a narrow sense—particularly in the view of some
opponents of GMOs—the term presumably refers mainly to organisms that have
been created using recombinant DNA technology to introduce foreign genetic
material.
55
See, e.g., Directive 2001/18/EC of the European Parliament and of the
Council on the Deliberate Release into the Environment of Genetically Modified
Organisms and Repealing Council Directive 90/220/EEC, OFFICIAL JOURNAL
OF THE EUROPEAN UNION, L 106, Art. 2 (2001) (“‘Genetically modified
organism (GMO)’ means an organism, with the exception of human beings, in
which the genetic material has been altered in a way that does not occur
naturally by mating and/or natural recombination.”) (emphasis added).
56
E.g., V. V. Mistry, Chymosin in Cheese Making, in FOOD BIOCHEMISTRY
AND FOOD PROCESSING 223 (Benjamin K. Simpson ed., 2d ed. 2012).
57
E.g., Production of Provitamin A Carotenoids in Mushrooms and Uses
Thereof, U.S. Patent No. 8,907,165 (filed Feb. 11, 2010).
58
Robert T. Fraley et al., Expression of Bacterial Genes in Plant Cells, 80
PROC. NAT’L ACAD. SCI. U.S. 4803 (1983).
59
E.g., Bernadette M. Dunham, AquAdvantage Salmon Approval Letter and
Appendix,
FDA
(Nov.
19,
2015),
http://www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/GeneticEn
gineering/GeneticallyEngineeredAnimals/ucm466214.htm; Enríquez, supra note
1, at 661–64.
60
GM food sources can encompass a wide array of living organisms
consumed by humans including edible fungi (e.g., mushrooms), plants, and
animals (vertebrate or invertebrate).
61
Other GMO-derived products exist including, but not limited to, drugs,
cosmetics, antibodies, and more. See, e.g., infra note 65.
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made their way into our food supply62 as humans have availed
themselves of myriad living organisms on Earth for agriculture and
food processing purposes.
Thus, in the case of plants, which are the focus of this Article,63
the manipulation of GM crops through biotechnology seeks to
introduce genetic material into crop plants to address ongoing
issues64—pest and chemical resistance, manipulation of nutritional
content, susceptibility to disease or suboptimal environmental
conditions, yield optimization, storage tolerance, drought
resistance, etc.—that affect the improvement of agricultural
practices worldwide.65
A. From Domestication . . .
From times immemorial, humans have utilized domestication
as a strategy for altering, taming, or influencing wild living
organisms to suit particular needs. The transition of ancient wolves
into domestic dogs, for example, is thought to date as far back as
33,000 years ago.66 Breeding and non-natural selection67 of docile
62

See, e.g., G. Bruening and J. M. Lyons, The Case of the FLAVR SAVR
Tomato, 54 CAL. AGRIC. 6 (2000); Enríquez, supra note 1, at 656–57; David
Johnson & Siobhan O’Connor, These Charts Show Every Genetically Modified
Food People Already Eat in the U.S., TIME MAG. (Apr. 30, 2015),
http://time.com/3840073/gmo-food-charts/.
63
Although this Article specifically covers plant-derived GM foods, food
from other GM organisms share many similarities with GM crops, including the
methods with which they are created and, to some extent, how they are
regulated. For a brief overview of genome editing and other biotechnological
uses of GM animals in agriculture, see Enríquez, supra note 1, at 662–64.
64
Enríquez, supra note 1, at 654–55, 660–61.
65
It bears noting that genetic modification of plants, including crops, has also
been used for other non-food agricultural purposes beyond the scope of this
Article, such as bioremediation and the production of biofuels and
pharmaceutical compounds. See, e.g., Krämer & Chardonnes, supra note 10
(bioremediation); Moser, supra note 10 (biofuels); Mason et al., supra note 10
(pharmaceuticals).
66
Nikolai D. Ovodov et al., A 33,000-Year-Old Incipient Dog from the Altai
Mountains of Siberia: Evidence of the Earliest Domestication Disrupted by the
Last Glacial Maximum, 6 PLOS ONE e22821 (2011).
67
Guo-dong Wang et al., The Genomics of Selection in Dogs and the Parallel
Evolution Between Dogs and Humans, 4 NATURE COMM. 1860 (2013).
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behavior—and other traits—eventually led to striking genetic
changes,68 critical for domestication,69 that facilitated the evolution
of wolves into an entirely novel species; 70 one which did not
naturally occur, and would not exist today, but for human
intervention.
From an evolutionary standpoint, domestication has proven to
be remarkable. It can exert substantial pressure to induce rapid
phenotypic evolution that yields great variation from a limited
genetic pool. 71 What was done with the wolf is not a unique
historical or anthropological anomaly. Roughly 10,000 years ago,
domestication of all major crop plants occurred through ancient
agricultural practices, 72 which led to allele 73 fixation of desired
agronomic traits over the span of several hundred years.74
Among the first crops to undergo artificial, or non-natural,
selection 75 resulting in genetic alterations was a domesticated
version of the wild Mexican grass Balsas teosinte, the progenitor
of modern day maize (corn).76 Molecular evidence demonstrates
that maize and teosinte are strikingly similar. Indeed, they share

68

Pontus Skoglund et al., Estimation of Population Divergence Times from
Non-Overlapping Genomic Sequences: Examples from Dogs and Wolves, 28
MOLECULAR BIOLOGY & EVOLUTION 1505 (2011).
69
Adam H. Freedman et al., Genome Sequencing Highlights the Dynamic
Early History of Dogs, 10 PLOS GENETICS e1004016 (2014).
70
Simon J. M. Davis & François R. Valla, Evidence for Domestication of the
Dog 12,000 Years Ago in the Natufian of Israel, 276 NATURE 608 (1978).
71
Gianni Liti et al., Population Genomics of Domestic and Wild Yeasts, 458
NATURE 337 (2009).
72
Rong-Lin Wang et al., The Limits of Selection During Maize
Domestication, 398 NATURE 236, 236 (1999) (citation omitted).
73
An allele is a variant form of a gene. See Allele, SCITABLE,
http://www.nature.com/scitable/definition/allele-48 (last visited Dec. 1, 2016 ).
74
Wang et al., supra note 72, at 238.
75
Artificial selection and non-natural selection are used interchangeably
throughout this Article to denote human-induced evolution through selective
breeding of sexually compatible or incompatible organisms to produce desirable
offspring.
76
Id. See also George W. Beadle, Teosinte and the Origin of Maize, 30 J.
HEREDITY 245 (1939) (first proposing the idea that maize descended from
teosinte).
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identical centromere positions and chromosome arm lengths. 77
They also possess equal number of chromosomes, and knobs at the
same chromosomal positions, which occur at similar frequencies.78
Furthermore, modern maize varieties can be crossed with teosinte
to form hybrids that exhibit complete chromosomal pairing and
fertility.79
Despite their genetic similitude, maize and teosinte are not only
drastically different in appearance, but also in terms of utility. For
instance, the teosinte ear (Figure 1)80 features between five and
twelve kernels, each sealed tightly in a stony casing that is
impervious to the digestive tract environment of birds and
mammals.81 In contrast, the maize ear bears over 500 naked kernels
that are easily digested by any animal that ingests them.82 These
and other significant differences between maize and teosinte have
been empirically linked to a mere five genes.83 Thus, maize is a
vivid illustration of the principle that few naturally occurring
mutations, derived through non-natural selection of rare and
desirable characteristics, can exert combinatorial effects that
account for a wide array of seemingly complex phenotypes.84
More importantly, although the transformation of modern crops
from their ancient progenitors is thought to have occurred within a
period of several hundreds of years,85 our current understanding of
77

John Doebley, The Genetics of Maize Evolution, 38 ANN. REV. GENETICS
37, 40–41 (2004).
78
Id.
79
Id.
80
See infra note 104.
81
Id. at 39.
82
Id.
83
See Allison Weber et al., Major Regulatory Genes in Maize Contribute to
Standing Variation in Teosinte (Zea mays ssp. parviglumis), 177 GENETICS 2349
(2007).
84
Id. Genome-wide association studies have also provided important evidence
of this principle. See, e.g., Edouard Cadieu et al., Coat Variation in the Domestic
Dog Is Governed by Variants in Three Genes, 326 SCIENCE 150 (2009)
(providing evidence from a study of more than 1,000 dogs from 80 breeds,
which revealed that distinct mutations in only three genes account for the
majority of coat characteristics in purebred dogs in the Unites States).
85
See Wang et al., supra note 72.
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systematic breeding practices followed by artificial selection has
revealed that such drastic genetic transformations can successfully
take place within just a few generations.86
Other crops have experienced similar non-natural selection in
their path toward domestication. Modern day wheat (Triticum
aestivum) originates from the hybridization of a wild wheat grass
(Aegilops tauschii) and an ancient tetraploid 87 wheat hybrid
(Triticum turgidum), 88 which led to the creation of the vastly
popular hexaploid wheat species89 that are produced and consumed
all over the world today. 90 Rice, arguably the world’s most
important crop to human nutrition and caloric intake, 91 has
experienced drastic transformations. Wild rice species often
display long awns and severe shattering, which are important for
seed dispersal.92 In contrast, domestic rice species have evolved to

86

For instance, artificial selection in dog breeds (that is, systematic breeding
practices involving crosses between different breeds, followed by selection of
specific traits) over the last 200 years is primarily responsible for the dramatic
diversification of traits—body size, coat color, hair texture, etc.—observed in
modern canines. See Robert K. Wayne & Bridgett M. vonHoldt, Evolutionary
Genomics of Dog Domestication, 23 MAMMALIAN GENOME 3 (2012).
87
Polyploidy refers to the heritable condition of having more than two
complete sets of chromosomes. See Margaret Woodhouse et al., Polyploidy,
SCITABLE (2009), http://www.nature.com/scitable/nated/topicpage/polyploidy1552814 (last visited Dec. 1, 2016). Accordingly, a tetraploid organism has four
sets of chromosomes, and a hexaploid organism has six sets of chromosomes.
88
Moshe Feldman & Mordechai E. Kislev, Domestication of Emmer Wheat
and Evolution of Free-Threshing Tetraploid Wheat, 55 ISRAEL J. PLANT SCI. 207
(2007).
89
Yoshihiro Matsuoka, Evolution of Polyploid Triticum Wheats Under
Cultivation: The Role of Domestication, Natural Hybridization and
Allopolyploid Speciation in Their Diversification, 52 PLANT CELL PHYSIOLOGY
750, 751 (2011).
90
Global Crop Production Analysis: Maps, U.S.D.A. (Dec. 9, 2016),
https://www.pecad.fas.usda.gov/ogamaps/Default.aspx?cmdty=Wheat&attribute
=Production.
91
Gurdev S. Khush, Origin, Dispersal, Cultivation and Variation of Rice, 35
PLANT MOLECULAR BIOLOGY 25 (1997).
92
Megan Sweeney & Susan McCouch, The Complex History of the
Domestication of Rice, 100 ANNALS BOTANY 951 (2007).
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contain short awns, if any, and reduced shattering, thereby
resulting in maximum seed count for harvesting.93
Human-dependent selection has not been limited to grain crops
throughout history. The wild progenitors of present day tomatoes
(Figure 1)94 had very small fruit designed for species propagation
rather than human consumption.95 However, artificial selection of
large fruit size and shape transformed the wild species, once
endogenous to the South American Andes, into today’s prized
tomato cultivars.96
The modern strawberry (Figure 1)97 was derived from hybrids
between two octoploid Native American species that were
subsequently selected for fruit size and firmness. 98 Numerous
similar fates have been reported for the evolution of other fruits
and crops (Figure 1),99 including the potato,100 banana,101 broccoli,102
and a vast list of others,103 all of which have been selected for size,
taste, shape, nutritional content, and a variety of other desirable
agronomic traits.

93

Id.
See infra note 104.
95
Yuling Bai & Pim Lindhout, Domestication and Breeding of Tomatoes:
What Have We Gained and What Can We Gain in the Future?, 100 ANNALS
BOTANY 1085, 1087 (2007).
96
Id.
97
See infra note 104.
98
Jules Janick, The Origins of Fruit, Fruit Growing, and Fruit Breeding, 25
PLANT BREEDING REVS. 255, 302 (2005).
99
See infra note 104.
100
See generally David M. Spooner et al., A Single Domestication for Potato
Based on Multilocus Amplified Fragment Length Polymorphism Genotyping,
102 PROC. NAT’L ACAD. SCI. U.S. 14694 (2005).
101
See Janick, supra note 98, at 298–99.
102
See, e.g., id. at 258.
103
See id. at 272–308 (providing related accounts all over the world for the
evolution of papaya, kiwi, peach, grape, plum, pineapple, apricot, avocado,
mango, olive, pomegranate, fig, cherry, citrus fruit, and others).
94
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FIGURE 1

Crop evolution depicted by juxtaposition of select popular crops
genetically modified through artificial selection and their
unmodified wild progenitors. A. Fruit of wild bananas (left) featuring
large and hard seeds compared to the cultivated Cavendish banana
(right), the most popular fruit in the world. B. Fruit of domesticated
tomatoes (left) relative to the fruit of their wild progenitors (right). C.
Wild strawberry fruit (left) compared to the large, modern, cultivated
strawberry fruit (right). D. Juxtaposition of fruit from a domestic
eggplant cultivar (left) and the small, bitter fruit from its wild
progenitor species (right). E. The evolution of modern-day maize—
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corn—cobs and kernels from teosinte, maize’s wild ancestor. The
figure contrasts the ears of teosinte (left), domestic maize (right), and a
teosinte-maize hybrid (middle).104 The figure appears in color in the
online version of the Article.105

The evolution—from wild ancestor to domestic progeny—of
various agriculturally important crops sheds light on the crucial
role that non-natural selection driven by humans has played in the
development of agriculture. The overwhelming evidence related to
domestication-induced genetic modification of crops, which has
accrued over the past few millennia, provides strong support
against arguments that humans ought not to interfere with nature’s
course. Without human intervention, none of these important
crops, which collectively feed the world, would exist today.
Indeed, human intervention is vital for the survival of many of
today’s staple crops, which could not grow and reproduce in the
wild without human assistance.106
B . . . . To Molecular Manipulation
For millennia, genetic modification of organisms via
domestication constituted the primary method of manipulating the
genetic composition of crop plants. That all changed with the dawn
104

Items are representative (not to scale) of the actual relative size difference
between each wild progenitor and its corresponding domesticated crop. The
figure comprises photographs adapted from the following sources: Wild Banana,
WIKIPEDIA,
https://en.wikipedia.org/wiki/Banana#/media/File:Inside_a_wildtype_banana.jpg; Cavendish Banana, IMPEXOR, http://impexor.com/wpcontent/uploads/2012/12/cavendishbanana.png;
Domesticated
and
Wild
Tomatoes, IMGUR, https://i.stack.imgur.com/2AZ7a.jpg; Wild Strawberry,
LESLIELAND,
http://leslieland.com/wp-content/uploads/2008/07/strawberrysizes-1.jpg;
Domesticated
Strawberry,
WIKIPEDIA,
https://en.wikipedia.org/wiki/Strawberry#/media/File:PerfectStrawberry.jpg;
Domesticated
and
Wild
Eggplant,
GENETICS,
http://www.genetics.org/content/genetics/161/4/1713/F1/graphic-1.large.jpg;
Teosinte, Maize, and Teosinte-Maize Hybrid, UNIVERSITY OF WISCONSINMADISON, https://teosinte.wisc.edu/Images_to_download/Maize-teosinte.jpg.
105
The online version can be accessed at the Journal’s website, ncjolt.org, by
clicking on the “Articles” tab, Volume 18, Issue 4.
106
See, e.g., Doebley, supra note 77, at 39 (affirming that “maize is
completely dependent on humans for its survival”).
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of the age of evolutionary and molecular biology. Alfred Russel
Wallace and Charles Darwin’s co-discovery 107 of natural
selection,108 which prompted Darwin to publish his book On the

107

Charles Darwin & Alfred Wallace, On the Tendency of Species to Form
Varieties; and on the Perpetuation of Varieties and Species by Natural Means of
Selection, 3 J. PROC. LINNEAN SOC’Y LONDON ZOOLOGY 45 (1858).
108
Over the years, controversy has surrounded the Darwin-Wallace codiscovery of the theory of evolution by natural selection, credit for which has
been suggested to belong to Wallace alone. See, e.g., ROY DAVIES, THE DARWIN
CONSPIRACY: ORIGINS OF A SCIENTIFIC CRIME (2008); JOHN LANGDON BROOKS,
JUST BEFORE THE ORIGIN: ALFRED RUSSEL WALLACE’S THEORY OF EVOLUTION
(1984). Among the main accusations against Darwin is the allegation that he
plagiarized ideas found in a paper Wallace sent to him in 1858, which prompted
Darwin to revise elements of his own theory and rush to publish it in 1859. John
van Wyhe & Kees Rookmaaker, A New Theory to Explain the Receipt of
Wallace’s Ternate Essay by Darwin in 1858, 105 BIOLOGICAL J. LINNEAN
SOC’Y 249 (2012) (arguing against the same theory).
Wallace sent Darwin the draft of his unpublished essay titled On The
Tendency of Varieties to Depart Indefinitely from the Original Type in
confidence, requesting Darwin to review it and pass it along to Charles Lyell, a
close friend of Darwin’s, if he found it worthwhile. Id. In his essay, Wallace laid
out a version of the theory of evolution by natural selection, which Darwin
understood to be precisely what he intended to propose in his own theory. See
Letter from C. Darwin to C. Lyell (June 18, 1858), in THE LIFE AND LETTERS OF
CHARLES DARWIN, INCLUDING AN AUTOBIOGRAPHICAL CHAPTER VOL. II 116
(Francis Darwin ed., 1887) (publishing Darwin’s personal letter to Lyell upon
receipt of Wallace’s draft in which he wrote: “I never saw a more striking
coincidence; if Wallace had my MS. sketch written out in 1842, he could not
have made a better short abstract! Even his terms now stand as heads of my
chapters.”).
Following Wallace’s letter, Lyell and Joseph Hooker, another one of Darwin’s
influential close friends in scientific circles, advised Darwin to publish extracts
from his prior work on evolution alongside Wallace’s essay at a meeting of the
Linnean Society of London. Van Wyhe & Rookmaaker, supra, at 249. Lyell and
Hooker subsequently submitted Darwin and Wallace’s work, without Wallace’s
knowledge, to the Linnean Society explaining that both men had “independently
and unknown to one another, conceived the same very ingenious theory to
account for the appearance and perpetuation of varieties and of specific forms on
our planet . . . .” Darwin and Wallace, supra note 107, at 45. Lyell and Hooker
made it known that Darwin thought Wallace’s work to be of high value and
worthy of prompt publication, which they approved of “provided Mr. Darwin
did not withhold from the public” his own work on the same subject. Id. at 45–
46. Notably, although Lyell and Hooker’s letter to the Linnean Society credited
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Origin of Species,109 and Gregor Mendel’s discovery of “discrete
inherited units” 110 —better known today as genes—laid the
foundation for the genetics-based era of modern plant breeding.
Farming practices before the 19th century involved crossbreeding, domestication, and non-natural selection of traits.

both men, it also highlighted and preserved their dear friend’s (Darwin)
purported priority. Id.
Despite the controversy surrounding who rightfully deserves credit for the
theory of evolution by natural selection, researchers have not found clear and
convincing evidence to corroborate theories that Darwin plagiarized Wallace.
See generally JOHN VAN WYHE, DISPELLING THE DARKNESS: VOYAGE IN THE
MALAY ARCHIPELAGO AND THE DISCOVERY OF EVOLUTION BY WALLACE AND
DARWIN (2013); Van Wyhe & Rookmaaker, supra. Indeed, Darwin’s own
writings reveal he was ethically torn vis-à-vis Wallace’s disclosure and did not
wish to minimize Wallace’s contribution. See Letter from C. Darwin to C. Lyell
(June 25, 1858), in THE LIFE AND LETTERS OF CHARLES DARWIN, INCLUDING AN
AUTOBIOGRAPHICAL CHAPTER VOL. II 117 (Francis Darwin ed., 1887) (“as I had
not intended to publish any sketch, can I do so honourably [sic], because
Wallace has sent me an outline of his doctrine? I would far rather burn my
whole book, than that he or any other man should think that I had behaved in a
paltry spirit. Do you not think his having sent me this sketch ties my hands?”).
Nevertheless, the circumstances surrounding Lyell and Hooker’s decision to
help their friend Darwin hang on to a slice of glory in world history by making
Wallace a co-discoverer remain questionable, particularly when Darwin himself
realized that his priority had been shattered by Wallace’s 1858 essay. See Letter
from C. Darwin to C. Lyell (June 18, 1858), in THE LIFE AND LETTERS OF
CHARLES DARWIN, INCLUDING AN AUTOBIOGRAPHICAL CHAPTER VOL. II 116–
17 (Francis Darwin ed., 1887) (documenting Darwin’s mourning of his loss of
priority when he wrote: “So all my originality, whatever it may amount to, will
be smashed [by Wallace’s essay], though my book, if it will ever have any
value, will not be deteriorated; as all the labour [sic] consists in the application
of the theory.”). Whatever the case may be concerning Darwin and Wallace’s
contributions, there is no question that Wallace’s essay triggered prompt
publication of the theory of evolution in 1858 and Darwin’s own book nearly a
year later in 1859.
109
CHARLES DARWIN, ON THE ORIGIN OF SPECIES BY MEANS OF NATURAL
SELECTION, OR THE PRESERVATION OF FAVOURED RACES IN THE STRUGGLE FOR
LIFE (1859).
110
Gregor Mendel, Versuche über Plflanzenhybriden [Experiments in Plant
Hybridization], ABHANDLUNGEN 3–47 (1866), Read at Meetings of the Brünn
Natural History Society (Feb. 8 & Mar. 8, 1865), reprinted in GREGOR MENDEL,
EXPERIMENTS IN PLANT HYBRIDIZATION 33–41 (1963).
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Insights from Mendel’s pea plant hybridization experiments, 111
which ultimately led to conceptualization of Mendel’s Laws of
Inheritance,112 opened the door for subsequent researchers to apply
the dual principles of heredity and natural selection in plant
breeding for purposes of increasing genetic diversity. In time, these
principles had a combined lasting effect on conventional farming,
transforming it from an agricultural practice into a bona fide
agricultural science.
Scientific discoveries throughout the 20th century involving
DNA and the molecular mechanisms of genetic inheritance helped
promote the advent of recombinant DNA technology.113 By 1972,
breakthrough discoveries—in restriction enzyme 114 and DNA
double-stranded repair mechanisms—allowed scientists to produce
the first recombinant DNA molecules by fusing DNA fragments
from two viruses.115 Within a year, the first genetically modified
organism created through modern genetic engineering was
reported in the literature, after a team of researchers introduced
recombinant DNA into bacterial cells.116
The science progressed rapidly after those proof-of-concept
studies were established. In 1974, the world’s first transgenic117

111

Id.
The Laws of Inheritance originated from Mendel’s observations of how
traits were passed down from parents to progeny. His studies helped him to
introduce the Law of Segregation and the Law of Independent Assortment,
which together form the bulk of his Laws of Inheritance. Ilona Miko, Gregor
Mendel and the Principles of Inheritance, 1 NATURE EDUC. 134 (2008).
113
Enríquez, supra note 1, at 621–22.
114
Restriction enzymes, also known as restriction endonucleases, are proteins
capable of cutting DNA at or near specific nucleotide sequences. See Richard J.
Roberts & Kenneth Murray, Restriction Endonucleases, 4 CRITICAL REVS.
BIOCHEMISTRY 123 (1976).
115
David A. Jackson, Robert H. Symons, & Paul Berg, Biochemical Method
for Inserting New Genetic Information into DNA of Simian Virus 40: Circular
SV40 DNA Molecules Containing Lambda Phage Genes and the Galactose
Operon of Escherichia Coli, 69 PROC. NAT’L ACAD. SCI. U.S. 2904 (1972).
116
Stanley N. Cohen et al., Construction of Biologically Functional Bacterial
Plasmids in Vitro, 70 PROC. NAT’L ACAD. SCI. U.S. 3240 (1973).
117
The term “‘transgenic”’ refers to the artificial introduction of genetic
material from one organism into the genome of another unrelated organism. See,
112
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animal was reported.118 The first genetically engineered plants were
developed by inserting antibiotic resistance genes into tobacco
plant cells in 1983.119 A genetically modified bacterium capable of
breaking down crude oil for bioremediation purposes became the
first patented GMO.120 The Supreme Court’s decision endorsing
intellectual property rights for living microorganisms spawned a
multi-billion dollar biotechnology industry.121
Soon thereafter, global commercialization of the first GM
crops got under way. In 1992, a virus-resistant tobacco plant
produced by Chinese researchers became the world’s first
commercial GM crop.122 In the United States, a California-based
firm brought the first GM food—the FLAVR SAVR tomato—to
market in 1994.123 The first insect and herbicide resistant crops
were approved in the mid-1990s,124 and marked a turning point in
agriculture. By 1996, a total of thirty-five approvals had been
granted for the commercialization of a variety of transgenic crops

Transgene, SCITABLE, http://www.nature.com/scitable/definition/transgene-223
(last visited Dec. 1, 2016).
118
Rudolf Jaenisch & Beatrice Mintz, Simian Virus 40 DNA Sequences in
DNA of Healthy Adult Mice Derived from Preimplantation Blastocysts Injected
with Viral DNA, 71 PROC. NAT’L ACAD. U.S. 1250 (1974).
119
Luis Herrera-Estrella et al., Expression of Chimaeric Genes Transferred
into Plant Cells Using a Ti-Plasmid-Derived Vector, 303 NATURE 209 (1983);
Michael W. Bevan & Richard B. Flavell, A Chimaeric Antibiotic Resistance
Gene as a Selectable Marker for Plant Cell Transformation, 304 NATURE 184
(1983); R. T. Fraley et al., Expression of Bacterial Genes in Plant Cells, 80
PROC. NAT’L ACAD. SCI. U.S. 4803 (1983).
120
U.S. Patent No. 4,259,444 (filed June 7, 1972).
121
See Diamond v. Chakrabarty, 447 U.S. 303, 318 (1980) (holding that
certain genetically modified microorganisms meet the patent eligibility
requirements set forth in 35 U.S.C. § 101).
122
VALEIRE J. KARPLUS & XING WANG DENG, AGRICULTURAL
BIOTECHNOLOGY IN CHINA: ORIGINS AND PROSPECTS 62 (2008).
123
G. Bruening & J. M. Lyons, The Case of the FLAVR SAVR Tomato, 54
CAL. AGRIC. 6 (2000).
124
Charles M. Benbrook, Impacts of Genetically Engineered Crops on
Pesticide Use in the U.S.—The First Sixteen Years, 24 ENVTL. SCIS. EUR. art.
24, at 4 (2012).
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worldwide.125 Genetic engineering also began to be used in the
production of biofortified crops.126
The new age of recombinant DNA technology and molecular
genetics has ushered in a revolution in crop agricultural science the
world has never before seen. In 2014, a reported 18 million
farmers in twenty-eight countries across the world devoted 181.5
million hectares (448 million acres) of arable land for cultivation
of GM crops. 127 This marked a 107-fold increase in global
hectarage devoted for GM crops—from the 1.7 million hectares
reported in 1996—since commercialization of GM crops began.128
As of 2014, the global market value of GM crops was estimated at
15.7 billion U.S. dollars129 and continues in an upward trend.
II. MAKING A GMO
As pointed out in Part I, genetic modification of crops can be
achieved through artificial (non-natural) selection of desirable
agronomic traits. As a result, domestication-induced genetic
modification technically also leads to the creation of GMOs, even
though propagation of these crops does not involve genetic
engineering.130 This is an important and common misperception
regarding GMOs, namely that (1) intentional breeding followed by
selection is a natural process—it is not; absent human intervention,
such breeding and selection would be extremely unlikely to
occur—and (2) genetic engineering is the only method available to
125

Clive James & Anatole F. Krattiger, Global Review of the Field Testing
and Commercialization of Transgenic Plants: 1986 to 1995: The First Decade
of Crop Biotechnology 23 (1996).
126
E.g., Ye et al., supra note 5, at 303 (engineering rice enriched in levels of a
Vitamin A precursor).
127
Clive James, Global Status of Commercialized Biotech/GM Crops: 2014,
at 1 (2014).
128
Id. at 2.
129
Id. at 12.
130
Note that, although domestication-induced genetic modification is not a
“natural” process by any means, there are some opponents of GMOs who
selectively consider only organisms derived through recombinant DNA
technologies to be genetically modified.
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produce GMOs—it is not; other methods exist to introduce new
alleles and increase genetic diversity.
This section discusses several methods that have been, and
continue to be, used in GMO production. Two main categories are
identified: non-recombinant DNA methods, which do not involve
genetic engineering, and genetic engineering methods. A third
category involving genome editing technologies will be discussed
in Part V.
A. Non-Recombinant DNA Methods
Improving crops by modifying plant genetic make-up has been
a long-standing goal throughout the history of human
agriculture. 131 The most basic way to introduce genetic
modifications involves traditional plant breeding, which is
inherently a human-directed, discriminatory process. In traditional
breeding, a heterogeneous population of plants undergoes
inspection to determine the presence of individuals that exhibit a
trait deemed desirable. Once those particular individuals have been
identified, their seeds are collected and sown for continuous
propagation. Over a period of many years, the iterative
dissemination of genes belonging to the parental line—coupled
with inter-crossing the most valuable individuals from different
populations of the same species—leads to a shift in the gene pool,
thereby ensuring fixation of the desirable trait.
Another traditional way to increase biodiversity involves crossbreeding of plants that are sexually compatible. This method has
proven useful for plant breeders wishing to produce a hybrid that
exhibits desirable traits from each parent. Cross-breeding sexually
compatible plants can successfully generate desirable hybrids, but
getting there requires substantial time and resource commitment.
This is mainly because of the physical and biological limitations of
natural genetic recombination. 132 Ensuring the recombination of
131

See supra Part I.B.
Genetic recombination refers to the exchange of DNA between multiple
chromosomes or different regions of the same chromosome. Suzanne Clancy,
Genetic Recombination, 1 NATURE EDUC. 40 (2008). It is sometimes commonly
described as the process of gene shuffling that increases genetic variation.
132
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only one particular gene from the parental lines during a cross,
while leaving all other genes undisturbed, is simply not possible
through natural means. One hybrid may inherit an intended trait—
e.g., bigger fruit—from one of the parents, but it also may inherit
other traits, some of which could make the plant undesirable to
breeders—e.g., a hybrid that produces bigger fruit but is
susceptible to pests. Although back-crossing to the parental line
followed by multiple rounds of artificial selection can breed out
potential undesirable traits and maintain advantageous
characteristics, the process is time-consuming and inefficient.
Simply put, cross-breeding requires screening hundreds, or even
thousands,133 of hybrid progeny to identify offspring having the
desired traits.
It bears noting that these processes are human-centric, that is,
the shift in the genetic population of the plants is driven
exclusively by human desire. What is most beneficial in a plant
from a human perspective, may not necessarily promote the plant’s
fitness from an evolutionary perspective. Bigger fruit size and
sweet flavor are likely to be important agronomic traits for
humans, but having those traits might render the plant more
susceptible to prey, pests, or even reduce its ability to propagate
the species.
Scientific advances in the last century now offer plant breeders
a wide array of alternatives to these laborious and time-consuming
approaches for increasing genetic diversity beyond natural means.
The following non-recombinant DNA methods have been routinely
performed in human agriculture for decades to expand the
biodiversity of crops.
1. Interspecific and Intergeneric Hybridization
This type of hybridization technique involves wide crosses
between different plant species (interspecific) or genera
(intergeneric). The goal is to develop novel hybrid cultivars that
feature traits—improved biotic and abiotic stress tolerance, etc.—
133

J. R. Witcombe & D. S. Virk, Number of Crosses and Population Size for
Participatory and Classical Plant Breeding, 122 EUPHYTICA 451, 460 (2001).
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that do not occur within a single species. 134 Both types of
hybridization have been established with multiple cultivars and
wild relatives in flowering plants, 135 trees, 136 tomato plants, 137
cereals,138 and other grasses.139 However, cross incompatibility in
interspecific and intergeneric hybridizations has prevented
widespread development of these hybrids. Comparable sterility,
susceptibility to shattering,140 low seed set, and poor germination
rates141 pose great limitations for this technique. Even when the
distant species are sufficiently compatible to reproduce, abnormal
endosperm development and other aberrations often lead to
abortion of hybrid embryos.142
Importantly, it should be noted that these types of hybridization
lead to reshuffling of parental genes,143 which may result in myriad
changes to chromatin structure of unknown and unpredictable
function.
2. Embryo Rescue
Embryo rescue is an in vitro technique developed in the 1920s
to address the problem of interspecific and intergeneric

134

See, e.g., Jaap M. Van Tuyl & Ki-Byung Lim, Interspecific Hybridisation
and Polyploidisation as Tools in Ornamental Plant Breeding, 612 ACTA
HORTICULTURAE 13 (2003).
135
See, e.g., Knobloch, supra note 31.
136
See, e.g., Susan M. Hawkins et al., Interspecific and Intergeneric
Hybridization in Dissotis and Tibouchina, 51 HORTSCIENCE 325 (2016).
137
See, e.g., G. Kalloo, Interspecific and Intergeneric Hybridization in
Tomato, in GENETIC IMPROVEMENT OF TOMATO, 14 MONOGRAPHS ON
THEORETICAL AND APPLIED GENETICS 73 (1991).
138
See, e.g., Arne Müntzing, Triple Hybrids Between Rye and Two Wheat
Species, 20 HEREDITAS 137 (1935).
139
See, e.g., D. C. Smith, Intergeneric Hybridization of Cereals and Other
Grasses, 64 J. AGRIC. RES. 33 (1942).
140
See id. at 33.
141
See Hawkins et al., supra note 136.
142
Yukio Kaneko and Sang Woo Bang, Interspecific and Intergeneric
Hybridization and Chromosomal Engineering of Brassicaceae Crops, 64
BREEDING SCI. 14, 16 (2014).
143
Knobloch, supra note 31, at 97.

462

N.C. J.L. & TECH.

[VOL. 18: 432

hybridization embryonic abortion.144 An immature or weak embryo
is excised from its natural growing environment before it stops
growing, and moved directly into culture media.145 The wide-cross
embryo continues to develop in vitro, and then it is inserted into
the removed endosperm of a compatible species.146 Eventually the
nursed embryo develops into a plant. This method has proven
successful at overcoming hybrid embryo inviability and halting
abortion of starving embryos. Several embryo rescue techniques
have been devised to mediate completion of gene transfer between
unrelated species of plants including embryo, ovary, ovule, and
placenta cultures.147
3. Chromosome Engineering
Chromosome engineering148 refers to the use of artificial “mini
chromosomes” for gene transfer via recombination.149 This method
comprises a chromosome-based vector system150 that allows the
transformation of large fragments of DNA encoding one or more
genes alongside regulatory elements.151 It seeks to overcome some
of the limitations associated with other gene transfer methods that
144

F. Laibach, Ectogenesis in Plants: Methods and Genetic Possibilities of
Propagating Embryos Otherwise Dying in the Seed, 20 J. HEREDITY 201 (1929).
145
Sandra M. Reed, Embryo Rescue, in PLANT DEVELOPMENT AND
BIOTECHNOLOGY 237 (2005).
146
Id.
147
See Kaneko & Woo Bang, supra note 142, at 16 (citations omitted).
148
For a detailed exposition of a wide range of aspects related to chromosome
engineering research in plants, see generally, CHROMOSOME ENGINEERING IN
PLANTS: GENETICS, BREEDING, EVOLUTION, VOLS. I & II (P. K. Gupta & T.
Tsuchiya eds., 1991).
149
See Weichang Yu et al., Plant Artificial Chromosome Technology and its
Potential Application in Genetic Engineering, 14 PLANT BIOTECHNOLOGY J.
1175 (2016).
150
It should be noted that, although plant minichromosomes have been used
for gene transfer with non-recombinant DNA methods, chromosome
engineering in plants is now also used with recombinant DNA technology to
manipulate plant genomes. See, e.g., id. at 1177 (citations omitted) (stating that
minichromosomes have been used for genetic engineering in maize, rice, barley,
and other crops).
151
Andreas Houben & Ingo Schubert, Engineering Plant Minichromosomes:
A Resurrection of B Chromosomes?, 19 PLANT CELL 2323 (2007).
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allow insertion of one or a few genes. Site-specific recombination
between a minichromosome and a normal chromosome was
recently established in plant cells. 152 Overall, chromosome
engineering aims to mediate safe, controlled, and persistent
expression of the genes intended for transfer, and to avoid
chromosomal rearrangements often linked with insertion events.153
However, this method is limited by the low efficiency rates of
plant homologous recombination.
4. Induced Mutagenesis
Induced mutagenesis refers to the practice of exposing plants
or seeds to a physical or chemical mutagen—a mutation-inducing
agent—intending to trigger random changes in the plant’s genetic
composition.154 The technique, as applicable to plants, was first
reported in the scientific literature in 1928, when it was shown that
irradiation with X-rays was capable of inducing mutations in maize
plants.155 To date, several physical—e.g., X-rays, gamma rays, UV
light—and chemical—e.g., ethyl methanesulfonate (EMS), diethyl
sulfate (dES), ethyleneimine (EI), etc.—mutagens have been
characterized as capable of inducing mutations in plants. 156
Progeny from induced mutants must be subsequently screened for
the presence of potential desirable traits.157
Notably, mutagenesis of plant cells using this technique results
in random mutation events throughout the plant cell’s genome.
This means that even if a mutagen-induced GMO plant exhibits a
desirable trait, there is a strong likelihood that mutations other than
152

See, e.g., W. Yu et al., Construction and Behavior of Engineered
Minichromosomes in Maize, 104 PROC. NAT’L ACAD. SCI. U.S. 8924 (2007).
153
Houben & Schubert, supra note 151.
154
M. C. Kharkwal, A Brief History of Plant Mutagenesis, in PLANT
MUTATION BREEDING AND BIOTECHNOLOGY 22 (Q. Y. Shu et al., eds., 2011).
155
L. J. Stadler, Genetic Effects of X-Rays in Maize, 14 PROC. NAT’L ACAD.
SCI. U.S. 69 (1928).
156
Souleymane Bado et al., Plant Mutation Breeding: Current Progress and
Future Assessment, 39 PLANT BREEDING REVS. 23, 37 (2015).
157
See, e.g., L. J. Stadler and G. F. Sprague, Genetic Effects of Ultra-Violet
Radiation in Maize. I. Unfiltered Radiation, 22 PROC. NAT’L ACAD. SCI. U.S.
572 (1936).
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those responsible for said trait are present. Such mutations could,
in theory, lead to unknown and unpredictable effects. Without
sequencing the entire mutant plant’s genome, it would be
impossible to know the exact location and frequency of mutation
events.
Despite the potential risks associated with random
mutagenesis, this type of breeding method is wildly successful as a
tool for increasing genetic diversity in plants. A partnership
between the United Nations’ Food and Agricultural Organization
and the International Atomic Energy Agency has implemented, for
nearly half a century, plant breeding and genetics programs that led
to the official release of over 3,200 mutant varieties from 214
different plant species in more than sixty countries.158
5. Somaclonal Variation
Somaclonal variation refers to the genetic differences observed
among progeny of plants regenerated from somatic cells159 cultured
in vitro.160 Until the early 1980s, it was generally accepted that
plants regenerated from tissue culture should be genetically
identical to the somatic cell source from which they were
derived.161 However, trait differences were commonly observed in
these types of regenerated plants.162
The discrepancy was eventually explained by proposing that
somaclonal variation was not merely a tissue culture technique, but
also a new source of genetic variability.163 A number of processes
158

JOINT FAO/IAEA PROGRAMME, Plant Breeding and Genetics, http://wwwnaweb.iaea.org/nafa/Pbg/, (last visited Dec. 1, 2016).
159
Somatic cells are all of the body’s cells except the reproductive cells.
BIOLOGY
ONLINE,
Somatic
Cells,
http://www.biologyonline.org/dictionary/Somatic_cells, (last visited Dec. 1, 2016).
160
Robert A. Morrison et al., Somaclonal Variation: Its Genetic Basis and
Prospects for Crop Improvement, in OPPORTUNITIES FOR PHYTOCHEMISTRY IN
PLANT BIOTECHNOLOGY, 22 RECENT ADVANCES IN PHYTOCHEMISTRY 1 (1988).
161
P. J. Larkin & W. R. Scowcroft, Somaclonal Variation – A Novel Source of
Variability from Cell Cultures for Plant Improvement, 60 THEORETICAL &
APPLIED GENETICS 197, 198 (1981).
162
Id.
163
Id. at 197.
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have been associated with the molecular basis for this phenomenon
including changes in chromosome number, point mutations,
chromosomal rearrangements, epigenetics, 164 and others. 165
Although somaclonal variation is considered a nuisance from a
micropropagation perspective, it nevertheless has become a
convenient alternative for breeders seeking to introduce genetic
variability without the need for expensive equipment.166
B. Genetic Engineering Methods
1. Agrobacterium tumefaciens-Based Plant Transformation
Gene transfer via Rhizobium radiobacter, formally known as
Agrobacterium tumefaciens,167 is the most common method used in

164

Epigenetics refers to the field of scientific research that studies the role of
histone post-translational modifications, DNA modifications, and non-coding
RNA molecules in the regulation of gene expression and chromatin structure
that occur without altering DNA sequences. Paul Enríquez, CRISPR-Mediated
Epigenome Editing, 89 YALE J. BIOLOGY & MED. 471, 471 (2016).
165
See Hare Krishna et al., Somaclonal Variations and Their Applications in
Horticultural Crops Improvement, 6 3 BIOTECH 54 (2016).
166
Id.
167
Rhizobium radiobacter or Agrobacterium radiobacter have, in recent
years, been proposed as more appropriate names to replace Agrobacterium
tumefaciens, which was used throughout most of the 20th century. See, e.g., H.
Sawada et al., Proposal for Rejection of Agrobacterium tumefaciens and Revised
Descriptions for the Genus Agrobacterium and for Agrobacterium radiobacter
and Agrobacterium rhizogenes, 43 INT’L J. SYSTEMATIC BACTERIOLOGY 694
(1993); J. M. Young et al., A Revision of Rhizobium Frank 1889, with an
Emended Description of the Genus, and the Inclusion of all Species of
Agrobacterium Conn 1942 and Allorhizobium undicola de Lajudie et al. 1998 as
New Combinations: Rhizobium radiobacter, R. rhizogenes, R. rubi, R. undicola
and R. vitis, 51 INT’L J. SYSTEMATIC & EVOLUTIONARY MICROBIOLOGY 89
(2001); J. M. Young et al., Proposal that Agrobacterium radiobacter Has
Priority over Agrobacterium tumefaciens. Request for an Opinion, 56 INT’L J.
SYSTEMATIC & EVOLUTIONARY MICROBIOLOGY 491 (2006). Although the new
name has been proposed, I use both names interchangeably in this Article,
mainly because of the systemically widespread use of the term Agrobacterium
tumefaciens in the scientific literature.

466

N.C. J.L. & TECH.

[VOL. 18: 432

plant transformation for genetic engineering. 168 This naturally
occurring, Gram-negative, rod-shaped bacterium was discovered
over one hundred years ago,169 when it was first identified as the
causal agent for particular types of plant tumors or galls.170
Nearly seven decades would pass before researchers realized
that a large plasmid171 carried within the bacterium was responsible
for the tumors observed in crown gall disease.172 An explosion of
interest related to the molecular basis of tumor induction by A.
tumefaciens ensued in the late 1970s and early 1980s. 173 The
combined research efforts led to a surprising breakthrough in 1983,
when various research teams almost simultaneously reported the
ability to genetically engineer plants by co-opting the A.
tumefaciens tumor-inducing system.174
The mechanism by which A. tumefaciens modifies a plant’s
genetic make-up is now well characterized. When plant tissue
sustains injury—e.g., a wound—the plant releases a series of
compounds 175 that trigger recruitment of A. tumefaciens to the
168

See, e.g., Sang-Min Chung et al., Agrobacterium is Not Alone: Gene
Transfer to Plants by Viruses and Other Bacteria, 11 TRENDS PLANT SCI. 1
(2006).
169
The original name proposed for this organism was Bacterium tumefaciens.
Erwin F. Smith & C. O. Townsend, A Plant-Tumor of Bacterial Origin, 25
SCIENCE 671, 672 (1907).
170
Id. at 672.
171
A plasmid is “a small, circular, double-stranded DNA molecule that is
distinct from a cell’s chromosomal DNA.” See, Plasmid / plasmids, SCITABLE,
http://www.nature.com/scitable/definition/plasmid-plasmids-28 (last visited
Dec. 1, 2016).
172
I. Zaenen et al., Supercoiled Circular DNA in Crown Gall Inducing
Agrobacterium Strains, 86 J. MOLECULAR BIOLOGY 109 (1974).
173
E.g., Mary-Dell Chilton et al., Stable Incorporation of Plasmid DNA into
Higher Plant Cells: The Molecular Basis of Crown Gall Tumorigenesis, 11
CELL 263 (1977); P. Zambryski et al., Tumor DNA Structure in Plant Cells
Transformed by A. tumefaciens, 209 SCIENCE 1385 (1980).
174
See studies cited in supra note 119 and accompanying text.
175
One such compound is the phenolic molecule acetosyringone, which
induces expression of virulence genes in A. tumefaciens. See Charles H. Shaw,
virA and virG Are the Ti-Plasmid Functions Required for Chemotaxis of
Agrobacterium tumefaciens Towards Acetosyringone, 2 MOLECULAR
MICROBIOLOGY 413 (1988) (investigating acetosyringone chemotaxis).
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injury site via chemotaxis.176 In turn, chemical interaction between
the bacterium and plant cell induces expression of virulence genes
within A. tumefaciens’ tumor-inducing (“Ti”) plasmid.177 The Ti
plasmid encodes the genetic information for a fragment of DNA
known as transfer DNA (“T-DNA”), which is the segment that
ultimately integrates into the genome of the plant host cell and
induces proliferation of crown gall disease.178 T-DNA is flanked by
short “border” sequences at opposite ends of the fragment179 that
serve as cleavage sites, which are in turn recognized by proteins
expressed from the virulence genes. Once the T-DNA is excised
from the Ti-plasmid, other virulence proteins mediate transfer—
and random integration—of the T-DNA into the nuclear genome of
the host plant cell.180
Initially, A. tumefaciens-mediated transformation was thought
to be limited to dicot181 plant species only. However, it is now well
established that transformation can be achieved in a wide range of
plant hosts including monocots 182 —rice, 183 banana, 184 wheat, 185
176

Chemotaxis refers to the process by which the organism moves in the
direction corresponding to a gradient of concentration of a specific substance or
set of substances. See Charles H. Shaw, Swimming Against The Tide:
Chemotaxis in Agrobacterium, 13 BIOESSAYS 25 (1991) (discussing chemotaxis
related to A. tumefaciens).
177
Id.
178
Chilton et al., supra note 173.
179
Narendra S. Yadav et al., Short Direct Repeats Flank the T-DNA on a
Nopaline Ti Plasmid, 79 PROC. NAT’L ACAD. SCI. U.S. 6322 (1982).
180
For a more detailed exposition of the molecular mechanisms by which A.
tumefaciens mediates plant transformation, see Stanton B. Gelvin,
Agrobacterium-Mediated Plant Transformation: The Biology Behind the “GeneJockeying” Tool, 67 MICROBIOLOGY & MOLECULAR BIOLOGY REVS. 16 (2003).
181
The term dicot refers to plants that have a pair of leaves, or cotyledons, in
the embryo of the seed. Dicotyledon, ENCYCLOPEDIA BRITANNICA,
https://www.britannica.com/plant/dicotyledon (last visited Dec. 1, 2016).
182
Monocots can be distinguished from dicots by the presence of only one
seed leaf, or cotyledon, in the embryo of the seed. Monocotyledon,
ENCYCLOPEDIA BRITANNICA, https://www.britannica.com/plant/monocotyledon
(last visited Dec. 1, 2016).
183
Y. Hiei et al., Efficient Transformation of Rice (Oryza sativa L.) Mediated
by Agrobacterium and Sequence Analysis of the Boundaries of the T-DNA, 6
PLANT J. 271 (1994).
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etc.—and gymnosperms,186 as well as other unrelated organisms
such as fungi187 and even human cells.188 Moreover, although A.
tumefaciens has become the most popular method of plant
transformation for genetic engineering, other Rhizobium species
have now been shown capable of shuttling DNA of interest into
plant hosts.189 Alternative methods of plant transformation based
on other Rhizobium species could become important open source
biological tools that allow researchers to circumvent intellectual
property restrictions imposed by current Agrobacterium-related
patents.190
The key insight that paved the way for transgenic plants was
the realization that the tumor-inducing T-DNA fragment flanked
by border sequences could be entirely replaced with any DNA
piece of interest; one that would in theory produce a desirable trait.
By co-opting this bacterial tumor-inducing system in plants,
scientists figured out a way to mediate the transfer of any DNA
fragment—regardless of whether the DNA belonged to the same
plant species or not—from bacterial plasmid into a plant host using
bacteria as a shuttle.
There are a few major unresolved issues related to A.
tumefaciens transformation. One concern is that scientists cannot
control the site of T-DNA integration and, therefore, a transgene
184

Gregory D. May et al., Generation of Transgenic Banana (Musa
acuminata) Plants via Agrobacterium-Mediated Transformation, 13 NATURE
BIOTECHNOLOGY 486 (1995).
185
M Cheng et al., Genetic Transformation of Wheat Mediated by
Agrobacterium tumefaciens, 115 PLANT PHYSIOLOGY 971 (1997).
186
Anne-Marie Stomp, Extended Host Range of Agrobacterium tumefaciens
in the Genus Pinus, 92 PLANT PHYSIOLOGY 1226 (1990).
187
P. Bundock et al., Trans-Kingdom T-DNA Transfer from Agrobacterium
tumefaciens to Saccharomyces cerevisiae, 14 EMBO J. 3206 (1995).
188
T. Kunik et al., Genetic Transformation of HeLa Cells by Agrobacterium,
98 PROC. NAT’L ACAD. SCI. U.S. 1871 (2001).
189
See, e.g., Urmi Patel & Sarika Sinha, Rhizobia Species: A Boon for “Plant
Genetic Engineering”, 51 INDIAN J. MICROBIOLOGY 521, 521 (2011).
190
For a review of some Agrobacterium-related patents, see Benoît Lacroix et
al., Recent Patents on Agrobacterium-Mediated Gene and Protein Transfer, for
Research and Biotechnology, 2 RECENT PATS. ON DNA & GENE SEQUENCES 69
(2008).
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may theoretically be inserted into a site that could interfere with
the function of other plant genes. Additionally, duplications,
translocations, 191 and transfer of genetic material other than TDNA—such as bacterial chromosomal and Ti plasmid fragments—
have been shown to occur,192 which has prompted concerns for
greater scrutiny of transgenic plants. These, in a nutshell, are the
two major limitations of transgenic plants created via genetic
engineering.
2. Particle Bombardment Transformation
Another common technique to generate GM crops is the
particle bombardment method, also known as biolistics,
microprojectile bombardment, or gene gun.193 This technique was
developed to circumvent gene transfer limitations that existed at
the early stages of A. tumefaciens transformation research. The
method comprises an acceleration device that can deliver micronsized tungsten or gold particles coated with desired DNA
molecules for plant cell transformation.194 The technique literally
involves firing metal-complexed DNA microprojectiles into a cell.
The particles penetrate thousands of cell walls and membranes
simultaneously without inducing cell lethality.195 Once delivered
inside the cell, the DNA comes off the metal particles and may
subsequently be integrated into the host genome.196

191

See, e.g., Frans E. Tax & Daniel M. Vernon, T-DNA-Associated
Duplication/Translocations in Arabidopsis. Implications for Mutant Analysis
and Functional Genomics, 126 PLANT PHYSIOLOGY 1527 (2001).
192
See, e.g., B. Ulker et al., T-DNA-Mediated Transfer of Agrobacterium
tumefaciens Chromosomal DNA into Plants, 26 NATURE BIOTECHNOLOGY 1015
(2008) (documenting transfer of unexpectedly large fragments of A. tumefaciens
genic chromosomal DNA during plant transformation).
193
John C. Sanford et al., Delivery of Substances into Cells and Tissues Using
a Particle Bombardment Process, 5 PARTICULATE SCI. & TECH. 27 (1987).
194
Julie R. Kikkert et al., Stable Transformation of Plant Cells by Particle
Bombardment/Biolistics, in TRANSGENIC PLANTS: METHODS AND PROTOCOLS,
286 METHODS MOLECULAR BIOLOGY 61 (2004).
195
Sanford et al., supra note 193, at 27.
196
Kikkert et al., supra note 194, at 62.
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Particle bombardment transformation has been used to
transform many economically important crops197 that were initially
recalcitrant to A. tumefaciens-mediated gene transfer. However,
now that A. tumefaciens transformation has been firmly established
in a long list of plant species, particle bombardment may be used
with less frequency. This is particularly because particle
bombardment-mediated plant transformation requires specialized
equipment and often leads to insertion of many copies of a
transgene at multiple sites of the host genome, 198 which can
potentially lead to altered patterns of gene expression or even gene
silencing.199
3. Polyethylene Glycol- and Electroporation-Based Protoplast
Transformation
Direct gene transfer using polyethylene glycol (PEG) or
electroporation for protoplast 200 transformation have also been
established as viable techniques for plant genetic engineering. The
mechanism for PEG-mediated DNA uptake is not very well
understood, but the technique is very simple and relatively
inexpensive to implement. 201 Electroporation involves polarity
changes on the cell membrane that trigger pore formation upon

197

See, e.g., Isabel Dupuis & Gary M. Pace, Gene Transfer to Maize Male
Reproductive Structure by Particle Bombardment of Tassel Primordial, 12
PLANT CELL REP. 607 (1993) (using particle bombardment to transform maize).
198
See, e.g., H. Shou et al., Assessment of Transgenic Maize Events Produced
by Particle Bombardment or Agrobacterium-Mediated Transformation, 13
MOLECULAR BREEDING 201 (2004); W. P. Pawlowski et al., Transgenic DNA
Integrated into the Oat Genome Is Frequently Interspersed by Host DNA, 95
PROC. NAT’L ACAD. SCI. U.S. 12106 (1998).
199
See, e.g., Ana Leonor Rivera et al., Physical Methods for Genetic Plant
Transformation, 9 PHYSICS LIFE REVS. 308 (2012).
200
A plant protoplast refers to a plant cell from which the cell wall has been
removed.
201
See Zhaohui Liu & Timothy L. Friesen, Polyethylene Glycol (PEG)Mediated Transformation in Filamentous Fungal Pathogens, in PLANT FUNGAL
PATHOGENS: METHODS AND PROTOCOLS, 835 METHODS IN MOLECULAR
BIOLOGY 366 (Melvin D. Bolton & Bart P.H.J. Thomma eds., 2012) (describing
protocol for PEG-mediated genetic transformation).
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exposure to an electrical field.202 Both methods induce changes in
the cell membrane’s permeability, thereby allowing the entry of the
foreign DNA of interest. Although relatively simple to perform,
they are not very popular due to reported marginally low
transformation efficiency rates 203 and the need for protocol
optimization to increase transformation efficiency.
4. Microinjection
Microinjection-based plant transformation is a direct physical
approach that relies on glass micro-capillary injection pipettes to
directly deliver DNA of interest into the plant cell.204 The technique
requires specialized equipment and is labor-intensive and relatively
inefficient compared to other methods.205
5. Other Methods
Aside from the techniques detailed above, other less common
methods have been used to mediate plant cell transformation of
recombinant DNA molecules including, but not limited to,
liposome encapsulation,206 laser microbeams, vacuum infiltration,

202

See, e.g., George W. Bates, Fusion of Plant Protoplasts by Electric Fields,
72 PLANT PHYSIOLOGY 1110 (1983); Ariel Arencibia et al., Production of
Transgenic Sugarcane (Saccharum officinarum L.) Plants by Intact Cell
Electroporation, 14 PLANT CELL REP. 305 (1995).
203
See, e.g., Carl Rathus & Robert G. Birch, Stable Transformation of Callus
from Electroporated Sugarcane Protoplasts, 82 PLANT SCI. 81 (1992); A.P.
Sorokin et al., Production of Fertile Wheat Plants via Tissue Electroporation,
156 PLANT SCI. 227 (2000); Hiromufi Uchimiya et al., Expression of a Foreign
Gene in Callus Derived from DNA-Treated Protoplasts of Rice (Oryza sativa
L.), 204 MOLECULAR & GENERAL GENETICS 204 (1986).
204
A. de la Peña et al., Transgenic Rye Plants Obtained by Injecting DNA into
Young Floral Tillers, 325 NATURE 274 (1987).
205
Gunther Neuhaus and German Spangenberg, Plant Transformation by
Microinjection Techniques, 79 PHYSIOLOGIA PLANTARUM 213 (1990).
206
Alain Deshayes et al., Liposome-Mediated Transformation of Tobacco
Mesophyll Protoplasts by an Escherichia coli Plasmid, 4 EMBO J. 2731 (1985).
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ultrasound, electrophoresis, and agrolistic transformation.207 More
recently, an additional category of tools for targeted genome
editing have been developed that could fundamentally change the
way we think about GMOs. These will be discussed in more detail
in Part V.
III. HEALTH AND ENVIRONMENTAL GMO SAFETY CONCERNS
In the last two decades, frequent and arduous contention vis-àvis the development and commercialization of GMOs for human
consumption has pitted numerous groups among the general
public, industry, governmental organizations, and the scientific and
legal communities against one another. Ill-tempered disputes have
fomented rapid deterioration of the quality of discourse and public
attitudes pertinent to the use of biotechnology in this realm.
Accordingly, it is no surprise that GMOs have become one of the
most controversial topics in modern times.
When it comes to bioengineered foods, the controversy can be
divided into two main categories. The first concerns the view that
GM food poses grave risk to human health. The second links GM
crops to detrimental environmental effects.208
In this section, the Article explores those concerns and
discusses their merits primarily from a scientific standpoint. The
motivation for doing so stems from the view that law and policy
makers must proactively strive to grasp core scientific elements
associated with that which they must regulate. In previous work, I
have advocated for adoption of a Jurisprudence of Scientific
Empiricism as a structural framework to address questions of
science in law and combat the deleterious effects of scientific

207

For a detailed review of some of these less common plant transformation
techniques, see Ana Leonor Rivera et al., Physical Methods for Genetic Plant
Transformation, 9 PHYSICS LIFE REVS. 308 (2012).
208
Other concerns exist, but human health and the environment dominate the
public’s familiarity with GM food. See, e.g., Gary Null, 44 Reasons to Ban or
Label GMOs, PROGRESSIVE RADIO NETWORK (Nov. 6, 2015), http://prn.fm/44reasons-to-ban-or-label-gmos/.
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illiteracy.209 The objective here is to provide a succinct resource
concerning the current scientific status of GM crops for the legal
community.
A. Human and Animal Health
To date, the totality of institutional, governmental, and
international organizations, as well as the scientific literature
analyzing the safety of GM foods, has concluded that consuming
GM-derived foodstuff poses no more a threat to human health than
foodstuff derived from conventional breeding methods.210
1. Institutional Authorities and International Organizations
The National Academies of Science, Engineering, and
Medicine recently tasked its Committee on Genetically Engineered
Crops: Past Experience and Future Prospects to assess purported
negative effects and benefits of GM crops and publish its findings
in a detailed report.211
The Committee answered the NASEM’s call and, over a period
of eight months, heard over eighty presentations from speakers all
over the world, read more than 700 comments and documents
submitted from diverse members of the public and organizations,
and carefully examined peer- and non-peer-reviewed literature
relevant to the risks and benefits of GM crops in the U.S. and
abroad.212 The Committee found that, on the basis of comparisons
between GM and non-GM food in compositional analysis, animal
toxicity tests, long-term research data on the health of livestock fed
GM food diets, and human epidemiological data, there is no

209

See Enríquez, supra note 1, at 611–14.
See infra Sections III.A.1–2 and accompanying footnotes.
211
COMMITTEE ON GENETICALLY ENGINEERED CROPS: PAST EXPERIENCE AND
FUTURE PROSPECTS; BOARD ON AGRICULTURE AND NATURAL RESOURCES;
DIVISION ON EARTH AND LIFE STUDIES; NATIONAL ACADEMIES OF SCIENCES,
ENGINEERING, AND MEDICINE, GENETICALLY ENGINEERED CROPS: EXPERIENCES
AND PROSPECTS 7 (2016) [hereinafter NASEM REPORT].
212
Id. at 39–42.
210
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evidence to suggest that consuming GM food is any riskier than
consuming non-GM food.213
The NASEM’s assessment mirrors findings of other
independent authoritative agencies, international organizations,
and scientific panels. The American Association for the
Advancement of Science stated that it is “quite clear” that
scientific evidence corroborates the safety of GM crops developed
through biotechnology. 214 The European Commission too has
published an extensive report presenting findings from hundreds of
research groups funded by European research grants totaling over
300 million euros.215 The Commission declared that “[t]he main
conclusion to be drawn from the efforts of more than 130 research
projects, covering a period of more than 25 years of research, and
involving more than 500 independent research groups, is that
biotechnology, and in particular GMOs, are not per se more risky”
than non-GM crops.216 Notably, the Commission’s endorsement of
GM crop safety came despite the fact that a number of European
countries currently ban production of GM crops in their
territories.217
213

Id. at 225.
AM. ASS’N FOR THE ADVANCEMENT OF SCI., STATEMENT BY THE AAAS
BOARD OF DIRECTORS ON LABELING OF GENETICALLY MODIFIED FOODS (Oct.
20, 2012), http://www.aaas.org/sites/default/files/AAAS_GM_statement.pdf.
215
EUROPEAN COMM’N, A DECADE OF EU-FUNDED GMO RESEARCH (20012010) 15 (2010), http://ec.europa.eu/research/biosociety/pdf/a_decade_of_eufunded_gmo_research.pdf.
216
Id. at 16.
217
See, e.g., U.S.D.A., FAS REPORT, RUSSIAN BANS CULTIVATION AND
BREEDING
OF
GE
CROPS
AND
ANIMALS
(2016),
https://gain.fas.usda.gov/Recent%20GAIN%20Publications/Russia%20Bans%2
0Cultivation%20and%20Breeding%20of%20GE%20Crops%20and%20Animal
_Moscow_Russian%20Federation_7-12-2016.pdf (providing an account of the
enactment of Russia’s Federal Law 358-FZ, which was signed into law by
Vladimir Putin on July 3, 2016, and prohibits cultivation and breeding of GMOs
on the Russian Federation territory for all purposes, except scientific research);
GM Crop Ban, supra note 45 (announcing Scotland’s recent ban of GMOs in
order to “protect and further enhance [its] clean, green status.”); France Joins
Green Wave of GM Crop Bans in Europe, SUSTAINABLE PULSE (Sept. 17, 2015,
6:40 PM), http://sustainablepulse.com/2015/09/17/france-joins-green-wave-ofgm-crop-bans-in-europe/#.WL1bRXe-Jn4 (reporting on France’s recent decision
214
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The American Medical Association (“AMA”) conducted a
broad appraisal of peer-reviewed, published scientific literature
and found that although bioengineered foods have been consumed
for nearly two decades, no overt consequences on human health
have been substantiated in the peer-reviewed literature. 218 The
AMA further urged government, industry, consumer advocacy
groups, and the scientific community to educate the general public
and increase access to unbiased information on GM food.219 At the
same time, the AMA indicated that, with respect to GM foods, “a
small potential for adverse events exists, due mainly to horizontal
gene transfer, allergenicity, and toxicity.”220
In similar fashion, the United Nations’ Food and Agriculture
Organization (“FAO”) has proclaimed that foods derived from
transgenic crops “have been judged safe to eat and the methods
used to test their safety have been deemed appropriate.”221 Despite
human consumption of GM food by millions of people, “no
verifiable untoward toxic or nutritionally deleterious effects . . .
have been discovered anywhere in the world.”222 The Union of the
German Academies of Science and Humanities also published a
to ban GMOs); Germany and Poland Join Green Wave of EU GM Crop Bans,
SUSTAINABLE
PULSE
(Sept.
30,
2015,
10:27
PM),
http://sustainablepulse.com/2015/09/30/germany-and-poland-join-green-waveof-eu-gm-crop-bans/#.WL1b_Xe-Jn4 (covering news on GMO bans in
Germany, Poland, Slovenia, and Serbia). But see, e.g., Jonathan Stearns,
European Parliament Opposes National Bans on GMO-Food Imports,
BLOOMBERG
(Oct.
28,
2015,
8:46
AM)
https://www.bloomberg.com/news/articles/2015-10-28/european-parliamentopposes-national-bans-on-gmo-food-imports (reporting on the European Union
Parliament’s disagreement with EU member states vis-à-vis the enactment of
national bans concerning GMO products).
218
A M A, Report 2 of the Council on Science and Public Health (A-12):
Labeling
of
Bioengineered
Foods
(2012),
https://web.archive.org/web/20120907023039/http://www.amaassn.org/resources/doc/csaph/a12-csaph2-bioengineeredfoods.pdf.
219
Id. at 9.
220
Id. at 1.
221
FOOD AND AGRIC. ORG. OF THE UNITED NATIONS, THE STATE OF FOOD
AND AGRICULTURE: AGRICULTURAL BIOTECHNOLOGY MEETING THE NEEDS OF
THE POOR? 58 (2004), ftp://ftp.fao.org/docrep/fao/006/y5160e/y5160e.pdf.
222
Id.
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report stating that scientific evidence suggests it is “most unlikely
that the consumption of the well-characterised [sic] transgenic
DNA from approved GMO food harbours [sic] any recognisable
[sic] health risk.”223 The Royal Society of the United Kingdom, the
International Council for Science, various National Academies of
Science in Brazil, Australia, China, France, India, and the United
Kingdom, the World Health Organization, and other institutions
have all concurred in that judgment.224
2. Scientific Literature
The vast majority of the relevant published scientific literature
on the topic of GMO safety spanning the last two decades has
reached the consensus that GM crops and human health hazards
are not linked or correlated.225 Published animal feeding studies
have provided evidence that GM crops are as safe and nutritional
as conventional breeding crops. 226 Long-term and multigenerational studies on the effects of diets containing GM maize,
potato, soybean, rice, or triticale on animal health have found no
health hazards,227 and concluded that GM crops are nutritionally
223

UNION OF THE GERMAN ACADS. OF SCI. AND HUMANITIES, ARE THERE
HEALTH HAZARDS FOR THE CONSUMER FROM EATING GENETICALLY MODIFIED
FOOD? (2006), http://www.interacademies.net/File.aspx?id=6749.
224
See id.; AM. ASS’N FOR THE ADVANCEMENT OF SCI., supra note 214.
225
See, e.g., Alessandro Nicolia et al., An Overview of the Last 10 Years of
Genetically Engineered Crop Safety Research, 34 CRITICAL REVS.
BIOTECHNOLOGY 1 (2013); Rod A. Herman & William D. Price, Unintended
Compositional Changes in Genetically Modified (GM) Crops: 20 Years of
Research, 61 J. AGRIC. & FOOD CHEMISTRY 11695 (2013); José L. Domingo,
Safety Assessment of GM plants: An Updated Review of the Scientific Literature,
95 FOOD & CHEMICAL TOXICOLOGY 12 (2016).
226
See, e.g., P. Liu et al., A 90-day Subchronic Feeding Study of Genetically
Modified Maize Expressing Cry1Ac-M Protein in Sprague–Dawley Rats, 50
FOOD & CHEMICAL TOXICOLOGY 3215 (2012); X. He et al., A 90-day
Toxicology Study of Transgenic Lysine-Rich Maize Grain (Y642) in SpragueDawley Rats, 47 FOOD & CHEMICAL TOXICOLOGY 425 (2009).
227
Although some small differences have been documented between animals
fed GM and non-GM foods, studies have indicated that the differences fall
within the normal variation parameters and, thus, had no biological or
toxicological significance. See, e.g., Chelsea Snell et al., Assessment of the
Health Impact of GM Plant Diets in Long-Term and Multigenerational Animal
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equivalent to non-GM crops.228 Life-long studies have found no
long-term structural alterations of the lining of the small or large
intestines in animals fed GM food, and reported that ageing affects
animals in similar ways—regardless of whether they are fed GM
food or not.229
GM crops have been reported to exert no significant influence
on health, performance, quality of meat or eggs, milk production,
or DNA-transfer of animals—e.g., livestock 230 and poultry 231 —
grown for human consumption. A study performed on publicly
available field data sets over a period of almost thirty years
(thirteen years before, and fifteen years after the introduction of
GM crops), representing more than 100 billion animals, “did not
reveal unfavorable or perturbed trends in livestock health and
productivity.” 232 Although nucleic acids—such as DNA—and
proteins are common macromolecular components of all diets, no
study has revealed detectable or reliably quantifiable233 traces of
GM foreign DNA in dairy products and meat, or any differences in
the nutritional profile of products derived from GM crop-fed
animals.234
Feeding Trials: A Literature Review, 50 FOOD & CHEMICAL TOXICOLOGY 1134
(2012).
228
See id.
229
See, e.g., S. Battistelli et al., Histochemical and Morpho-Metrical Study of
Mouse Intestine Epithelium After a Long Term Diet Containing Genetically
Modified Soybean, 54 EUROPEAN J. HISTOCHEMISTRY e36 (2010).
230
See, e.g., Patrick Guertler et al., Long-Term Feeding of Genetically
Modified Corn (MON810)—Fate of cry1Ab DNA and Recombinant Protein
During the Metabolism of the Dairy Cow, 131 LIVESTOCK SCI. 250 (2010); K.
Steinke et al., Effects of Long-Term Feeding of Genetically Modified Corn
(event MON810) on the Performance of Lactating Dairy Cows, 94 ANIMAL
PHYSIOLOGY & ANIMAL NUTRITION e185 (2010).
231
See, e.g., Gerhard Flachowsky et al., Long Term Feeding of Bt-Corn—A
Ten-Generation Study With Quails, 59 ARCHIVES ANIMAL NUTRITION 449
(2005).
232
A. L. Van Eenennaam & A.E. Young, Prevalence and Impacts of
Genetically Engineered Feedstuffs on Livestock Populations, 92 J. ANIMAL SCI.
4255 (2014).
233
At least using today’s standard methods of detection.
234
Van Eenennaam & Young, supra note 232. To the contrary, the data
available show that U.S. livestock health and feed-conversion efficiency rates
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With respect to cancer, the scientific literature predominantly
agrees that GM food consumption does not induce, or substantially
contributes to the incidence of, cancer.235 For example, a study that
examined breast and cervical cancer incidence and mortality rates
in 187 countries between 1980 and 2010236 found similar patterns
in the prevalence of these cancers in North America, where GM
foods are commercialized, and Europe, where GM foods are
typically not consumed. These observations are important because
they dispel the notion that GMOs are directly associated with
cancer.
If consumption of GM foods were directly linked to higher
occurrence of cancer, a putative increase in cancer rates between
the two populations (a control—Europe, and an experimental—
North America) would be expected. Yet, the data do not support
this hypothesis. Likewise, data available from the National Cancer
Institute for trends in cancer incidence among men and women in
the U.S. compared to data from the United Kingdom’s Cancer
Research UK organization shows no obvious difference in the
patterns of several types of cancers that could be attributed to the
increase in consumption of GM foods.237 This lack of correlation
was also noted by the NASEM’s 2016 report on GM crops.238

actually improved over time despite widespread adoption of GM crops in U.S.
agriculture and livestock diets. Id. at 4259, 4262. However, the increase in
productivity and animal health could not be directly attributed to the use of GM
crops for dietary intake because improved rates continued in an upward trend
observed before and after introduction of GM crops.
235
See, e.g., Pamela J. Mink et al., Epidemiologic Studies of Glyphosate and
Cancer: A Review, 63 REG. TOXICOLOGY & PHARMACOLOGY 440 (2012). It
should be noted that, although the studies analyzed in this publication came
from a variety of independent, government, and industry-funded research
groups, the researchers who published this review received financial support
from Monsanto, Inc. The authors themselves disclosed funding for this research.
Id. at 451. But cf. infra Section III.A.3.
236
Mohammad H. Forouzanfar et al., Breast and Cervical Cancer in 187
Countries Between 1980 and 2010: A Systematic Analysis, 378 LANCET 1461
(2011).
237
NASEM REPORT, supra note 211, at 208–11 (citations omitted).
238
Id.
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Data on the onset of type II diabetes rates over the past four
decades,239 as well as obesity rates between 1984 and 2013,240 also
seem to reject the hypothesis that GM food consumption is
contributing to the obesity and diabetes epidemics in the U.S.
Incidence for both diseases appears to have steadily increased
before GM crops were introduced and continued to increase at a
steady pace throughout the 1990s and 2000s. Yet, type II diabetes
and obesity rates appear to have reached a plateau in the last
decade.241
The NASEM’s 2016 report on GM crops also considered
public comments for a number of other chronic conditions,
including chronic kidney disease, Celiac disease, food allergies,
autism spectrum disorders, and more. The report determined, after
examining the relevant scientific literature and government
statistics on the prevalence of these conditions, that no palpable
link exists between them and consumption of GM crops.242
On the topic of exposure to plant chemicals—e.g., pesticides—
produced by GM crops and the potential adverse effects to human
health, the scientific literature reveals that both natural and
synthetic compounds found in all plants could be harmful to
humans depending on the amount of exposure. For instance, an
investigation of naturally occurring pesticides in a laundry list of
common human foods—fruits, legumes, vegetables, herbs, and
even coffee, chocolate, and honey—found that all contained
natural pesticides that induced carcinogenicity in rodents. 243
Although a big focus of GM food products lies in testing for
toxicity of newly introduced proteins or compounds in rodents, it
appears that the administration of chemicals at the maximum
tolerated dose (“MTD”) in standard animal cancer tests may not
239

Tobin M. Abraham et al., Trends in Diabetes Incidence: The Framingham
Heart Study, 38 DIABETES CARE 482 (2015).
240
Ruopeng An, Educational Disparity in Obesity Among U.S. Adults, 1984–
2013, 25 ANNALS EPIDEMIOLOGY 637 (2015).
241
See supra notes 239–40 and accompanying text.
242
NASEM REPORT, supra note 211, at 213–14, 217–21 (citations omitted).
243
Lois Swirsky Gold et al., Pesticide Residues in Food and Cancer Risk: A
Critical Analysis, in HANDBOOK OF PESTICIDE TOXICOLOGY 801 (R. Krieger ed.,
2d ed. 2001).
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the most robust method to assess toxicity.244 More than 99.9% of
the chemicals ingested by humans are naturally occurring, and of
the small proportion of natural pesticides tested for
carcinogenicity, more than half have been found to be rodent
carcinogens.245
During conventional cross-breeding, gene recombination gives
rise to a great number of novel gene arrangements and interactions,
which have not been associated with hazardous effects on human
health and nutrition, despite the lack of review by regulatory
agencies.246 Of the hundreds of thousands of GM plant varieties
that have been created through non-genetic engineering methods,
the emergence of any novel toxin or allergen has never been
documented either.247 Thus, because changes in GM crops derived
through genetic engineering are more precise than those created
via non-genetic engineering methods, the number of potential
novel gene recombination events and interactions is incredibly
miniscule.248
Some studies have also investigated potential effects of
exposure to glyphosate, the main broad-spectrum herbicide (Figure
3)249 used to treat many GM—as well as non-GM250—crops, and
found no evidence of a pattern of positive associations linking a

244

Bruce N. Ames & Lois Swirsky Gold, Chemical Carcinogenesis: Too
Many Rodent Carcinogens, 87 PROC. NAT’L ACAD. SCI. U.S. 7772 (1990).
245
Gold et al., supra note 243, at 801.
246
Henry-York Steiner et al., Evaluating the Potential for Adverse
Interactions Within Genetically Engineered Breeding Stacks, 161 PLANT
PHYSIOLOGY 1587, 1589 (2013).
247
Id. at 1588. However, the emergence of predictable toxins has been
documented at least three times in potato, lima bean, and canola, all of which
involved toxins that were already known to be endogenous to the crop and were
detected through screenings mandated by regulatory agencies. Id.
248
Id.
249
See infra note 454.
250
Glyphosate has also been used as a ripening agent or pseudo-desiccant on
crops. See, e.g., Clarification of Pre-harvest Uses of Glyphosate, The
Advantages, Best Practices, and Residue Monitoring, GLYPHOSATE,
http://www.glyphosate.eu/system/files/sidebox-files/clarification_of_preharvest_uses_of_glyphsate_en_0.pdf.
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number of non-cancer outcomes with glyphosate exposure. 251
Lastly, a public database of peer-reviewed research on the relative
risks of GM crops run by an independent, tax-exempt, non-profit
organization focusing on plant genetics and genetic engineering in
agriculture has been created. 252 The database, called GENERA,
features over 400 publications on GMO research including feeding
studies, toxicology, efficacy, and other topics and lists funding
information for each study where it is available.
As is evident from this Section, there is widespread concord in
the scientific community regarding the safety of GM crops.
However, although this section is comprehensive and
representative of the scientific consensus, I would be remiss to
claim it is complete, particularly given the thousands of studies
performed over the last two decades related to this topic.
Furthermore, no discussion of the safety of GM crops would be
complete without highlighting the few dissenting—and loud—
voices in select scientific niches that have departed from the
general scientific consensus to argue that GM crops pose grave
hazards to human health.
3. Dissenting Voices—Opposition to the Scientific Consensus
Notwithstanding the scientific consensus that has crystallized
on the topic of safety of GM crops, there are few dissenting voices
that have spawned one of the most impassionate controversies in
modern times.
Of those voices, perhaps the most prominent is that of GillesEric Séralini, a French scientist and anti-GMO activist, who has

251

See, e.g., Pamela J. Mink et al., Epidemiologic Studies of Glyphosate and
Non-cancer Health Outcomes: A Review, 61 REG. TOXICOLOGY &
PHARMACOLOGY 172 (2011).
252
GENETIC
ENGINEERING
RISK
ATLAS
[GENERA],
http://genera.biofortified.org/viewall.php (last visited Dec. 1, 2016). The
database is currently in beta testing and plans to add more than a thousand
additional peer-reviewed reports on GMOs.
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published a series of reports in the last decade253 warning about the
health dangers of GMOs. Séralini and his colleagues’ studies have
warned that GM foods can be directly associated with reproductive
aberrations, 254 liver and kidney damage, 255 cardiotoxicity, 256
embryonic disturbances,257 and more.258
The most visible—and notorious—report was published in
2012,259 which documented a series of long-term effects, including
the induction of tumors in rats fed GM maize treated with
Roundup, Monsanto’s popular glyphosate-based herbicidal
formulation.260 Upon publication, the article was highly criticized
by many in the scientific community, which pointed to, inter alia,
the study’s inadequate methods, erroneous conclusions
unsupported by empirical data, lack of proper statistical analyses,
improper use of animals,261 etc.262
253

For a list of research papers published by Séralini and his colleagues, see
Gilles-Eric
Séralini,
Relevant
Research,
GMOSERALINI,
http://www.gmoseralini.org/research-papers/.
254
Estelle Cassault-Meyer et al., An Acute Exposure to Glyphosate-Based
Herbicide Alters Aromatase Levels in Testis and Sperm Nuclear Quality, 38
ENVTL. TOXICOLOGY & PHARMACOLOGY 131, 138–39 (2014).
255
Robin Mesnage et al., Transcriptome Profile Analysis Reflects Rat Liver
and Kidney Damage Following Chronic Ultra-Low Dose Roundup Exposure, 14
ENVTL. HEALTH 70 (2015).
256
Steeve Gress et al., Cardiotoxic Electrophysiological Effects of the
Herbicide Roundup® in Rat and Rabbit Ventricular Myocardium in Vitro, 15
CARDIOVASCULAR TOXICITY 324 (2015).
257
Nora Benachour & Gilles-Eric Séralini, Time- and Dose-Dependent Effects
of Roundup on Human Embryonic and Placental Cells, 53 ARCHIVES ENVTL.
CONTAMINATION & TOXICOLOGY 126 (2007).
258
See Relevant Research, supra note 253 (providing a compilation of
research published by Séralini and colleagues purportedly linking GMOs, or the
use of GMO-related chemicals, to a range of deleterious cellular and
physiological outcomes in animal in vitro and in vivo studies).
259
Gilles-Eric Séralini et al., RETRACTED: Long-Term Toxicity of a Roundup
Herbicide and a Roundup-Tolerant Genetically Modified Maize, 50 FOOD &
CHEMICAL TOXICOLOGY 4221 (2012).
260
I have discussed this study in prior work. See Enríquez, supra note 1, at
655–56 n.342.
261
One of the most damaging criticisms of this study involved the use of the
Sprague-Dawley rat strain, which is commonly known to develop spontaneous
endocrine tumors with ageing regardless of whether rats are fed GM food or not.
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Initially the Journal stood by the peer review process and its
decision to publish. But, ultimately, the Journal initiated an
independent investigation of the study’s conclusions and—upon
review—decided to retract it due to the inconclusiveness of its
results.263 Séralini then republished the same paper—without peer
review and including minor modifications—in another journal.264
Notably, the NASEM’s 2016 review of the study also concluded
that the research was “not conclusive and used incorrect statistical
analysis.”265
Opponents of GMOs point to Séralini’s republished paper and
other studies 266 in support of claims that greedy corporations,
See H. Suzuki et al., Spontaneous Endocrine Tumors in Sprague-Dawley Rats,
95 J. CANCER RES. & CLINICAL ONCOLOGY 187 (1979) (finding a high
occurrence of spontaneous endocrine tumors in Sprague-Dawley rats,
particularly those two years of age and older).
262
Many of these criticisms were subsequently published by the Journal. See
Enríquez, supra note 1, at 655–56, n.342.
263
Id.
264
See Gilles-Eric Séralini et al., Republished Study: Long-Term Toxicity of a
Roundup Herbicide and a Roundup-Tolerant Genetically Modified Maize, 26
ENVTL. SCIS. EUR. 14 (2014).
265
NASEM REPORT, supra note 211, at 212.
266
For instance, the International Agency for Research on Cancer (“IARC”)
for the World Health Organization published a report in 2015 stating that despite
“limited evidence of carcinogenicity in humans,” there is “convincing evidence
that glyphosate” can cause cancer in laboratory animals. INTERNATIONAL
AGENCY FOR RESEARCH ON CANCER, IARC MONOGRAPHS VOLUME 112:
EVALUATION OF FIVE ORGANOPHOSPHATE INSECTICIDES AND HERBICIDES, 1, 2
(Mar.
20,
2015),
http://www.iarc.fr/en/mediacentre/iarcnews/pdf/MonographVolume112.pdf.; see also, I. M. Zdziarski et al.,
GM Crops and the Rat Digestive Tract: A Critical Review, 73 ENV’T INT’L 423,
432 (2014) (arguing that a majority of published long-term GM crop feeding
studies concerning histopathological investigations of rat digestive tracts lack
transparent methodologies and results and, thus, provide incomplete information
regarding the safety and toxicity of GM foodstuff consumed by humans and
animals).
However, the European Food Safety Authority (“EFSA”) and Canada’s
federal health regulatory agency evaluated glyphosate following the IARC’s
report and dismissed the IARC’s hypothesis of probable glyphosate
carcinogenicity. The Canadian health regulatory agency found the WHO had not
taken into consideration “the level of human exposure, which determines actual
risk.” See HEALTH CANADA, PROPOSED RE-EVALUATION DECISION PRVD2015-
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lobbyists, and corrupt government officials have conspired against
public health by allowing commercialization of GM crops.267 They
also rely on these studies to demand long-term investigations and
permanent bans on all GMOs. 268 These demands are often
sensationalized and receive a great deal of media attention.269
Moreover, anti-GMO scientists and activists routinely point to
apparent conflicts of interest arising from the publication of safety
studies that are funded by the very industries that will benefit from
favorable GMO reports. For instance, one study found that there
was a strong correlation between author affiliation to industry and
a favorable outcome reported for peer-reviewed journal articles
written on the safety of GM foods. 270 This would give some
credence to anti-GMO activists and scientists, except that they too
are guilty of the same type of professional conflicts of interests
they often decry from proponents of GMOs.
01:
GLYPHOSATE,
3
(Apr.
13,
2015),
http://publications.gc.ca/collections/collection_2015/sc-hc/H113-27-2015-1eng.pdf. Similarly, the EFSA concluded “glyphosate is unlikely to pose a
carcinogenicity risk to humans.” See European Food Safety Authority,
Conclusion On The Peer Review of The Pesticide Risk Assessment Of The Active
Substance Glyphosate, 13 EUR. FOOD SAFETY AUTHORITY J. 4302 (2015).
267
See, e.g., Mel Gurtov, Food Politics: The GMO Conspiracy, PEACEVOICE
(Dec. 3, 2016), http://www.peacevoice.info/2016/12/03/food-politics-the-gmoconspiracy/; Barbara H. Peterson, Monsanto’s Wheat Conspiracy Theory, FARM
WARS (June 24, 2013), http://farmwars.info/?p=10908; cf. Mark Lynas, Time to
Call Out the Anti-GMO Conspiracy Theory, ENVTL. NEWS & COMMENT (Apr.
29, 2013), http://www.marklynas.org/2013/04/time-to-call-out-the-anti-gmoconspiracy-theory/ (recounting the reversal of a former anti-GMO activist).
268
See, e.g., Null, supra note 208.
269
See, e.g., Mike Adams, The Evil of Monsanto and GMOs Explained: Bad
Technology, Endless Greed and the Destruction of Humanity, NAT. NEWS (Sept.
23,
2012),
http://www.naturalnews.com/037289_Monsanto_corporations_ethics.html#ixzz
4VEmt6BPM; Donald L. Barlett & James B. Steele, Monsanto’s Harvest of
Fear,
VANITY
FAIR
(May
2008),
http://www.vanityfair.com/news/2008/05/monsanto200805.
270
Johan Diels et al., Association of Financial or Professional Conflict of
Interest to Research Outcomes on Health Risks or Nutritional Assessment
Studies of Genetically Modified Products, 36 FOOD POL’Y 197 (2011). It should
also be noted the report found that slightly less than half of GMO-related articles
in the study were published by authors having industry ties. Id. at 201–02.
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Séralini, for example, receives funding from CRIIGEN, a
company he co-founded in 1999 and of which he is President of
the Scientific Board,271 as well as other organizations that oppose
GMOs, including Greenpeace and the Sustainable Food Trust.272
Sevene Pharma, a company that sells homeopathic remedies,273 has
provided Séralini—a consultant of the company—mixtures of
“medicinal plant extracts” that purportedly provide some level of
protection against GM crop-derived “pollutants.”274 According to
an article correction issued by a Journal that noted a failure to
disclose all conflicts of interest, Séralini received funding from
Sevene for the last five years to study the detoxifying capacity of
plant extracts sold by Sevene Pharma, and received payment for a
lecture organized by the company.275 Worse, proponents of GMOs
have accused Séralini of profiting from shady science by timing
release of his scientific reports to book and documentary film
releases, all while forbidding the press to discuss his work with
other scientists via bizarre confidentiality agreements during the
book and film promotional periods.276
Séralini’s supporters argue that he has been ostracized by
members of the scientific community because he represents a
271

Gilles-Eric Séralini, We Can Depollute Ourselves: The Film,
http://nous.depolluer.free.fr/gilles-eric-seralini-cv.html (last visited Dec. 1,
2016).
272
David Despain, Organic Industry and Other Funders Behind Séralini’s
Anti-GMO Studies, GENETIC LITERACY PROJECT (June 18, 2015),
https://www.geneticliteracyproject.org/2015/06/18/organic-industry-and-otherfunders-behind-seralinis-anti-gmo-studies/. See also supra notes 253–59.
273
Sevene Pharma, 15 Homeopathic Medicines: A Range of Products To
Relieve Common Pains, http://www.sevenepharma.com/medicines/ (last visited
Dec. 1, 2016).
274
See Céline Gasnier et al., Dig1 Protects Against Cell Death Provoked By
Glyphosate-Based Herbicides in Human Liver Cell Lines, 5 J. OCCUPATIONAL
MED. & TOXICOLOGY 29 (2010); Steeve Gress et al., Dig1 Protects Against
Locomotor and Biochemical Dysfunctions Provoked by Roundup, 16 BMC
COMPLEMENTARY & ALTERNATIVE MED. 234 (2016).
275
The PLoS ONE Staff, Correction: Laboratory Rodent Diets Contain Toxic
Levels of Environmental Contaminants: Implications for Regulatory Tests, 10
PLOS ONE e0135542 (2015).
276
E.g., Declan Butler, Hyped GM Maize Study Faces Growing Scrutiny, 490
NATURE 158 (2012).
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danger to powerful corporate interests 277 and, as a result, his
scientific work is often relegated to low-tier journals. But this
proposition has little merit, especially given that other scientific
research—featuring unfavorable evidence that could impact
industry interests278—has been published in prominent journals and
proven to be controversial. 279 For instance, in 2014, a paper
published in Nature reported data suggesting that consumption of
non-caloric artificial sweeteners—such as those commonly found
in sugar-free foods and beverages—is associated with metabolic
dysfunction and glucose intolerance. 280 The first report of the
potentially harmful effects of GM crops on non-target species,
such as the monarch butterfly, was also published in Nature back
in 1999.281
The overwhelming majority of scientists are not keen on
hiding, or hindering the advancement and dissemination of,
knowledge. A research team capable of showing a clear and
convincing link between human health hazards and a commercial
GM crop—that is reproducible and backed by rigorous empirical
testing—is likely to have access to the most prominent platforms in
the scientific world. Instead, Séralini has not helped himself, or the
reputation of his research, by publishing studies either without peer
review or in obscure journals. For example, one of his recent

277

See, e.g., FEDERATION OF GERMAN SCIENTISTS, 2015 Whistleblower Award
(Sept.
17,
2015),
http://neu.vdw-ev.de/wpcontent/uploads/2015/10/Presseinformation-Whistleblower-Preisverleihung2015_150917_eng.pdf (awarding the Whistleblower Award to Séralini for
revealing the health risks associated with GMOs and standing up to “‘interested
circles’ from the chemical industry as well as the industry-financed British
Science Media Centre.”).
278
See Jotham Suez et al., Artificial Sweeteners Induce Glucose Intolerance
by Altering the Gut Microbiota, 514 NATURE 181 (2014).
279
Kai Kupferschmidt, Artificial Sweeteners May Contribute to Diabetes,
Controversial
Study
Finds,
SCIENCE
(Sept.
17,
2014),
http://www.sciencemag.org/news/2014/09/artificial-sweeteners-may-contributediabetes-controversial-study-finds.
280
Suez et al., supra note 278.
281
John E. Losey et al., Transgenic Pollen Harms Monarch Larvae, 399
NATURE 214 (1999).
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papers282 was published in a Nigerian journal, whose website home
page features multiple typos.283
Many in the scientific community have become frustrated by
what they perceive to be baseless obstructionism over the past
twenty years. A 2016 letter signed by 107 Nobel Laureates urged
Greenpeace to “cease and desist” in its campaign against GM
crops, and exhorted the United Nations and other governments
across the world to reject Greenpeace’s unscientific efforts to
oppose modern methods of plant breeding.284 Notwithstanding the
scientific consensus on GM crops, the debate carries on. A joint
statement signed by more than “300 independent researchers”—
most, though not all, of whom are scientists—recently rejected the
existence of a scientific consensus concerning the safety of GM
crops.285
B. The Environment
With respect to the environmental effects of GM crop
production, the prevailing scientific outlook is that no substantial
evidence or causal relationship has been established between the
adoption of GM crops and harmful agronomic and environmental

282

Gilles-Eric Séralini, The Experience of One of the First GM Crop Farmers
in Europe, 6 SCHOLARLY J. AGRIC. SCI. 9 (2016).
283
See
SCHOLARLY
J.
AGRIC.
SCI.,
http://www.scholarlyjournals.com/sjas/archive/2016/January/toc.htm, (last visited Jan. 9, 2017)
(showing the Journal’s logo on the home page as “Scholarly Joural [sic] of
Agricultural Science,” and providing a link for “Instruction for Authors”).
284
SUPPORT PRECISION AGRIC., Laureates Letter Supporting Precision
Agriculture
(GMOs)
(Jan.
29,
2016),
http://supportprecisionagriculture.org/nobel-laureate-gmo-letter_rjr.html.
285
Angelika Hilbeck et al., No Scientific Consensus on GMO Safety, 27
ENVTL. SCIS. EUR. 4 (2015). Contrary to common sentiments within anti-GMO
groups, the joint statement published did not “assert that GMOs are unsafe or
safe. Rather, the statement conclude[d] that the scarcity and contradictory nature
of the scientific evidence published to date prevents conclusive claims of safety,
or of lack of safety, of GMOs.” Id. It should be noted that the statement was
published in Environmental Sciences Europe, the same journal in which Séralini
republished his retracted study without peer review.
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impact.286 That was the assessment of the NASEM following an
extensive review of the global scientific evidence available to date.
At the same time, the NASEM underscored the need for
sustainable pest management practices, and acknowledged that
definitive conclusions are hard to reach in a few, but not all, areas
related to long-term evaluation of environmental changes.287
1. Crop Yield and Economics
Of all the traits introduced into GM plants, including resistance
to herbicides, insects, viruses, antibiotics, and others, 288 a clear
pattern has been established in the past twenty years. Insect-289 and
herbicide-resistance290 are the two most common traits in GM crops

286

See e.g., NASEM REPORT, supra note 211, at 154–55; Philip J. Dale et al.,
Potential For The Environmental Impact of Transgenic Crops, 20 NATURE
BIOTECHNOLOGY 567 (2002) (“From the current state of knowledge, the impact
of free DNA of transgenic origin is likely to be negligible compared with the
large amount of total free DNA. We can find no compelling scientific arguments
to demonstrate that GM crops are innately different from non-GM crops.”).
287
NASEM REPORT, supra note 211, at 154–55.
288
For a representative, though incomplete, list of GM traits currently studied,
see INT’L SERVICE FOR THE ACQUISITION OF AGRI-BIOTECH APPLICATIONS,
http://www.isaaa.org/gmapprovaldatabase/gmtraitslist/default.asp (last visited
Dec. 1, 2016).
289
Genes transferred from the Bacillus thuringiensis (Bt) soil bacterium
confer insect resistance in GM plants. See Richard L. Hellmich & Kristina
Allyse Hellmich, Use and Impact of Bt Maize, 3 NATURE EDUC. KNOWLEDGE 4
(2012). This species of bacteria produces unique proteins that are toxic to some
insects and has been used as a natural insecticide in organic farming for over
half a century. Id.
290
Glyphosate (N-phosphonomethyl-glycine), the active ingredient in
Roundup and other herbicide products, confers herbicide resistance in GM
crops. See Loredano Pollegioni et al., Molecular Basis of Glyphosate
Resistance: Different Approaches Through Protein Engineering, 278 FEBS J.
2753 (2011). This chemical compound kills plants by disturbing the shikimate
pathway in plants, which is pivotal for the synthesis of some essential aromatic
amino acids. Glyphosate is a competitive inhibitor of the enzyme 5enolpyruvylshikimate-3-phosphate synthase (“EPSPS”), which binds more
tightly to glyphosate than its natural substrate. Id.; see also infra note 454.
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worldwide, and account for more than 99% of total GM crop
area.291
Numerous scientific studies have investigated issues related to
improved yields stemming from the adoption of GM crops. For
instance, a study of forty-nine peer-reviewed publications reporting
results from a dozen countries revealed that, with few exceptions,
GM crops led to higher crop yields and benefited small farmers in
developing countries. 292 Similarly, a statistical analysis of the
economic and agronomic performance of GM crops worldwide
concluded that GM crops perform better than their conventional
counterparts.293 Another study investigating yield contributions of a
GM crop in ten universities across the United States over a
thirteen-year period found that the presence of GM traits has been
associated with an increase in yields.294 However, the NASEM
found that although some GM crops have contributed to a
statistically significant reduction in the gap between actual and
potential yield in some contexts, other factors may also play
important roles in yield differences.295
On the basis of reduced pesticide use, increased crop yields,
and increased farmer profits, primary data from farm surveys or
field trials demonstrate that GM crops benefit both developing and
developed nations. 296 Thus, although transgenic crop
biotechnologies have been initially targeted for developed

291

Janet E. Carpenter, Peer-Reviewed Surveys Indicate Positive Impact of
Commercialized GM Crops, 28 NATURE BIOTECHNOLOGY 319 (2010).
Interestingly, some evidence alludes that ‘stacking’ of GM traits in the same
hybrid crop does not lead to additive gains of the combined traits. See Elizabeth
Nolan & Paulo Santos, The Contribution of Genetic Modification to Changes in
Corn Yield in the United States, 94 AM. J. AGRIC. ECON. 1171 (2012).
292
Carpenter, supra note 291, at 319.
293
F. J. Areal et al., Economic and Agronomic Impact of Commercialized GM
Crops: A Meta-Analysis, 151 J. AGRIC. SCI. 7 (2013).
294
Nolan & Santos, supra note 291, at 1172.
295
See NASEM REPORT, supra note 211, at 115–16.
296
Wilhelm Klümper & Matin Qaim, A Meta-Analysis of the Impacts of
Genetically Modified Crops, 9 PLoS ONE e111629 (2014).
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countries, it appears that developing countries have benefited more
from the spill over technology.297
2. Pest Management
Cumulative benefits have been documented for the use of
transgenic Bacillus thuringiensis (Bt) maize to combat the
propagation of its primary pest, the European corn borer. 298
Transgenic maize-based pest suppression has been so effective,
that some populations of the European corn borer have declined to
historically low levels.299 Surprisingly, research shows that farmers
growing non-GM maize are actually reaping more economic
benefits than those planting GM maize.300 This is largely due to the
fact that GM seed costs are higher—thereby lowering profit
margins of GM maize farmers—and overall regional populations
of the pest have declined, which ultimately has benefited both GM
and non-GM crop farmers. 301 Such data has led to
recommendations for the maintenance of non-GM crop refuges as
a strategy for sustainable pest resistance management.302
3. Pesticide Use, Acquired Resistance, and Controversies
Assessments of the potential associations between GM crops
and the reduction of pesticide use vary.303 Overall, the scientific
literature points to a reduction of chemical pesticides applications,
but the decrease is larger for insect-resistant than herbicide297

Julian Witjaksono et al., Yield and Economic Performance of the Use of
GM Cotton Worldwide Over Time: A Review and Meta-Analysis, 6 CHINA
AGRIC. ECON. REV. 616 (2014).
298
W. D. Hutchison et al., Areawide Suppression of European Corn Borer
with Bt Maize Reaps Savings to Non-Bt Maize Growers, 330 SCIENCE 222
(2010).
299
Eric W. Bohnenblust et al., Current European Corn Borer, Ostrinia
nubilalis, Injury Levels in the Northeastern United States and the Value of Bt
Field Corn, 70 PEST MGMT. SCI. 1711 (2014).
300
Id.
301
See supra notes 298–300 and accompanying text.
302
Hutchison et al., supra note 298.
303
See infra notes 304–21.
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resistant crops.304 On one hand, the evidence clearly shows that the
use of insecticides has decreased as a result of GM crop
cultivation. Data from various countries including India,305 South
Africa, 306 Pakistan, 307 Australia, 308 the United States, 309 and other
parts of the world310 demonstrate that GM crop technology has
helped to shrink down the use of insecticides.
On the other hand, data for the reduction of herbicide use is
mixed. Research shows that herbicide use decreased for the first
few years after the adoption of GM crops, but then increased
modestly in later years. 311 This swing could presumably be
explained by the development of herbicide resistance among some
weed populations, which may have induced farmers to apply more
herbicides to combat glyphosate-resistant weeds. 312 Overreliance
on glyphosate and the rise of resistance in some weed species have
caused concern in recent years, particularly because some
glyphosate substitutes may be more toxic and persistent
herbicides.313 The NASEM acknowledged that weed resistance to
glyphosate is a problem, and recommended the use of “integrated

304

Klümper and Qaim, supra note 296.
See, e.g., Shahzad Kouser & Matin Qaim, Impact of Bt Cotton on Pesticide
Poisoning in Smallholder Agriculture: A Panel Data Analysis, 70 ECOLOGICAL
ECON. 2105 (2011).
306
See, e.g., Bhavani Shankar et al., Production risk, pesticide use and GM
crop technology in South Africa, 40 APPLIED ECONOMICS 2489 (2008).
307
Shahzad Kouser & Matin Qaim, Bt Cotton, Damage Control and Optimal
Levels of Pesticide Use in Pakistan, 19 ENV’T & DEV. ECON. 704 (2014).
308
See, e.g., Lewis Wilson et al., IPM in the Transgenic Era: A Review of the
Challenges from Emerging Pests in Australian Cotton Systems, 64 CROP &
PASTURE SCI. 737 (2013).
309
Edward D. Perry et al., Genetically Engineered Crops and Pesticide Use in
U.S. Maize and Soybeans, 2 SCI. ADVANCES e1600850 (2016).
310
See Klümper & Qaim, supra note 296, at e111629.
311
Jose Fernandez-Cornejo et al., Genetically Engineered Crops in the United
States, ERR-162 U.S.D.A., Economic Research Service, at 24 (2014),
http://www.beyondpesticides.org/assets/media/documents/USDA_GE[smallpdf.
com].pdf.
312
Id.
313
Id. at 24–25.
305
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weed-management approaches beyond simply spraying mixtures of
herbicides.”314
One controversial study published in 2012 concluded that,
contrary to claims that GM crops have reduced pesticide use, the
spread of glyphosate-resistant weeds has set off “substantial
increases in the number and volume of herbicides applied.” 315
Opponents of GMOs have relied on this and other similar reports
to argue that GM crops are polluting the planet and, thus, should be
banned to protect our health and the environment.316 Critics of this
study claimed it was flawed because the author, inter alia, “did not
take into account the fact that glyphosate is less toxic than the
herbicides it has replaced and, thus, the net toxicity of herbicide
use had decreased even as the total herbicide use increased.”317
However, subsequent peer-reviewed research has turned away
from overarching conclusions and, instead, revealed nuanced cropspecific differences related to herbicide use. Consider a report
published in 2016, which found that “[w]hen pesticides are
weighed by the environmental impact quotient,” non-GM and GM
crop farmers used about the same amount of soybean herbicides,
but roughly 10% less maize herbicides. 318 The NASEM also
reviewed the 2012 report319 and concluded that the study’s author
had failed to perform a statistical analysis.320 The NASEM also
discouraged researchers from publishing data that makes “simple
determination of whether total kilograms of herbicide used per
314

NASEM REPORT, supra note 211, at 15.
Benbrook, supra note 124.
316
See, e.g., Andrew Kimbrell, New Report: GMOs Causing Massive
Pesticide Pollution, HUFFINGTON POST (Mar. 18, 2010, updated May 25, 2011),
http://www.huffingtonpost.com/andrew-kimbrell/new-report-gmos-causingm_b_362888.html; Tom Laskawy, GMOs, Pesticides, and the New Scientific
Deadlock, GRIST (Oct. 5, 2012), http://grist.org/food/superweeds-story/.
317
GENETIC LITERACY PROJECT, Charles Benbrook: Former Washington
State Adjunct Consultant for Organic Industry (Aug. 10, 2016),
https://www.geneticliteracyproject.org/glp-facts/charles-benbrook-formerwashington-state-adjunct-consultant-organic-industry/.
318
Perry et al., supra note 309, at e1600850.
319
The study was published in Environmental Sciences Europe, the same
journal that republished Séralini’s controversial 2012 retracted paper in 2014.
320
NASEM REPORT, supra note 211, at 139.
315
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hectare per year has gone up or down,” because such data “is not
useful for assessing changes in human or environmental risks” and
could “mislead readers.”321
4. Non-Target Species and Biodiversity
In the last two decades, the mass production and
commercialization of GM crops has raised environmental concerns
involving biodiversity and the reduction of non-target species
populations.
The first study to report a possible risk for non-target
organisms that feed on plants producing transgenic Bt insecticides
(Figure 2)322 was published in 1999 and focused on the monarch
butterfly. 323 Through laboratory assays, the study showed that
larvae of monarch butterflies reared on milkweed leaves dusted
with pollen from a GM crop exhibited retarded growth and high
mortality rates.324 Following that report, a research collaboration
between several scientists in the U.S. and Canada performed a twoyear study to examine Bt corn pollen toxicity on the monarch
butterfly.325 The study found that the impact of transgenic pollen
was negligible primarily because Bt expression in pollen is low,
and laboratory and field tests failed to establish acute toxic effects
at concentrations the insects would likely encounter in the field.326
The study criticized the 1999 report for not having specified the
dose of pollen used in the study.327

321

Id.
See infra note 328.
323
Losey et al., supra note 281, at 214.
324
Id.
325
Mark K. Spears et al., Impact of Bt Corn Pollen on Monarch Butterfly
Populations: A Risk Assessment, 98 PROC. NAT’L ACAD. SCI. U.S. 11937, 11937
(2001).
326
Id.
327
Id.
322
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FIGURE 2

The molecular basis for insecticide resistance in GM crops—A Bt
insecticidal Cry protein. X-Ray, crystal structure of the full-length
insecticidal protein Cry1Ac from Bacillus thuringiensis. After ingestion
by a susceptible insect, this inactive full-length protoxin becomes active
via proteolytic cleavage inside the insect’s midgut environment. The
protoxin domain (yellow) is cleaved off and the toxic core (blue and
red) becomes active. The unleashed toxic core is then free to bind
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specific midgut receptors, thereby creating ion channels or pores in the
midgut membrane. 328 Systemic infection resulting from the ulcerated
midgut eventually kills the host insect.329 The figure appears in color in
the online version of the Article.330

The potential effects on monarch butterfly fitness arising from
the use of glyphosate and other herbicides to control milkweed, the
main source of monarch larvae nutrition, has also been studied in
recent years. Ample disagreement among researchers can be found
in the literature, with some groups arguing that glyphosate-based
reduction of milkweeds can be a negative factor in the monarch
butterfly’s survival,331 and others claiming no such effect exists.332
The debate carries on.333
Honey bee pollination is vital in agriculture.334 A concern about
the effects of Bt crops on honey bees has prompted research into
this field. Results from a meta-analysis of twenty-five studies
focused on chronic toxicity of Bt proteins or plant tissues on honey
328

The model of this Bt insecticidal protein was built using the atomic
coordinates deposited in the Protein Data Bank, accession code 4W8J (2014),
http://www.rcsb.org/pdb/explore/explore.do?structureId=4W8J.
329
For a more detailed exposition of various Bt pesticidal proteins, see
generally E. Schnepf et al., Bacillus thuringiensis and Its Pesticidal Crystal
Proteins, 62 MICROBIOLOGY & MOLECULAR BIOLOGY REVS. 775 (1998).
330
The online version can be accessed at the Journal’s website, ncjolt.org, by
clicking on the “Articles” tab, Volume 18, Issue 4.
331
See, e.g., John M. Pleasants & Karen S. Oberhauser, Milkweed Loss in
Agricultural Fields Because of Herbicide Use: Effect on the Monarch Butterfly
Population, 6 INSECT CONSERVATION & DIVERSITY 135 (2012).
332
See, e.g., Leslie Ries et al., The Disconnect Between Summer and Winter
Monarch Trends for the Eastern Migratory Population: Possible Links to
Differing Drivers, 108 ANNALS ENTOMOLOGICAL SOC’Y AM. 691, 691 (2015)
(attributing certain regional declines to factors other than milkweed loss).
333
Compare John M. Pleasants et al., Conclusion of No Decline in Summer
Monarch Population Not Supported, 109 ANNALS ENTOMOLOGICAL SOC’Y AM.
169 (2016) (pointing to evidence that the key driver of monarch butterfly
population decline is a massive loss of milkweeds), with Hidetoshi Inamine et
al., Linking the Continental Migratory Cycle of the Monarch Butterfly to
Understand its Population Decline, 125 OIKOS 1081(2016) (rejecting the
milkweed limitation hypothesis).
334
Jian J. Duan et al., A Meta-Analysis of Effects of Bt Crops on Honey Bees
(Hymenoptera: Apidae), 3 PLOS ONE e1415, e1415 (2008).
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bee larvae and adults showed that GM crops do not negatively
affect the species’ survival in laboratory settings, but that
additional field environmental stresses could, in theory, lead to
indirect effects. 335 Another study concluded that a common Bt
protein—even at concentrations too high to be found in natural
conditions—was not lethal to the bees. 336 However, such high
concentrations could likely affect the honey bees’ food
consumption or learning processes, which in turn could impact
honey bee foraging efficiency.337
In addition, some studies of the effects of glyphosate on soil,
water, and air contamination have determined that, compared to
some of the herbicides that glyphosate replaced, the environmental
effects are minimal. 338 For example, one meta-analysis of a
drought-tolerant GM crop found no impact on yield, and shoot or
root architecture when grown in moderate- to high-yield
environments. 339 Another meta-analysis examining forty-four
studies addressing diversity trends associated with eight different
field crops demonstrated that overall, in the long run, “no
substantial reduction in the regional diversity of crop varieties
released by plant breeders has taken place.”340 Comparative risk
assessments have found that transgenic crops behave similarly to
their non-transgenic counterparts and are not invasive. 341 Other
various studies also describe that, overall, currently
commercialized GM crops have reduced the impacts of agriculture
on biodiversity primarily through enhanced adoption of
335

Id.
R. Ramirez-Romero et al., Does Cry1Ab Protein Affect Learning
Performances of the Honey Bee Apis mellifera L. (Hymenoptera, Apidae)?, 70
ECOTOXICOLOGY & ENVTL. SAFETY 327, 332 (2008).
337
Id. at 332.
338
Antonio L. Cerdeira et al., The Current Status and Environmental Impacts
of Glyphosate-Resistant Crops: A Review, 35 J. ENVTL. QUALITY 1633 (2006).
339
Chang et al., supra note 14, at 125.
340
Mark van de Wouw et al., Genetic Diversity Trends in Twentieth Century
Crop Cultivars: A Meta Analysis, 120 THEORETICAL & APPLIED GENETICS 1241,
1241 (2010).
341
Alan Raybould et al., Assessing the Ecological Risks from the Persistence
and Spread of Feral Populations of Insect-Resistant Transgenic Maize, 21
TRANSGENIC RES. 655 (2012).
336
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conservation tillage practices, reduction of insecticide use,
adoption of more benign herbicides, and improved yields that have
prevented conversion of additional land for agricultural use.342
The NASEM’s 2016 report concluded that the bulk of
scientific evidence shows that the planting of GM crops tends to
result in higher insect biodiversity than the planting of non-GM
crops that are treated with synthetic insecticides, and that GM crop
fields sprayed with glyphosate have similar or more weed
biodiversity than non-GM crop fields.343 The report concluded that
the totality of evidence on the environmental impacts of GM crops
currently grown in agriculture shows no cause-and-effect
relationships between transgenic crops and environmental harm.344
IV. THE REGULATORY LANDSCAPE—A COORDINATED
FRAMEWORK
The advent, and swift progress, of recombinant DNA
technologies throughout the 1970s and 1980s signaled the start of a
new era. Public health and environmental concerns about the
prospects of new biotechnologies surfaced. 345 Legislative and
judicial developments in the early to mid-1980s began to exert
pressure on the executive branch to take action.346
On one front, Congress held hearings and entertained the
possibility of enacting legislation to deal specifically with new
technological developments.347 Around the same time, an activist
342

See, e.g., Janet E. Carpenter, Impacts of GM Crops on Biodiversity, 2 GM
CROPS & FOOD 1 (2011).
343
NASEM REPORT, supra note 211, at 146.
344
Id. at 154–55.
345
See supra Part III for a discussion of some of the health and environmental
concerns surrounding GMO biotechnology.
346
See infra notes 347–55 and accompanying text.
347
Biotechnology Regulation: Hearing Before the Subcomm. on Oversight
and Investigations of the House Comm. on Energy and Commerce, 98th Cong.
98–193 (1984); Environmental Implications of Genetic Engineering: Hearing
Before the Subcomm. on Investigations and Oversight and the Subcomm. on
Science, Research and Technology of the House Comm. on Science and
Technology, 98th Cong. 2–3 (1983).
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environmental organization filed a lawsuit in the D.C. District
Court against federal officials in charge of supervising scientific
research performed at the National Institutes of Health (“NIH”).348
The complaint alleged violations of the National Environmental
Policy Act of 1969 (“NEPA”)349 and the Administrative Procedure
Act (“APA”),350 and sought a preliminary injunction to enjoin a
deliberate release experiment involving genetically modified
bacteria.351
The Reagan Administration’s response to congressional and
judicial pressures was to task a group of the White House Office of
Science and Technology Policy (“OSTP”) with outlining a federal
framework for the regulation of biotechnology. OSTP published a
proposal draft on the last day of 1984. 352 The proposal was
subsequently finalized in 1986 and gave birth to a new
“Coordinated Framework for the Regulation of Biotechnology.”353
This policy document avowed that, for the most part, current laws
would adequately address regulatory needs related to products
derived from traditional genetic manipulation techniques.354 Thus,
OSTP argued successfully that “existing health and safety laws . . .
could provide more immediate regulatory protection and certainty
for the industry than . . . new legislation.”355
The Coordinated Framework assigned broad federal
jurisdiction over biotechnology products to three federal agencies:
the United States Department of Agriculture (“USDA”), the Food
and Drug Administration (“FDA”), and the Environmental
Protection Agency (“EPA”).356 Significantly, the new regulatory
348

Found. on Econ. Trends v. Heckler (Heckler I), 587 F. Supp. 753, 754
(D.D.C. 1984), aff’d, 756 F.2d 143 (D.C. Cir. 1985).
349
42 U.S.C. §§ 4321–70 (2012).
350
5 U.S.C. § 706 (2012).
351
Heckler I, 587 F. Supp. at 754.
352
See Proposal for a Coordinated Framework for Regulation of
Biotechnology, 49 Fed. Reg. 50,856 (proposed Dec. 31, 1984).
353
Coordinated Framework for the Regulation of Biotechnology, 51 Fed. Reg.
23,302 (June 26, 1986).
354
Id.
355
Id.
356
The 1986 final policy draft followed the 1984 proposal’s vision, which
stated that
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scheme made it clear that biotechnology products should be
reviewed by the pertinent agencies in “essentially the same manner
for safety and efficacy as products obtained by other
techniques.”357 Accordingly, U.S. policy would primarily follow a
products-based, rather than a process-based, approach as had been
the case for products derived without genetic engineering
techniques. Where needed, OSTP recommended that “[a]n
independent review of potential risks should be conducted on a
case-by-case basis . . . .”358
OSTP further declared the new Coordinated Framework would
be expected to evolve and could be modified via administrative or
legislative action. 359 Clarifications to the scope of the
biotechnological regulatory scheme were delineated in a 1992
policy statement, which reaffirmed that federal oversight should be
confined to a science-based risk assessment with emphasis on the
characteristics, risks, and applications of a biotechnological
product, rather than the process by which it was created.360 The
policy was based on OSTP’s view that “[p]roducts developed
through biotechnology processes do not per se pose risks to human
health and the environment; risk depends instead on the
characteristics and use of individual products.”361 Those products
the Food and Drug Administration (FDA) would regulate genetic
engineering products no differently that those achieved through
traditional techniques. The Environmental Protection Agency (EPA)
described existing and proposed new policies for regulating pesticidal
and nonpesticidal microorganisms. The Department of Agriculture
(USDA) stated that under its different legislative authorities it could
broadly regulate genetically engineered plants and animals, and plant
and animal pathogens.
Id.
357
Id.
358
Id.
359
Coordinated Framework for the Regulation of Biotechnology, 51 Fed. Reg.
23,302 (proposed June 26, 1986).
360
Exercise of Federal Oversight Within Scope of Statutory Authority:
Planned Introductions of Biotechnology Products into the Environment, 57 Fed.
Reg. 6753 (proposed Feb. 27, 1992).
361
Id. at 6760. The opinion mirrors the findings of an extensive review
performed by the National Research Council (“NRC”) on the potential risks of
introductions of organisms made from new biotechnology processes. The NRC

500

N.C. J.L. & TECH.

[VOL. 18: 432

posing little to no risk ought not to be subject to onerous regulation
during testing and commercialization.362
A. The United States Department of Agriculture
The Coordinated Framework co-commissioned the USDA as
one of the agencies with jurisdiction over GM crops. The USDA
derives its authority to regulate biotechnology primarily via the
Plant Protection Act (“PPA”).363 The PPA sanctions the Secretary
of Agriculture with power to restrict the interstate commerce of
plants, plant pests, noxious weeds, and other articles that could
harm U.S. agriculture, so as to avoid their dissemination.364
Pursuant to that authority, the Animal and Plant Health
Inspection Service (“APHIS”) promulgated regulations that, in
effect, created a presumption that categorized GM crops as
“regulated articles”365 or “plant pests”366 simply because they are
found that “the nature of the process is not a useful criterion for determining
whether [a] product requires less or more oversight . . . [and] [n]o conceptual
distinction exists between genetic modification of plants and microorganisms by
classical methods or by molecular techniques that modify DNA and transfer
genes.” Id. at 6755.
362
Id. at 6760.
363
See 7 U.S.C. §§ 7701–86 (2012). Before the PPA was enacted, USDA
derived authority in this realm from the Federal Plant Pest Act. See infra note
368.
364
§ 7712(a) states that in general
[t]he Secretary may prohibit or restrict the importation, entry,
exportation, or movement in interstate commerce of any plant, plant
product, biological control organism, noxious weed, article, or means
of conveyance, if the Secretary determines that the prohibition or
restriction is necessary to prevent the introduction into the United
States or the dissemination of a plant pest or noxious weed within the
United States.
Id.
365
7 C.F.R. § 340.0(a)(2), n.1 (1997). A regulated article is defined as
[a]ny organism which has been altered or produced through genetic
engineering, if the donor organism, recipient organism, or vector or
vector agent belongs to any genera or taxa designated in § 340.2 and
meets the definition of plant pest, or is an unclassified organism and/or
an organism whose classification is unknown, or any product which
contains such an organism, or any other organism or product altered or
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derived through genetic engineering techniques. Furthermore, a
GM crop may also be deemed a “noxious weed,”367 if APHIS
believes it is capable of causing injury or damage to any
agricultural interest, such as crops or livestock. Accordingly, under
current law, GM crops fall within the purview of the PPA until
APHIS makes a determination to the contrary.368
A developer may receive authorization to use and
commercialize a GM crop by (1) a notification procedure, (2) a
permit for release into the environment, or (3) a petition for
determination of nonregulated status. 369 The first category is
difficult for a GM crop to overcome because it prohibits the plant
to have genetic material from animal or human pathogens, and
requires the introduced genetic material to be of known function,
not result in plant disease, and lack substances that can be toxic to

produced through genetic engineering which the Administrator
determines is a plant pest or has reason to believe is a plant pest.
Excluded are recipient microorganisms which are not plant pests and
which have resulted from the addition of genetic material from a donor
organism where the material is well characterized and contains only
non-coding regulatory regions.
Id. § 340.1.
366
7 C.F.R. § 340.1 defines a plant pest as
[a]ny living stage (including active and dormant forms) of insects,
mites, nematodes, slugs, snails, protozoa, or other invertebrate animals,
bacteria, fungi, other parasitic plants or reproductive parts thereof;
viruses; or any organisms similar to or allied with any of the foregoing;
or any infectious agents or substances, which can directly or indirectly
injure or cause disease or damage in or to any plants or parts thereof, or
any processed, manufactured, or other products of plants.
Id.
367
7 C.F.R. § 360.100 defines a noxious weed as “[a]ny plant or plant product
that can directly or indirectly injure or cause damage to crops (including nursery
stock or plant products), livestock, poultry, or other interests of agriculture,
irrigation, navigation, the natural resources of the United States, the public
health, or the environment.”
368
Prior to the enactment of the PPA, the USDA derived its authority to
regulate the movement of “plant pests,” from the Federal Plant Pest Act, which
was repealed in 2000. See 7 U.S.C. § 150aa-jj (repealed 2000).
369
7 C.F.R. §§ 340.3, 340.4, 340.6 (2016).
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non-target species that may feed on the plant.370 In essence, this
forecloses any crop that produces Bt insecticides and has herbicide
resistance—virtually all GM crops371—from being authorized by a
notification procedure.
The second category delineates the rules for applying for a
permit to introduce a regulated article. 372 APHIS takes into
consideration information ranging from the intended use and
distribution to the article’s composition and molecular biology of
the system by which it was produced. 373 If APHIS grants the
permit, rules related to containment and other measures to prevent
dissemination come into force.374 Such a permit can be rescinded
for noncompliance of the conditions listed on the document.375
The third category involves a process of consultation by which
APHIS determines whether the GM crop should or should not be
regulated. “Any person may submit . . . a petition to seek a
determination that an article should not be regulated” because it
does not present a plant pest risk.376 The petition must include all
relevant published and unpublished scientific studies, data from
tests performed, and information deemed to contain trade secrets or
confidential business information (“CBI”), which must be marked
“CBI.”377 The promulgations also impose a duty of disclosure by
requiring that a petitioner include any information known which

370

See §§ 340.3(b-c) (stating that regulated articles must meet six
requirements and performance standards to be eligible for introduction under the
notification procedure).
371
Nearly 100% of GM crops sold are genetically engineered with either
herbicide tolerance or insect resistance, or both. Those traits account for almost
all of the GM crops grown commercially over the past 20 years. Canadian
Biotechnology Action Network (CBAN), Where in the World are GM Crops
and
Foods?,
1,
2
(2015),
http://gefreekamloops.org/wpcontent/uploads/2015/07/where-in-the-world-gm-crops-foods.pdf.
See also
supra note 328 and infra note 454 and accompanying text.
372
7 C.F.R. § 340.4 (2016).
373
See §§ 340.4(b)(1–12).
374
§§ 340.4(f)(1–11).
375
§ 340.4 (g).
376
§ 340.6.
377
§ 340.6(b).
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would be unfavorable to the petition, or state that no such
unfavorable information is known at the time of the petition.378
B. The Food and Drug Administration
The Coordinated Framework empowers the FDA to, inter alia,
protect the public health and ensure the safety of our nation’s food
supply.379 The agency has jurisdiction over GM crops through the
Federal Food, Drug, and Cosmetic Act (“FFDCA”)380 and its food
adulteration (§ 402) and additive (§ 409) provisions.381
Under the FFDCA, a foodstuff is deemed to have been
“adulterated” “[i]f it bears or contains any poisonous or deleterious
substance which may render it injurious to health.” 382 The law
prohibits introduction, or delivery for introduction, of any
adulterated food in interstate commerce. 383 The adulterated
provision grants the FDA power to impose sanctions—including
injunctive relief, fines, imprisonment, and seizures—on
violators,384 and to remove any food from interstate commerce that
could pose injury to health by virtue of either (1) its adulterated
status or (2) the presence of large quantities of an inherent
constituent of the food that renders it injurious to health.385
A GM crop is also subject to review if the FDA considers it to
contain a “food additive,” which has been defined as any substance
that can potentially become “a component or otherwise affect[] the
characteristics of any food.”386 The FFDCA mandates that plants
containing food additives must undergo a safety review prior to
378

7 C.F.R. § 340.6(b) (2016).
U.S.
FOOD
&
DRUG
ADMIN.,
FDA
Mission,
http://www.fda.gov/AboutFDA/WhatWeDo/ (last updated Oct. 24, 2016).
380
See 21 U.S.C. § 301 (2012).
381
It bears noting that other statutes, such as the Public Health Service Act, 42
U.S.C. §§ 201–300mm-61 (2012), also grant the FDA jurisdiction over certain
aspects related to GM crops, including the regulation of drugs and biological
products derived from GM plants, which are outside the scope of this Article.
382
21 U.S.C. § 342(a)(1).
383
§ 331.
384
See §§ 331–35.
385
See § 342.
386
§ 321(s).
379
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market release, regardless of how the additive found its way into
the food.387 A petitioner wishing to bring said food to market must
establish the existence of reasonable scientific certainty that the
food additive is not harmful.388
Importantly, the law acknowledges that establishing complete
certainty of absolute lack of harm may be impossible given the
current state of scientific knowledge.389 In any event, safety must
be established by a series of “scientific procedures”390 aimed at
studying stability, purity, potential toxicity, potency, and
performance of the food additive.391 If the food additive is not
approved following a formal petition, the item is deemed unsafe
and subject to the adulterated provision. 392 Alternatively, if a
substance added to food is generally recognized as safe (“GRAS”)
“among experts qualified by scientific training and experience to
evaluate its safety,”393 it is exempt from the food additive provision
and no market pre-approval is warranted.
The new FDA authority under the Coordinated Framework
guidelines gave rise to numerous inquiries from industry,
government agencies, academia, and the public concerning the
regulatory status of new plant varieties, including those derived
from recombinant DNA technologies. 394 As a result, the FDA
published a policy statement in 1992 to clarify its interpretation of
the FFDCA regarding the extent of the agency’s jurisdictional
reach vis-à-vis GM crops.395 In it, the FDA made three important
remarks.
First, the FDA reiterated the position that the process by which
food is produced or developed should bear no adverse impact on a

387

21 U.S.C. § 348 (2012).
21 C.F.R. § 170.3(i) (2016).
389
Id.
390
Id.
391
§ 171.1(c) (2016).
392
See 21 U.S.C. § 342(a)(2)(c).
393
§ 321(s).
394
See U.S. Food & Drug Administration, Statement of Policy: Foods Derived
From New Plant Varieties, 57 Fed. Reg. 22,984 (proposed May 29, 1992).
395
Id.
388
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safety calculus. 396 Thus, the key factors for a determination of
safety ought to be the characteristics of the food product, rather
than the method used to produce it.397
Second, the agency declared that material derived from nucleic
acids are presumed to be GRAS because they can be found in
every living organism, including all animals and plants used for
human consumption, and do not raise safety concerns as food
components.398 Thus, transferred genetic material is not likely to
call into question the safety of GRAS substances or trigger the
need for increased regulatory scrutiny.
Third, the agency introduced a policy of informal, voluntary
consultation to determine the regulatory status of new GM crop
varieties. This policy was based on the recognition that expression
of nucleic acids introduced via genetic engineering could, in
theory, lead to production of proteins, carbohydrates, metabolites,
and other materials not substantially equivalent to those found in
current food.399 The FDA refrained from making the consultation
process a legal requirement, but it explicitly stated that each food
producer is responsible for assuring the safety of products
introduced in interstate commerce.400
Although the consultation process instituted by the FDA is not
compulsory, in practice, it has become a de facto pre-market
approval mandate. To date, FDA has completed 174 consultations
related to GM plants under its 1992 voluntary consultation
policy. 401 A possible explanation for this phenomenon is that
developers wish to minimize their exposure to stringent product
liability laws.402 Indeed, because each developer is charged with
396

Id. at 22,984–85.
Id.
398
Id. at 22,989–90.
399
U.S. Food & Drug Administration, Statement of Policy: Foods Derived
From New Plant Varieties, 57 Fed. Reg. 22,990.
400
Id.
401
U.S. FOOD & DRUG ADMIN. Biotechnology Consultations on Food from
GE Plant Varieties, http://www.accessdata.fda.gov/scripts/fdcc/?set=Biocon
(last visited Dec. 1, 2016).
402
See, e.g., GRANT ISAAC, AGRICULTURAL BIOTECHNOLOGY AND
TRANSATLANTIC TRADE: REGULATORY BARRIERS TO GM CROPS 186 (2002).
397
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ensuring the safety of its food product,403 it is hard to conceive,
from a risk-management perspective, that developers would be
willing to invest considerable resources to introduce a product that
could be later recalled by the FDA.
C. The Environmental Protection Agency
The EPA is the federal agency in charge of enforcing
environmentally-conscious federal statutes concerning human
health and the environment. The agency’s authority to develop and
promulgate rules to ensure the safety of GM plants, and pesticides
thereof, stems primarily from two statutes. Jurisdiction over
pesticides and plant-incorporated protectants (“PIPs”) 404 comes
from the Federal Insecticide, Fungicide, and Rodenticide Act
(“FIFRA”). 405 In contrast, authority over pesticide residues in
foodstuff flows from § 408 of the FFDCA.406
Under FIFRA, it is unlawful for any person to sell or distribute
pesticides without a proper registration from the federal
government.407 A pesticide within the meaning of the Act refers to
“any substance, or mixtures thereof, intended for 1) the prevention,
destruction, or mitigation of any pest; or 2) use as a plant regulator,
defoliant, or desiccant.”408
The law aims to prevent “unreasonable adverse effects on the
environment,”409 which encompass “any unreasonable risk to man
or the environment.” 410 The analysis for establishing the
unreasonable adverse effects of this provision is two-fold. First,
403

57 Fed. Reg. 22,984.
A plant-incorporated protectant is “a pesticidal substance that is intended
to be produced and used in a living plant, or in the produce thereof, and the
genetic material necessary for production of such a pesticidal substance. It also
includes any inert ingredient contained in the plant, or produce thereof.” 40
C.F.R. § 152.3 (2016).
405
Federal Insecticide, Fungicide, and Rodenticide Act, 7 U.S.C. §§ 136–
136y (2012).
406
Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §§ 301–399h (2012).
407
7 U.S.C. § 136a(a).
408
§ 136(u).
409
§ 136a(a).
410
§ 136(bb).
404
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EPA’s determination cannot be solely based on scientific data; it
warrants a cost-benefit analysis that takes into consideration
relevant economic, social, and environmental factors connected
with the pesticide’s use. 411 Second, the risks associated with
residues in foodstuff resulting from pesticide use must be
consistent with the safety standards outlined in § 408 of the
FFDCA.412 Consequently, registration of a pesticide substance is
only warranted if both prongs of the unreasonable adverse effect
test are satisfied.
In addition, registration may be granted only after the petitioner
submits sufficient scientific information to demonstrate adequate
testing and safety of the pesticide.413 This helps to ensure that
“when used in accordance with widespread and commonly
recognized practice[,] [the pesticide] will not generally cause
unreasonable adverse effects on the environment. 414 Prior to
commercialization, the EPA exercises authority over field tests via
Experimental Use Permits (“EUPs”), which sanction the limited
use of pesticides on a set number of acres of land or surface water
under controlled conditions. 415 Minimum risk pesticides—
substances that pose little to no risk to human and animal health,
plants, or the environment—are exempt from the registration
requirements under FIFRA.416
Pesticides, or chemical residues thereof, that may find their
way into foodstuff come under the purview of the EPA’s authority
under the FFDCA. As discussed earlier, a food is deemed
“adulterated” under FFDCA when it contains a substance that
could be potentially injurious to health. 417 Thus, the EPA has
determined pesticides to be the type of substances covered under
FFDCA’s adulterated food provision. Furthermore, FFDCA grants

411

Id.
Id.
413
See, e.g., 7 U.S.C. § 136a(c)(5) (2012); 40 U.S.C. §§ 152.50, 152.170,
158.70, 158.130 (2012).
414
7 U.S.C. § 136a(c)(5).
415
§ 136c.
416
40 U.S.C. § 152.25(f) (2012).
417
21 U.S.C. § 342(a)(1) (2012).
412
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EPA authority to set tolerance levels for a pesticide chemical
residue in or on food if the agency determines it is safe to do so.418
A pesticide substance or residue is safe within the meaning of
21 U.S.C. § 342 if (1) a tolerance pronouncement is in effect and
the quantity of the residue is within the limits of said tolerance, or
(2) the EPA has carved out an exemption for the pesticide
chemical residue. 419 Safety, insofar as tolerance concerns, is
established when there is “a reasonable certainty that no harm will
result from aggregate exposure to the pesticide[,]” which includes
all foreseeable dietary exposures.420 When contemplating whether
to grant an exemption for a pesticide in food under FIFRA, the
EPA uses the FFDCA “reasonable certainty” safety standard.421
Tolerance determinations and exemptions are dynamic. They can
be modified or revoked on the basis on available information
related to several safety factors.422
V. CRISPR GMOS—NEW FOOD OR JUST GMOS 2.0?
The Coordinated Framework for the regulation of
biotechnology has now been in force for over three decades.
During that time, biotechnology and basic scientific knowledge
about diverse mechanisms to accomplish genetic manipulation in
cells and whole organisms has progressed immensely. Compared
to previous generations, scientists and plant breeders of this
generation have, at their disposal, more powerful and precise tools
to manipulate nucleotide sequences at will. Few, if any,
scientists—let alone law and policy makers—could have predicted,
at the time the Coordinated Framework went into effect, all the
ways in which humans are now able to alter the genetic
composition of whole organisms.

418

§ 346a(b)(2)(A).
§§ 342(a)(2)(A)–(B).
420
§ 346a(b)(2)(A)(ii).
421
Id.
422
§ 346a(b)(2)(D).
419
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The era of recombinant DNA is in the past. A genome editing
revolution is now underway. 423 This revolution, led by
macromolecular machines that shear DNA with tremendous
precision, is challenging long-held conventions of how humans
view life and the incipient power to control and alter the genetic
destiny of every living creature.
In the last few years, new methods of genetic manipulation
involving programmable nucleases such as Zinc Finger Nucleases
(“ZFNs”), Transcription Activator-Like Effector Nucleases
(“TALENs”), and CRISPR systems have emerged and taken root
in laboratories around the world with remarkable speed. 424 Of
these, CRISPR systems are the most renown due to their ease of
use, efficiency, and modular nature.
A. CRISPR-Based, Targeted Genome Editing—A Brief Overview
CRISPR is an adaptive immunity system used by bacteria and
archaea that provides resistance to attacks by phages and other
foreign genetic elements. 425 This immune system uses
complementary RNAs to recognize and cleave select foreign DNA.
In other words, when a virus infects a bacterium, the CRISPR
system—alongside a variety of CRISPR-associated (“Cas”)
proteins—responds to the invasion by recruiting specific RNAs
and Cas proteins that will be subsequently targeted to the foreign
DNA. Once the CRISPR-Cas complex encounters the foreign
DNA, it triggers a precise double-stranded cut that ultimately
neutralizes the ability of the pathogen to wreak havoc in the host.
This seek-and-destroy machinery has been co-opted in recent
years for targeted genome editing in various organisms ranging
from plants and animals, to even human cells.426 To induce targeted
genome editing, scientists engineer a short, synthetic RNA
423

For a detailed exposition of the history of genome editing, as well as some
of its applications and implications for science and law, see generally Enríquez,
supra note 1.
424
Other tools for genome editing exist. See Enríquez supra note 1, at 622–33.
425
Rodolphe Barrangou et al., CRISPR Provides Acquired Resistance Against
Viruses in Prokaryotes, 315 SCIENCE 1709, 1709 (2007).
426
Enríquez, supra note 1, at 632.
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molecule, called a single-guide RNA (“sgRNA”),427 that is partly
complementary to the DNA sequence that will be modified. The
sgRNA forms a complex with a Cas—e.g., Cas9—protein.
Following complex formation, the sgRNA guides the Cas protein
to its target DNA site. Upon binding to the desired DNA sequence,
the Cas protein cleaves the DNA backbone and leaves an open cut.
Because DNA cuts are highly deleterious, mechanisms to
repair DNA breakage have evolved within cells.428 Scientists have
figured out that they can take advantage of various DNA repair
mechanisms to either delete endogenous DNA sequences or insert
new DNA into the cleavage sites. This breakthrough system for
genetic manipulation is revolutionizing science and has significant
implications for the future of biotechnology and medicine.429
B. CRISPR-Based Genome Editing and the Coordinated
Framework
Genetic manipulation via modern genome editing technologies,
such as CRISPR systems, is strikingly different—in a few, but
significant areas—from older genetic engineering methods based
on recombinant DNA technology. With respect to GM crops, the
primary difference rests on the fact that older methods of plant
transformation are limited by the random integration of foreign
DNA sequences into the target plant species. Simply put, it is
impossible to control where, and with what frequency, insertion of
foreign DNA occurs via older genetic engineering techniques. In
contrast, modern genome editing technologies are precise and need
not rely on the insertion of foreign DNA sequences at all to carry
out intended genetic manipulations.

427

The sgRNA is an engineered fusion of two RNA molecules—a crRNA and
tracrRNA—naturally found in CRISPR-Cas9 systems. The first report of a
sgRNA for use in genome editing was reported in 2012. See Martin Jinek et al.,
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial
Immunity, 337 SCIENCE 816 (2012).
428
For a brief overview of DNA repair mechanisms, see Enríquez, supra note
1, at 620–21.
429
Id. at 628–33.
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The most important implication, for purposes of this
discussion, is that modern genome editing methods extend
previously unavailable opportunities to help allay controversies
surrounding GM crops.430
Consider the case of Arctic Apples431 and Innate potatoes432
recently approved by the FDA for human consumption after fiveand two-year review periods, respectively. The apples, for
example, are engineered to resist browning associated with cuts
and bruises via introduction of foreign nucleotide sequences to
suppress endogenous genes and the addition of a selectable marker
gene (nptII) for antibiotic resistance.433 This is precisely one of the
most unacceptable aspects of GM crops for critics: the transfer of
genetic material from an unrelated species—bacteria, fungi,
animals, etc.—into the genome of a crop plant, which would not
otherwise occur in nature.434
But what if a non-browning apple cultivar could be grown
without introducing any foreign DNA and selectable markers, and
instead possessed modifications that were no different from a
naturally occurring event? What if there was an alternative method

430

The opportunities referred to in this Section may not be entirely adequate
or meaningful for some people who oppose GMOs from a purist perspective.
That is, some anti-GMO people believe that any type of genetic engineering, no
matter what the approach or end point, is inherently inappropriate because
nature must be allowed to take its course without human intervention. For those
who hold that view, modern genome editing technologies are not likely to help
minimize the controversies surrounding GMOs.
431
U.S. FOOD & DRUG ADMIN., Biotechnology Consultation Agency Response
Letter
BNF
000132
(Mar.
20,
2015),
http://www.fda.gov/Food/FoodScienceResearch/GEPlants/Submissions/ucm436
163.htm.
432
U.S. FOOD & DRUG ADMIN., Biotechnology Consultation Agency Response
Letter
BNF
000141
(Mar.
20,
2015),
http://www.fda.gov/Food/FoodScienceResearch/GEPlants/Submissions/ucm436
169.htm.
433
Biotechnology Consultation Agency Response Letter BNF 000132, supra
note 431.
434
CENTER FOR FOOD SAFETY, About Genetically Engineered Foods,
http://www.centerforfoodsafety.org/issues/311/ge-foods/about-ge-foods# (last
visited Dec. 1, 2016).
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to locally suppress the endogenous genes that contribute to
browning?
Prior to 2016, inquiries to USDA’s APHIS led the agency to
issue determinations that a GM crop modified using earlier
genome editing technologies—such as ZFNs and TALENs—does
not fall within the purview of its regulatory oversight because it is
not deemed a regulated article.435 As discussed in Part IV, USDA
authority over GM crops is warranted if the genetically engineered
organism or product is, or there is a reason to believe it is, a “plant
pest.”436 However, the crop’s own DNA is not considered to be
plant pest material within the purview of the PPA.437
Less than a year ago, the USDA issued back-to-back responses
to the first two inquiries regarding the regulatory status of GM
crops modified using the CRISPR-Cas9 system438 The first inquiry
came from researchers at the Pennsylvania State University
regarding anti-browning, genome edited mushrooms designed to
produce less melanin—brown pigment—and improve the
mushroom’s appearance and shelf-life.439 The second inquiry came
from DuPont Pioneer concerning a type of waxy corn edited to
possess an altered starch composition.440 In letters issued five days
apart, the USDA declared that, based on the information provided
435

See, e.g., Michael Gregoire, APHIS Review as to Whether Zea mays Plants
with the IPK1 Gene Deleted Using Zinc Nuclease Technology is Regulated by
APHIS
2
(May
26,
2010),
https://www.aphis.usda.gov/biotechnology/downloads/reg_loi/DOW_ZFN_IPK
1_052610.pdf.
436
7 C.F.R. § 340.0(a)(2), n.1 (1997).
437
See § 340.1.
438
See Yinong Yang, UNITED STATES DEPARTMENT OF AGRICULTURE,
REQUEST FOR CONFIRMATION THAT TRANSGENE-FREE, CRISPR-EDITED
MUSHROOM IS NOT A REGULATED ARTICLE (Apr. 4, 2016),
https://www.aphis.usda.gov/biotechnology/downloads/reg_loi/15-32101_air_response_signed.pdf; Daria H. Schmidt, UNITED STATES DEPARTMENT
OF AGRICULTURE, CONFIRMATION OF REGULATORY STATUS OF WAXY CORN
DEVELOPED
BY
CRISPR-CAS
TECHNOLOGY
(Apr.
18,
2016),
https://www.aphis.usda.gov/biotechnology/downloads/reg_loi/15-35201_air_response_signed.pdf.
439
Yang, supra note 438.
440
Schmidt, supra note 438.
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by the researchers, neither crop fell under APHIS jurisdiction
pursuant to 7 C.F.R. § 340.441
USDA’s decision to decline jurisdiction to regulate these GM
crops marks a significant first that will likely open the gates for
some level of deregulation of CRISPR-based crops. Unlike older
genetic engineering methods, CRISPR-mediated genome editing
does not require the introduction of foreign DNA into a crop’s
genome—unless a researcher so desires—as a prerequisite for
proper function. Furthermore, the system can target select genes in
their native genomic loci. These are fundamental distinctions that
may eventually transform, alleviate, or even further complicate,
culture wars concerning GMOs.
One important note is that, although it appears that crops
generated using modern genome editing technologies are not
within the USDA’s jurisdiction, they may still face regulation by
the FDA and EPA. In any event, opponents of GMOs decry the
current regulatory scheme—including USDA’s decision not to
regulate CRISPR GM crops—and argue that conglomerates are
circumventing regulation through technical loopholes in outdated
regulations.442
VI. A REGULATORY PATH FOR GENOME EDITED CROPS IN THE
TWENTY-FIRST CENTURY
CRISPR-based genome editing technologies and their progeny
are poised to raise challenging problems that our legal system will
be forced to address. The current GM crop regulatory scheme
concocted by the Coordinated Framework is largely driven by the
realities and limitations of genetic engineering methods that rely
on recombinant DNA technology.443 In particular, the regulatory
calculus focuses heavily on the introduction of transgenic DNA,
from foreign organisms—e.g., viruses or bacteria—considered to
be plant pests, into GM food by virtue of human intervention.
441

See Yang, supra note 438; Schmidt, supra note 438.
Andrew Pollack, By ‘Editing’ Plant Genes, Companies Avoid Regulation,
N.Y. TIMES, Jan. 2, 2015, at B1.
443
See supra Part II.B.
442
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There is a high degree of dissonance between the ways in
which GM crops derived through transgenesis, or conventional
hybridization and plant breeding are regulated. On one hand, GM
crops developed with non-recombinant DNA techniques—e.g.,
intergeneric hybridization, induced mutagenesis, etc.—for crossbreeding non-related444 crop species are largely overlooked under
the Coordinated Framework. This is true even though these types
of modifications are, in theory, more likely to result in significant
reshuffling of parental genes, 445 which can lead to unexpected
phenotypic or compositional changes in GM food.
On the other hand, GM crops developed with recombinant
DNA technology, using either non-related or related crop species,
trigger immediate regulatory scrutiny because, despite being more
precise than non-recombinant methods, the technique used to
introduce DNA could also, in theory, lead to unexpected
phenotypic or compositional changes in GM food.
It is apparent that making a GM crop, using a myriad number
of techniques outlined in this Article, may in theory lead to
unforeseeable changes in foodstuff derived from it. It is also clear
that, despite the congruent likelihood of changes that could arise
from all GM crop methods, only recombinant DNA-based methods
have been associated with GMO controversies. The question, thus,
is one of risk. Namely, are the health and environmental risks
associated with recombinant DNA-derived GM crops greater than
those from their non-recombinant counterparts?
Three decades of scientific research suggests that the answer to
that question is no, and a scientific consensus has now formed to
support that proposition.446 From a strict risk-based standpoint, it
seems logical that some level of deregulation of GM crops would
be prudent. Indeed, many in the scientific community have
444

It is important to distinguish cross-breeding of non-related and related
plant species. Although both types are deemed not to fall under the regulatory
oversight of the Coordinated Framework, crosses between plants of the same
species are less likely to lead to unexpected phenotypic or compositional
changes in crops.
445
See Knobloch, supra note 31.
446
See studies previously cited supra note 225 and accompanying text; see
generally supra Section III.A.
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recently argued on behalf of a risk-based approach to replace the
current process-based approach to biotechnology.447
The risk-based deregulation line of reasoning comes at the eve
of forthcoming updates to modernize the Coordinated Framework
initiated by the Obama Administration in 2015.448 The Executive
Branch’s directive to modernize the U.S. regulatory system for
biotechnology aims to improve transparency, efficiency,
predictability, and public confidence in the federal government’s
ability to develop sound health and environmental policy.449 The
initiative explicitly aspires to ensure that biotechnology product
evaluations adhere to a “risk-based” system that is grounded in the
“best science available.”450
The White House initiative coupled with the findings in the
most recent report by the NASEM on the status of GM crops
suggests that the future regulatory landscape for GM crops will
likely be less restrictive than its current incarnation. However, if
the new approach to biotechnology is risk-based, how will
CRISPR-mediated genome edited crops be regulated? In the near
future, it will likely be increasingly cumbersome to distinguish a
genome-edited crop from a naturally occurring crop. Therefore,
technological advances in genome editing are likely to challenge
the very essence of what constitutes a GMO. And, if that is where
the technology is headed, should CRISPR GM crops be regulated
at all? To shed some light on these questions, a hypothetical
involving bananas and a fungus could be particularly illustrative.

447

See, e.g., Gregory Conko et al., A Risk-Based Approach to the Regulation
of Genetically Engineered Organisms, 34 NATURE BIOTECHNOLOGY 493 (2016).
448
See EXECUTIVE OFFICE OF THE PRESIDENT, Memorandum for Heads of
Food and Drug Administration, Environmental Protection Agency, and
Department of Agriculture: Modernizing the Regulatory System for
Biotechnology
Products
(July
2,
2015),
https://www.whitehouse.gov/sites/default/files/microsites/ostp/modernizing_the
_reg_system_for_biotech_products_memo_final.pdf.
449
Id. at 4.
450
Id.
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A. Banana vs. Fungus—A Hypothetical
Suppose a group of researchers is deeply concerned about
bananas and their susceptibility to a crippling fungus. 451 After
many years of study, the researchers have finally discovered that
the fungus secretes factors that bind to a small epitope site on a
receptor of the plant’s cell membrane. Upon binding, a series of
conformational changes occur in the receptor that make it easy for
the pathogen to perforate the membrane and cause cell lysis,
eventually leading to cell death. The researchers have further
discovered that resistance to this deadly fungus occurs naturally in
some populations of a distantly related crop.
Using the latest technologies on high-throughput sequencing,
bioinformatics, functional genomics, and molecular biology, the
researchers have discovered that the receptor in banana cells is
conserved across all plant species. Structural and biochemical
information has revealed that the epitope site is less than five
ångströms452 away from the active site of the receptor’s catalytic
domain, and that mutating or deleting only one residue453 in the
451

In fact, the Cavendish banana—the most popular fruit in the world—is
currently in danger of extinction in some parts of the world due to its
susceptibility to the Tropical Race 4 fungus. See DAN KOEPPEL, BANANA: THE
FATE OF THE FRUIT THAT CHANGED THE WORLD (2008); Dan Charles, Our
Favorite Banana May Be Doomed; Can New Varieties Replace It? NPR (Jan.
11, 2016), http://www.npr.org/sections/thesalt/2016/01/11/462375558/ourfavorite-banana-may-be-doomed-can-new-varieties-replace-it. The hypothetical
presented is not reflective of the actual pathophysiology of the Tropical Race 4
fungus disease and is merely based on the banana’s susceptibility to the disease
for illustrative purposes.
452
An ångström (Å) is a unit of length equal to 10–10 meters.
453
Mutations of only a few nucleotides in a gene can potentially lead to
dramatic phenotypes. For instance, a naturally occurring mutation of only two
amino acids (T102I and P106S) in the 5-enolpyruvylshikimate-3-phosphate
synthase (EPSPS) gene confers resistance to glyphosate in Eleusine indica, a
type of Indian grass. See Q. Yu et al., Evolution of a Double Amino Acid
Substitution in the 5-enolpyruvylshikimate-3-phosphate Synthase in Eleusine
indica Conferring High-Level Glyphosate Resistance, 167 PLANT PHYSIOLOGY
1440 (2015). This phenomenon is not unique to plants. For instance, a single
point mutation in human cells is responsible for the most common form of
Cystic Fibrosis, which has been corrected using CRISPR-Cas9 genome editing
in stem cells in vitro. See Gerald Schwank et al., Functional Repair of CFTR by
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receptor protein prevents binding of the fungus factor altogether,
thereby sparing the fate of the crop.
FIGURE 3

The molecular basis for herbicide resistance in GM crops—A
glyphosate-resistant EPSPS (5-enolpyruvylshikimate-3-phosphate
synthase) enzyme. X-Ray, crystal structure of the class I EPSPS from
Escherichia coli in complex with ligands shikimate-3-phosphate (S3P,
CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients, 13
CELL STEM CELL 653 (2013).
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green) and the broad spectrum herbicide glyphosate (represented by
spheres) caged between the enzyme’s globular N-terminal (blue and
orange) and C-terminal (red and cyan) domains. 454 The TIPS
(T97I/P101S—Threonine97-to-Isoleucine and Proline101-to-Serine in E.
coli—colored in purple) mutations confer glyphosate resistance by
causing fine structural changes in the active site that inhibit optimal
glyphosate binding without substantially compromising EPSPS
catalytic efficiency.455 The figure appears in color in the online version
of the Article.456

The researchers transfected preassembled complexes of
purified CRISPR-Cas9 and a sgRNA into banana protoplasts.457
The CRISPR-Cas9 complexes induced recombinant DNA-free
genome editing that generated small insertions or deletions that
either deleted the lone residue essential for binding of the fungus
factor, caused a point mutation that triggers misfolding and
premature degradation of the protein, or introduced a stop codon
that resulted in a truncated version of the receptor. With the
exception of plants harboring the mutation that causes receptor
misfolding and premature degradation—all of which exhibited
arrested development—all other plants developed to maturity and

454

The model of this double mutant EPSPS was built using the atomic
coordinates deposited in the Protein Data Bank, accession code 3FK1 (2009),
http://www.rcsb.org/pdb/explore/explore.do?structureId=3FK1.
455
Structural and biochemical details of the TIPS mutations as well as their
impact on EPSPS efficiency and glyphosate resistance are discussed in Todd
Funke et al., Structural Basis of Glyphosate Resistance Resulting from the
Double Mutation Thr97 ! Ile and Pro101 ! Ser in 5-Enolpyruvylshikimate-3phosphate Synthase from Escherichia coli, 284 J. BIOLOGICAL CHEMISTRY 9854
(2009).
456
The online version can be accessed at the Journal’s website, ncjolt.org, by
clicking on the “Articles” tab, Volume 18, Issue 4.
457
See KOEPPEL, supra note 451. A similar DNA-free genome editing
approach was recently reported to introduce targeted mutations in various genes
in Arabidopsis thaliana, tobacco, lettuce, and rice plants without using any
recombinant DNA. See Je Wook Woo et al., DNA-Free Genome Editing in
Plants with Preassembled CRISPR-Cas9 Ribonucleoproteins, 33 NATURE
BIOTECHNOLOGY 1162 (2015).
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are indistinguishable from wildtype458 plants. Furthermore, all the
banana plants developed from the CRISPR-Cas9 genome editing
experiment are immune to the fungus. Whole genome sequencing
of the new mutants revealed that the only change in the entire
banana genome was at the intended site, and that the mutations
were the same as those found naturally in the distant crop that is
resistant to the fungus.
In summary, the researchers used CRISPR-Cas9 to introduce a
point mutation in the banana receptor, which conferred resistance
to the fungus. The mutant banana has zero foreign DNA, is
genetically identical to all other bananas—but for the single
residue mutation or truncation of the receptor protein—and
contains mutations that have already been found to occur in nature
and confer natural resistance to the fungus in another crop species.
How should this new banana be regulated?
B. Applying the Coordinated Framework to Reveal Regulatory
Gaps
Under a broad interpretation of the current Coordinated
Framework, the new banana crop could arguably fall under the
jurisdiction of the USDA, FDA, and EPA because it involves the
genetic modification of a crop used in agriculture, grown with the
expectation that it will be sold across interstate lines for human
consumption, and comprising a substance that, in effect, acts as a
pesticide against the fungus.
However, because the crop was produced without addition of
foreign DNA and introduced only a small insertion or deletion in
the target gene, the USDA is likely to determine that the crop is not
a regulated article or plant pest—pursuant to 7 C.F.R. § 340—as it
has done with other CRISPR GM crops.459 Furthermore, because
the mutation is naturally occurring in a distant plant, APHIS may
declare that there is a miniscule risk for harm to U.S. agriculture
458

Wildtype refers to the most common phenotype for an organism in a
natural breeding population. BIOLOGY ONLINE, Wildtype, http://www.biologyonline.org/dictionary/Wildtype (last visited March 7, 2017).
459
See Yang, supra note 438; Schmidt, supra note 438.
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that could justify impediments for transit of the crop through
interstate commerce.
An argument could be made that the crop should not be
considered safe because it contains a mutation that, while found in
nature in distant species, is novel in bananas. Accordingly, the
researchers should seek a permit and a safety assessment should be
performed. But this argument falters460 because the new banana
mutation is of known function and does not result in plant
disease.461
Similarly, it would be unlikely that the FDA would determine
that the new banana is an adulterated food product within the
meaning of the FFDCA. 462 The single point mutation, which
already occurs in nature and was characterized in the distantly
related crop, is probably not going to trigger compositional
changes in the food that would qualify it as a food additive that is
injurious to human health.463 Given the (1) lack of foreign DNA
sequences, (2) genome-wide similarities between the normal and
the mutant bananas, (3) presumed lack of off-target effects from
CRISPR-Cas9 genome editing,464 and (4) well-established status of
the banana as a nutritious crop, it would be difficult to imagine that
the FDA would impose roadblocks in the path to
commercialization.
The EPA could decide that the point mutation in the receptor is
a plant-incorporated protectant or pesticide.465 However, because
the genetic material needed to produce the purported pesticidal
substance is endogenous to the plant and can be found in nature,
460

Suppose that the researchers subsequently find a region of the world in
which the banana evolved natural resistance to the fungus resulting from the
same mutation that was introduced with CRISPR-Cas9. Such a discovery would
seriously undermine any arguments in favor of restrictions based on safety.
461
See 7 C.F.R. § 340.3(b) (2016).
462
21 U.S.C. § 342(a)(1) (2012).
463
§ 321(s).
464
Off-target activity of CRISPR-based genome editing is an active field of
scientific research. Significant improvements in this area have been made in the
past three years. See, e.g., Seung Woo Cho et al., Analysis of Off-Target Effects
of CRISPR/Cas-Derived RNA-Guided Endonucleases and Nickases, 24 GENOME
RESEARCH 132 (2014).
465
See 40 C.F.R. § 152.3 (2016); 7 U.S.C. § 136 (2012).
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the agency could likely find that the crop does not represent an
“unreasonable adverse effect on the environment.” 466 Moreover,
under this specific scenario, the fungus is exclusively acting as a
pest and its eradication would presumably pose no threat to the
ecosystem. If the targeted species was an insect instead of a
fungus, it may be necessary to assess the potential unreasonable
adverse effects on the environment.467
An additional factor that may favor deregulation of the banana
crop comes from the unique requirement that, under FIFRA,
EPA’s determination cannot be solely based on scientific data, but
also on other economic, social, and environmental factors.468 This
standard might strengthen the argument for deregulation given that
the mutation is highly specific, characterized, and could potentially
save an extremely important agricultural crop from the brink of
extinction. Likewise, the EPA would probably issue an exemption
to the registration requirements because the banana mutation poses
a minimal risk to human and animal health, plants, or the
environment.469
The analysis would change slightly if the truncation, and not
the point mutation, was the dominant effect from genome editing.
It is possible that a non-functional, truncated receptor in a cell
membrane would interfere with cellular pathways and other
functional roles. If the truncation leads to accumulation of a
particular protein that has allergenic potential, it could, in theory,
represent a potential danger to human health or the environment.
The problem under this scenario would be predicting such adverse
effects, which are unlikely to occur.
C. Regulatory Outlook and Policy Perspectives
As is evident from the foregoing analysis, it is quite probable
that certain types of CRISPR GM crops will escape regulation
under the Coordinated Framework. However, perhaps the most
466

7 U.S.C. § 136a(a).
Id.
468
See § 136(bb).
469
See 40 C.F.R. § 152.25(f) (2016).
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interesting question is not how will CRISPR crops be regulated,
but rather should they be regulated at all?
If the banana crop is nearly identical to a naturally occurring
cultivar and the mutation has been found in nature, it is puzzling to
imagine the government treating the crop differently than one
developed via traditional plant breeding methods. If anything, this
banana would presumably be safer because any genetic changes
made are probably very precise and their exact location is known.
1. The Worlds of Science and Policy
For better or worse, issues concerning the contours of
regulatory oversight and policy making cannot be resolved in a
scientific vacuum, in which the sole and primary considerations
necessary to adjudicate controversies orbit the relevant scientific
facts and evidence. Quite the contrary, the process of developing
policy is inherently complex and dependent on a multitude of
factors—e.g., legal, economical, social, political, and others.470 In
fact, studies suggest that scientific-based evidence is often eclipsed
by other considerations, and those who develop and promote
model public health laws—laws or private policies publicly
recommended by organizations for adoption by government bodies
or private entities—frequently provide scant information about the
methods and evidence used in developing such laws.471 This policy
“reality” can be difficult to grasp for many scientists and advocates
of strict science-based law and policy making who are routinely
dismayed when law and policies eschew scientific evidence.
470

See, e.g., MASON A. CARPENTER & SANJYOT P. DUNUNG, CHALLENGES
OPPORTUNITIES IN INTERNATIONAL BUSINESS V. 1.0 67, 73 (2012),
http://2012books.lardbucket.org/pdfs/challenges-and-opportunities-ininternational-business.pdf (linking some of these factors to global trade); Andy
Norton & Diane Elson, What’s Behind the Budget? Politics, Rights and
Accountability
in
the
Budget
Process
5
(2002),
https://www.odi.org/sites/odi.org.uk/files/odi-assets/publications-opinionfiles/2422.pdf (connecting similar factors to budgetary policy).
471
See, e.g., DeKeely Hartsfield et al., A Review of Model Public Health Laws,
97 AM. J. PUB. HEALTH S56, S59 (2007) (revealing findings from a study of 107
model public health laws published between 1907 and 2004 in which only 7
(6.5%) of the 107 sponsors provided scientific information to support the laws).
AND
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Consider, for example, a scenario in which the CRISPR banana
illustrated earlier is commercially viable but threatens a select few
local economies because producers are suddenly unshackled from
considerable expenditure of resources associated with the non-GM
version of the crop. Technological advances may save the banana
from extinction, but impose high social costs such as job losses for
hundreds or thousands of workers that irrigate fields with
pesticides and fungicides, perform labor on the land, and remove
individual plants when signs of infection appear.472
Social, economic, and political costs may not rank at the top of
scientists’ concerns, but considering those costs is likely a pivotal
task for elected public officials and other policy makers who must
answer to their constituents.
Although scientists and policy makers can sometimes share
common interests and goals, they largely operate on a myriad of
472

This scenario is not far from the actual tensions between heeding scientific
recommendations and weighing other non-scientific factors. For instance,
President Donald Trump recently signed an Executive Order to “review existing
regulations that potentially burden the development or use of domestically
produced energy resources and appropriately suspend, revise, or rescind those
that unduly burden the development of domestic energy resources beyond the
degree necessary to protect the public interest or otherwise comply with the law.”
Exec. Order No. 13,782, 82 Fed. Reg. 16,093 (Mar. 27, 2017).
The Executive Order is seen by many as an effort to roll back climate change
policies implemented during the Obama Administration. See, e.g., Doral
Davenport & Alissa J. Rubin, Trump Signs Executive Order Unwinding Obama
Climate
Policies
(Mar.
28,
2017),
https://www.nytimes.com/2017/03/28/climate/trump-executive-order-climatechange.html?_r=0. Critics of the recent move to curb such policies argue that the
Trump Administration is favoring the coal industry and other energy interest
groups over scientists’ warnings concerning a “future of severe droughts, floods,
rising sea levels and food shortages” as a result of climate change. Id.
Trump’s comments during the Executive Order’s signing ceremony illustrate
the significance that non-scientific factors play in developing national policy. At
the conclusion of his speech, he addressed a group of coal miners present at the
ceremony and remarked: “Come on, fellas. Basically, you know what this is?
You know what it says, right? You’re going back to work.” Donald Trump, U.S.
President, Remarks at Signing of Executive Order to Create Energy
Independence (Mar. 28, 2017), https://www.whitehouse.gov/the-pressoffice/2017/03/28/remarks-president-trump-signing-executive-order-createenergy.
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distinct functional systems of accountability, career development,
research methodology, and problem-solving. Scientists—and
scholars in general—are typically interested in pushing the
boundaries of knowledge and drawn to questions of theoretical or
empirical value to them.473 They are accountable under a system of
peer-review and advance their careers by publishing work that will
impress others in their field.474 There often is no reward system for
scientists to engage in policy development. 475 Involvement in
controversial policy debates may actually be detrimental to
scientists’ careers by making them subject to personal attacks476—
which, unlike politicians, scientists are not sufficiently inured to—
or impacting their ability to secure funding for their work via
research grants. 477 Accordingly, it is no surprise that scientists
seldom engage in policy development.
Policy makers, on the other hand, have little to no interest in
the types of theoretical or empirical inquiries that fuel scientists’
endeavors.478 They value research, but usually only if it serves as a
tool to tackle problems their constituents face.479 Policy makers are
held accountable at the voting ballot, either directly or indirectly
depending on whether they are elected officials or appointed by
them. This system of accountability guarantees that individuals in
charge of policy development will give great weigh to public
opinion, particularly when an issue receives considerable attention
in the media.480 Indeed, research suggests that when confronted
with a tough policy issue, policy makers seldom turn to published
473

David N. Plank & Debbi Harris, Minding the Gap Between Research and
Policymaking, in THE SAGE HANDBOOK FOR RESEARCH IN EDUCATION:
ENGAGING IDEAS AND ENRICHING 38 (Clifton F. Conrad & Ronald C. Serlin eds.,
2006).
474
Id.
475
Ross C. Brownson et al., Researchers and Policymakers: Travelers in
Parallel Universes, 30 AM. J. PREVENTIVE MED. 164, 167 (2006).
476
Id.
477
See, e.g., Keelie Lyn Elektra Murdock & David Koepsell, Principals,
Agents, and the Intersection Between Scientists and Policy-Makers: Reflections
on the H5N1 Controversy, 2 FRONTIERS PUB. HEALTH art. 109, at 3 (2014).
478
Plank & Harris, supra note 473, 38.
479
Id.
480
Id.
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literature.481 Instead, they often turn to their constituents, a group
that may include lobbyists and other interests groups.482 The end
result of this process is that policy makers can adopt policies that
exhibit little regard, or run contrary to, scholarly and scientificbased research.483
2. Promoting Research- and Scientific-Based Policy Development
There are several obstacles to developing scientific-based
public policy in the realm of GMOs. Perhaps the most intractable
impediment is overcoming the breed of hyper sensationalism—i.e.,
deceptive simplicity484—that can sometimes flourish within public
opinion, which flows directly from the public’s lack of education
about the science concerning GMOs in general, and GM foods in
particular. A potentially effective strategy to ameliorate this
problem is to develop policies that aim to tackle a range of
seemingly peripheral, but fundamentally central, areas surrounding
regulation of GMOs and technological advances in general.
2.1 Facilitate Transparency in the Regulatory Process
The bulk of opposition to GMOs in the public discourse stems
primarily from perceptions that corporate conglomerates with
ulterior motives control the output of scientific research available
on the health and safety risks of GMOs.485 As pointed out in Part
III, evidence suggests that a vast majority of the peer-reviewed
studies on the safety of GMOs do not actually corroborate
conspiracy theories about insidious links between the research
published by scientists all over the world and corporate efforts to
undermine public health and the environment. However, it is also
481

See, e.g., Richard Sorian & Terry Baugh, Power of Information: Closing
The Gap Between Research and Policy, 21 HEALTH AFF. 264, 269 (2002).
482
Id.
483
Plank & Harris, supra note 473, at 39.
484
“Deceptive simplicity” is as an umbrella term used to refer to common
substantive impediments to constructive debate that consist of impractical and
often sensationalist claims about issues raised by scientific and technological
advances. See Enríquez, supra note 1, at 614–16.
485
See supra Section III.A.3.
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true that many peer-reviewed studies—both in favor and in
opposition of GMOs—are published by authors with some industry
ties.486
Given the highly charged controversies surrounding GMOs in
recent years, it would be beneficial for industry and government
agencies to work together to formulate and implement policies that
make more scientific health and testing data public. Publication of
these data would involve a careful and delicate balance between
(1) protecting intellectual property rights—e.g., trade secrets—and
confidential business information (“CBI”) of producers of GM
crops, and (2) ensuring adequate disclosure of health and safety
data to the public.487
In general, the law permits companies to avail themselves of
the right to claim some or all of data submitted to regulatory
agencies as CBI.488 However, the 1990 case concerning the use of
recombinant bovine growth hormone (rbGH) in dairy cattle489 set a
unique, and presumably limited, precedent for a federal regulatory
agency’s decision to publish scientific information used in the
safety evaluation of a product prior to its approval. In that case, the
FDA decided to publish a summary of the relevant health and
safety data to address public concerns about potential hazards from
the use of rbGH that had been reported in the media.490 Although
the FDA’s decision to make the data public did not put to rest all
controversies surrounding rbGH,491 it brought an increased level of
transparency to the regulatory process. Industry players and policy
makers should consider the rbGH case as a potential precursory
486

See supra note 270.
Rena Steinzor and Matthew Shudtz, Sequestered Science: Secrets
Threatening Public Health, CTR. FOR PROGRESSIVE REFORM 1 (Apr. 2007),
http://www.progressivereform.org/articles/Secrecy_703.pdf.
488
Id. at 5.
489
See generally Judith C. Juskevich & C. Greg Guyer, Bovine Growth
Hormone: Human Food Safety Evaluation, 249 SCIENCE 875 (1990).
490
Id.
491
See Richard Raymond et al., Recombinant Bovine Somatotropin (rbST): A
Safety Assessment, NAT’L ANIMAL INTEREST ALL. 14–15 (Mar. 22, 2010),
http://www.naiaonline.org/uploads/WhitePapers/RecombinantSomatotropinASa
fetyAssessment2010.pdf.
487
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model that can be tweaked to educate and allay public concerns
surrounding select biotechnologies.492
2.2 Disclose Conflicts of Interest
The concern engendered by the appearance of deep-seated
conflicts of interests as perceived by many who oppose GMOs is
not entirely unreasonable. After all, history has shown that in some
instances powerful corporate entities—as well as the individuals
who lead them—can act unethically and put financial interests
ahead of their social responsibilities to the public. A notorious
example is the case of the tobacco industry—circa the early
1950s—and the smear campaign it launched in response to the
peer-reviewed scientific evidence and consensus that had
crystallized around the deleterious health hazards of smoking.493
492

On the topic of transparency, The NASEM Report recommended that GM
crop producers publicly disclose as much health and safety data submitted to
regulatory agencies during the approval process as possible, and that regulatory
exemptions from disclosure should be as narrow as possible. See NASEM
REPORT, supra note 211, at 506. However, the NASEM did not elaborate or
provide guidance regarding what constitutes a narrow exemption, which would
ultimately be an issue of law. Furthermore, the amount of information a
corporation deems to fall under an “as much as possible” category for purposes
of voluntary disclosure is likely to be substantially different from the amount of
information that a regulatory agency, or even the public in general, will deem
appropriate to disclose. A recommendation without some degree of specificity is,
therefore, likely to vanish in rhetorical quicksand. Accordingly, this Article goes
a step further and recognizes that industry and government agencies could use
the rbGH case as a starting point to delineate the contours of the relationship
between data disclosure and regulatory exemptions that take into account the
interests of GM crop developers and the public.
493
See Allan M. Brandt, Inventing Conflicts of Interest: A History of Tobacco
Industry Tactics, 102 AM. J. PUB. HEALTH 63 (2012). Curiously, the case of the
tobacco industry involved a powerful lobby deploying an arsenal of strategies
designed to undermine the legitimacy of scientific research, engineer
controversies about purported conflicts of interest, and generate public
skepticism of science by calling for more research and offering funding as a
public relations plot. Id. In contrast, GMO-related controversies in the last
decade or so are propelled mainly by activist organizations that defy powerful
corporations that seek to commercialize the production of GM crops.
Although not exactly analogous, there are commonalities between the two
cases. The legitimacy of scientific evidence is at the core of both controversies.
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The infamous Volkswagen affair also comes to mind.494 The auto
maker recently agreed to plead guilty to federal conspiracy charges
to defraud the United States government and pay a record $ 4.6
billion fine for selling vehicles with software designed to cheat
pollution laws.495 Given some high profile corporate scandals in the
last decades, it is no surprise that some segments of the public may
distrust powerful interests and corporations.
To mitigate some of the controversies associated with either
the existence or appearance of conflicts of interest in scientific
research, policy makers and scientific publishers should promote
full disclosure of all potential conflicts in scientific publications.
Because the appearance of a conflict of interest can damage a
journal’s reputation, publishers ought to require disclosure of all
competing interests—financial, political, institutional, personal,
etc.496
Journals may enforce this policy by issuing special corrections
for inadvertent omissions, and imposing fines or banning repeat
offenders from publishing work in the journal and its affiliates.
Government agencies should implement strict guidelines outlining
compulsory disclosure of any possible conflicts of interest for
specified periods of time—e.g., sources of funding that may raise
conflicts for the three, five, or seven years preceding the published
research. The guidelines should further explicitly communicate
consequences for failing to disclose conflicts, which could include
However, unlike the case of the tobacco industry—in which the corporations
tried to undermine the science that had accumulated on the health risks of
tobacco—biotechnology corporations now seek shelter in the peer-reviewed
scientific evidence, while activist entities dismiss the peer-reviewed scientific
consensus and promote public skepticism by calling for more research to be
performed on the health impacts of GMO consumption. See supra Section
III.A.3.
494
Nathan Bomey, VW Pleads Guilty to Conspiracy, Obstruction of Justice; 6
Execs
Charged,
USA
TODAY
(Jan.
11,
2017,
6:26
PM),
https://www.usatoday.com/story/money/cars/2017/01/11/volkswagen-epa-dojdepartment-of-justice-settlement/96439678/.
495
Id.
496
Conflict of Interest in Peer-Reviewed Medical Journals, WORLD ASS’N OF
MEDICAL EDITORS (Jul. 25, 2009), http://www.wame.org/about/conflict-ofinterest-in-peer-reviewed-medical.
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a mix of penalties, requirements to enroll and attend ethics
seminars, or even temporary banning repeat offenders from
applying for government grants.
Adhering to clear and robust conflict of interest policies can
help scientists defend the integrity of their work. For instance,
shortly after the NASEM Report was released, a study criticized
some members of the committee for not disclosing apparent
financial and institutional conflicts of interest.497 The study claimed
that the NASEM failed to follow disclosure requirements set forth
in the Federal Advisory Committee Act.498 The NASEM quickly
responded to the allegations by pointing out that it has “a stringent,
well-defined, and transparent conflict-of-interest policy, with
which all members of [the] study committee complied[,]” and that
“its report underwent the Academies’ usual rigorous, external, and
anonymous peer-review process before it was approved for
publication.”499 The NASEM further characterized the authors of
the study and its conclusions as “unfair and disingenuous” for
applying “their own perception of conflict of interest . . . in place
of [] tested and trusted conflict-of-interest policies.”500
2.3 Develop Policies to Promote Dedicated Grants
Another potential strategy that could impact the advancement
of scientific-based policy development in the realm of GMOs is to
promote policies that erect a buffer zone between industry and
497

Sheldon Krimsky & Tim Schwab, Conflicts of Interest Among Committee
Members in the National Academies’ Genetically Engineered Crop Study, 12
PLOS ONE e0172317 (2017).
498
Id.
499
Statement by the National Academies of Sciences, Engineering, and
Medicine Regarding PLOS ONE Article on Our Study of Genetically Engineered
Crops, NAT’L ACADS. SCIS., ENG’G, & MED. (Mar. 1, 2017),
http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=31201
7b&utm_source=NASEM+News+and+Publications&utm_campaign=049bfc0b
62-NAP_mail_new_2017-0306&utm_medium=email&utm_term=0_96101de015-049bfc0b62101937173&goal=0_96101de015-049bfc0b62101937173&mc_cid=049bfc0b62&mc_eid=d85449f0d2.
500
Id.
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scientific research. Independent researchers at public universities
and non-profit institutions must sometimes rely on private industry
players for sources of funding due to scarcity of government funds
or programs. This, in turn, leads to perceived or apparent conflicts
of interest between the researchers and their funders.501
To address this problem, policy makers should consider the use
of dedicated grants to encourage independent study of the shortand long-term effects of GM food consumption. For instance, the
State of Washington recently appropriated funds for a Dedicated
Marijuana Account to study the short- and long-term health effects
of marijuana use as part of Initiative 502 (“I-502”). 502 I-502
provides research funds for proposals awarded under a peer-review
process on the basis of scientific merit.503
The National Institute of Food and Agriculture and the USDA
also jointly administer the Biotechnology Risk Assessment
Research Grants (BRAG) program. 504 The BRAG program was
created to “support the generation of new information that will
assist Federal regulatory agencies in making science-based
decisions about the environmental effects of introducing organisms
genetically engineered [] by recombinant nucleic acid
techniques.”505 However, funding for BRAG is currently limited to
roughly $ 4 million in fiscal year 2017, which means the program
is limited in reach.506 Similar programs of dedicated grants could be
instituted by other federal and state agencies to support increased
independent research on the potential long-term effects of GMOs
consumption.
501

See supra Section VI.C.2.2.2 and accompanying text.
Guidelines for ADAI Small Grants with I-502 Marijuana, ALCOHOL &
DRUG
ABUSE
INST.,
http://adai.uw.edu/grants/Small%20Grants%20Guidelines%20Marijuana%20FI
NAL.pdf (last visited Apr. 14, 2017).
503
Id.
504
Biotechnology Risk Assessment Research Grants Program, U.S.D.A.,
https://nifa.usda.gov/sites/default/files/rfa/FY2017%20Biotechnology%20Risk
%20Assessment%20Research%20Grants%20Program%20%28BRAG%29%20
RFA.pdf.
505
Id. at 4.
506
Id. at 12.
502
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Admittedly, developing such policies can be difficult in an
ever-increasing political environment of budgetary cuts to
scientific research. 507 However, from a science-based policy
perspective, it may be worthwhile in the long-run for policy
makers to consider all avenues to develop policies to support
independent scientific research. For instance, to pay for its
dedicated grants program, the State of Washington designated the
Liquor and Cannabis Board as the regulatory entity in charge of
collecting “marijuana excise taxes, license fees, penalties,
forfeitures, and all other moneys including income, or revenue
received [from] marijuana-related activities.”508
2.4. Incorporate Modern Technologies, When Feasible, and
Promote Technology Development
A fundamental question regarding crops developed via
traditional breeding methods and transgenic crops containing
recombinant DNA material is the degree to which changes in the
crop’s genome may ultimately render the plant hazardous to
humans.509 As detailed in Part II, GMOs are produced using nonrecombinant, as well as recombinant, DNA methods.510 However,
the current regulatory scheme under the Coordinated Framework
only requires health and safety testing of crops produced through
recombinant DNA technology, despite the fact that both categories
of making GMOs can lead to unintended changes in the plant’s
genome.
Although a large body of peer-reviewed literature concerning
the health and environmental safety of GMOs has accumulated in
the past two decades,511 it is important to recognize that human
knowledge is not absolute and we may continue to learn more
507

See, e.g., NIH, DOE Office of Science Face Deep Cuts in Trump’s First
Budget,
SCIENCE
(Mar.
16,
2017),
http://www.sciencemag.org/news/2017/03/nih-doe-office-science-face-deepcuts-trumps-first-budget.
508
H.B. 2136, 2015 Leg. 2d Spec. Sess. (Wash. 2015).
509
See supra Part II.
510
Id.
511
See supra Part III.
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about the science behind GM crops as technological improvements
in methods of detection and statistical analysis in the realm of
“omics”512 disciplines occur.
Already, a wealth of information has been compiled about the
equivalence of GM crops compared to their near isogenic513 nonGM counterparts.514 Many of the omics assessments performed to
date reveal that GM crops do not raise safety concerns relative to
non-GM crops, even when some compositional differences, which
are within the range of expected natural variation due to
environmental growth conditions, are detected. 515 Despite the
advantages and potential uses of emerging omics technologies as
powerful research tools, mandatory requirements of omics safety
assessments of GM crops are not appropriate at this point in time
given the early stage of some omics tools, which can be susceptible
to bias, experimental design flaws, and statistical errors.516
512

Omics is a term that refers to the study of “the collective characterization
and quantification of pools of biological molecules that translate into the
structure, function, and dynamics of an organism or organisms.” Omics,
WIKIPEDIA, https://en.wikipedia.org/wiki/Omics. This discipline concerns the
large-scale interactions, relationships, and networks within biological systems.
Thus, for example, genomics is the large-scale study of the genomes of
organisms, proteomics is the large-scale study of proteins produced by
organisms, and metabolomics is the large-scale study of metabolites produced
from cellular processes. Id.
513
A near isogenic line refers to a strain of an organism—e.g., a plant—that
has a near identical genetic composition, but for a few specific differences at
certain genomic loci. Guangdi Yuang et al., Development of Near-Isogenic
Lines in a Parthenogenetically Reproduced Thrips Species, Frankliniella
occidentalis, 8 FRONTIERS PHYSIOLOGY art. 130, at 1 (2017) (citations omitted).
514
See, e.g., Agnès E. Ricroch et al., Evaluation of Genetically Engineered
Crops Using Transcriptomic, Proteomic, and Metabolomic Profiling Techniques,
155 PLANT PHYSIOLOGY 1752, 1753–57 (2011). But cf. Robin Mesnage et al.,
An Integrated Multi-Omics Analysis of the NK603 Roundup-Tolerant GM Maize
Reveals Metabolism Disturbances Caused by the Transformation Process, 6
SCIENTIFIC REPS. art. no. 37855, at 1 (2016) (using a multi-omics approach to
compare a widely commercialized GM crop and its non-GM isogenic line, and
concluding that the two lines are not “substantially equivalent” in terms of
nutritional and compositional content).
515
Ricroch et al., supra note 514, at 1755, 1757–59.
516
See generally Jackson O. Lay Jr. et al., Problems with the “Omics”, 25
TRENDS ANALYTICAL CHEMISTRY 1046 (2006); Ricroch et al., supra note 514,
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However, as technological advances in omics disciplines
accrue and gaps in methodology and statistical analysis begin to
close, policy makers ought to develop policies that encourage
researchers and GM crop developers to incorporate modern
technologies—including
high-throughput
whole-genome
sequencing
(“WGS”),
mass
spectrometry,
chromatin
immunoprecipitation followed by sequencing (“ChIP-Seq”),
Bisulfite sequencing, RNA sequencing, and others—in their
research, so long as these tools do not pose undue financial
burdens.517 Fortunately, the use of modern technologies is unlikely
to be a burden on all major GM crop producers.
Consider the downward trend in genome sequencing costs over
the past decade and a half. Estimates of the total cost to sequence
the first human genome at the dawn of the twenty first century
range from half a billion to one billion dollars.518 By 2006, the cost
had dropped to roughly between twenty and twenty-five million
dollars.519 Today, that figure has dropped to approximately 1,000 to
1,500 dollars.520
Given the increasing accessibility of these technologies, it may
be prudent, in the near future, to require GM crop producers to
submit omics data to corroborate their products’ “substantial
equivalence” 521 to crops developed via traditional breeding
at 1757–58. See also NASEM REPORT, supra note 211, at 395 (stating that, in
order to realize the full potential of omics technologies, “a more comprehensive
knowledge base of plant biology at the systems level (DNA, RNA, protein, and
metabolites) should be constructed for the range of variation inherent in both
conventionally bred and genetically engineered crop species.”)
517
Note that some in the scientific community have criticized the idea of
introducing policy proposals that require the use of high-throughput “omics”
technologies in GM crop regulation because the state of the technology is not
fully developed, and there is not enough information as of yet to correlate omics
patterns to specific traits. See L. Val Giddings & Henry Miller, US National
Academies Report Misses the Mark, 34 NATURE BIOTECHNOLOGY 1226, 1227
(2017).
518
The Cost of Sequencing a Human Genome, NAT’L HUMAN GENOME RES.
INST. (Jul. 6, 2016), https://www.genome.gov/sequencingcosts/.
519
Id.
520
Id.
521
“Substantial equivalence” refers to the concept that “an assessment of a
novel food, in particular one that is genetically modified, should demonstrate
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methods when seeking approval before regulatory agencies. Policy
makers should weight the benefits and costs of imposing such a
requirement, which would inevitably add a regulatory burden on
developers in the short-term,522 but may help to allay the type of
fervid controversies concerning GM products in recent times. It
may also be in the interest of GM crop producers to make that
information publicly available to demonstrate to the general public
that GM crops are indeed virtually indistinguishable from
traditional crops.
Lastly, it is important to point out that promoting policies for
omics technology development could present new opportunities to
reassess what constitutes “substantial equivalence,” and whether
the concept in its current incarnation is an adequate standard for
GM crop production safety assessments.523
that the food is as safe as its traditional counterpart.” Substantial Equivalence,
OECD, https://stats.oecd.org/glossary/detail.asp?ID=2604. It was first
introduced in 1993 by the Organization for Economic Co-operation and
Development. Id. The concept has since been adopted as a global standard for
GM food safety assessment by many national and international agencies,
including the United States FDA. Substantial Equivalence in Food Safety
Assessment, COUNCIL FOR BIOTECHNOLOGY INFORMATION (2001),
http://thebeuselaer.weebly.com/uploads/6/3/8/4/6384873/substantial_equivalenc
e.pdf.
522
Policy makers must also weigh the potential effects of those regulatory
burdens on small businesses and farmers, which may not be able to compete
with corporate conglomerates in an undue regulatory environment.
523
In the past, the concept of substantial equivalence has been characterized as
unscientific, arbitrary, and intentionally vague by some critics. Compare Erik
Millstone et al., Beyond ‘Substantial Equivalence,’ 401 NATURE 525, 525–26
(1999) (arguing that “substantial equivalence has never been properly defined”
and “is a pseudo-scientific concept because it is a commercial and political
judgment masquerading as if it were scientific.”) and Mae-Wan Ho & Ricarda A.
Steinbrecher, Fatal Flaws in Food Safety Assessment: Critique of the Joint
FAO/WHO Biotechnology and Food Safety Report, THIRD WORLD NETWORK, 1,
23 (2002), http://www.twn.my/title2/biosafety/pdf/bio01.pdf (characterizing the
principle as “unscientific,” “arbitrary,” and “intentionally vague and ill-defined
so as to be as flexible, malleable and open to interpretation as possible.”), with
Harry A. Kuiper et al., Substantial Equivalence—An Appropriate Paradigm for
the Safety Assessment of Genetically Modified Foods?, 181–82 TOXICOLOGY
427, 430 (2002) (opining that “[t]he concept of substantial equivalence is an
adequate tool in order to identify safety issues related to genetically modified
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Case in point, a recent omics study of GM maize and its
isogenic non-GM counterpart reported that the nutritional and
compositional contents of the two crops were not substantially
equivalent and, thus, argued that the commonly used standard
should not be used as proof of safety. 524 Of course, finding a
compositional difference in a food or crop is not prima facie
evidence of a safety risk.525 However, although the study indicated
that a clear mechanistic link between food compositional
differences and deleterious health effects of long-term
consumption of the GM crop have not been established,526 antiGMO outlets rushed to sensationalize the report by claiming it
reveals “serious safety implications” related to the toxic and
carcinogenic effects of GMOs. 527 The study was promptly
criticized by many in the scientific community for, inter alia,
having inadequate statistical modeling, including flawed
experimental designs, and confusing statistically significant with
biologically significant differences.528
Without clear guidance on precisely what constitutes
substantial equivalence 529 among crop varieties, and necessary
products that have a traditional counterpart. It is not a safety assessment
procedure per se.”).
524
See Mesnage et al., supra note 514, at 6. The study was co-authored by
Gilles-Eric Séralini, who has published a string of anti-GMO reports in recent
years. See Relevant Research, supra note 253 (providing a compilation of
research published by Séralini and colleagues purportedly linking GMOs, or the
use of GMO-related chemicals, to a range of deleterious cellular and
physiological outcomes in animal in vitro and in vivo studies).
525
See NASEM REPORT, supra note 211, at 511.
526
Mesnage et al., supra note 514, at 10.
527 See, e.g., Why You Should Really Think Twice About Eating GMO Corn,
ALTERNET,
http://www.alternet.org/food/new-study-raises-questions-aboutsafety-eating-gmo-corn.
528
See, e.g., Expert Reaction to Multiomics Analysis of NK603 GM Maize,
SCIENCE MEDIA CENTRE, http://www.sciencemediacentre.org/expert-reaction-tomultiomics-analysis-of-nk603-gm-maize/; Séralini Paper: Molecular Analysis
Shows GMO Corn Differs from Non-GMO—Is Difference Meaningful?,
GENETIC
LITERARY
PROJECT,
https://geneticliteracyproject.org/2016/12/21/seralini-paper-molecular-analysisshows-gmo-corn-differs-non-gmo-difference-meaningful/.
529
Although the FDA has broad discretion to make determinations about the
safety and effectiveness of products under its regulatory oversight, courts have
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improvements in omics technologies discussed earlier in this
Section, increased controversy over the complex meaning of
substantial equivalence could ultimately fuel litigation.
Accordingly, technological progress in omics tools could lead to
significant developments for the implementation of the substantial
equivalence standard.
CONCLUSION
CRISPR GMOs are poised to fundamentally change how
humans perceive the future of food production. Unlike previous
technological advances in crop transgenesis, which have been rife
with issues concerning random insertion of foreign DNA material
from the start, CRISPR-based genome editing has proven to be
highly efficient and precise at modifying the genetic composition
of plants intended for human consumption. Remarkably, new
CRISPR crops can be produced without the need for foreign DNA
material. This scientific fact raises interesting issues about the
ability of the Coordinated Framework for the Regulation of
Biotechnology to provide adequate regulatory oversight of the
potential health and environmental safety effects—if any—
concerning this new breed of GMOs.
In the coming years, CRISPR technologies will offer a
meaningful opportunity to engage the public, developers of
biotechnology products, and law and policy makers in discussions
about how genetic engineering in general, and genome editing in
particular, can be used to the benefit or detriment of society. As
discussed throughout this Article, issues concerning regulatory
oversight and policy making cannot be resolved in a scientific
not always been “entirely comfortable with the FDA’s interpretation of
‘substantial equivalence.’” General Medical Co. v. FDA, 770 F.2d 214, 217 n.1
(D.C. Cir. 1985). In General Medical, a case involving a petition of
reclassification of an antiperspirant device, the D.C. Circuit Court of Appeals
acknowledged that “[t]he determinations of safety and effectiveness are clearly
crucial considerations in the classification of devices,” but expressed concerns
that FDA arguments may “require [the Court] to make a hop and a skip of faith
from the safety-and-effectiveness provisions to the classification provisions to
the substantial-equivalence provisions.” Id.
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vacuum, in which the sole and primary considerations necessary to
adjudicate controversies orbit the relevant scientific facts and
evidence. Sociopolitical, economical, and legal concerns are
pivotal in shaping policy. And it is in the interest of scientists and
GM crop developers to recognize how these factors can play
crucial roles in promoting scientific-based public policy.530
“Science is not democratic.” 531 The truth about established
scientific facts is neither susceptible to, nor dependent on, public
referenda. However, a majority of the scientific research around
the world takes place in countries where democracy guarantees the
right to vote, even for people who are not well educated in
scientific matters. As a result, scientific progress—regardless of
whether it is meritorious and seeks to address human problems—
depends heavily on societal support and can be stifled by undue
public concerns. 532 Opposition to scientific advances based on
public misperceptions about scientific facts can suppress or even
halt progress altogether. Legal challenges can cripple entire
industries and make it difficult to bring technologies to market.
Thus, failure to meaningfully engage the public through education
while dismissing opposing viewpoints533 can be very costly for the
development of scientific-based policies.
Significant legal issues surrounding CRISPR-based
technologies are looming in the horizon. For instance, complex

530

See supra Section VI.C.
Giddings & Miller, supra note 517, at 1227.
532
See, e.g., Found. on Econ. Trends v. Heckler, 756 F.2d 143, 146 (D.C. Cir.
1985) (enjoining the University of California from conducting a “deliberate
release experiment” to delay field testing of genetically altered bacteria on select
crops after environmental groups filed suit against federal officials for alleged
NEPA violations).
533 For instance, an article recently criticized the NASEM for not overtly
backing genetically engineered crops, while devoting time to examine the value
of scientific studies that depart from the consensus regarding the health and
environmental safety of GM crops. See Giddings & Miller, supra note 517, at
1226 (arguing that the NASEM “[R]eport’s efforts to give credence to
alternative viewpoints—rather like the media’s obsession with giving two sides
of an argument equal play, irrespective of which view is supported by the
evidence—is puzzling [and] . . . damaging.”).
531

538

N.C. J.L. & TECH.

[VOL. 18: 432

global problems 534 related to the national and international
governance of CRISPR GMOs are likely to exert effects on current
intellectual property, international trade, and foreign investment
regimes. Regulatory agencies will decide whether statutory
authority grants them jurisdiction to develop and promulgate rules
for genome-edited crops, and whether the crops fall under the
purview of new GMO labeling laws. 535 Issues of statutory
interpretation—e.g. substantial equivalence—may be the subject of
litigation as new methods of detection and statistical analysis
mature and become routine in the safety assessment of new crop
varieties. There is much the legal community can contribute to this
emerging field.
On the basis of the scientific evidence available to date, this
Article recommends that genome-edited crops should not be
subject to the same laws governing traditional GM crops derived
via recombinant DNA techniques. 536 Accordingly, the Article
534

Enríquez, supra note 44, at 1269, 1336.
The USDA has declared that at least two CRISPR crops do not fall under
APHIS jurisdiction pursuant to 7 C.F.R. § 340. See Yang, supra note 438;
Schmidt, supra note 438. However, the FDA and EPA have yet to make similar
determinations about the regulatory status of CRISPR crops. Whether CRISPR
GMOs are treated as GM or non-GM products will delineate the scope and reach
of new GMO labeling laws.
536
To be clear, this Article advocates for the deregulation of genome-edited
crops based on the analysis for the hypothetical model discussed in Sections
VI.A–B, which focused primarily on the case of DNA-free, CRISPR-based
genome editing. In the hypothetical, CRISPR-Cas9-sgRNA was delivered into
plant protoplasts as a ribonucleoprotein complex—i.e., the Cas9 protein and the
sgRNA were preassembled in vitro before transfection—which guarantees that
the CRISPR-Cas9-sgRNA complex will be degraded shortly after triggering the
target DNA cuts within cells.
There are other methods—e.g., A. tumefaciens-mediated transformation, nonintegrating plasmids, etc.—that can be used to deliver the CRISPR-Cas9
endonuclease and sgRNA and involve the introduction of plasmids encoding the
Cas9 and sgRNA components. These methods could presumably increase the
likelihood of inserting Cas9 and sgRNA recombinant DNA into the genomes of
target cells. Because of the presence of recombinant DNA, these methods would
likely fall within the current regulatory oversight of GM crops. See supra Part
IV. An argument can be made that CRISPR-based genome editing, even if
performed using recombinant DNA technology, should not be subject to the
same types of regulations that govern traditional GM crops because the changes
535
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advocates for the adoption of a rational framework for the
regulation of genome-edited crops. It also underscores the
importance of an interdisciplinary approach to address emerging
issues raised by gene editing technologies. Above all, the Article
seeks to jumpstart a conversation about global food security and
sustainable agricultural practices and, more broadly, about how
science and technology can influence the world.

made to the organism’s genome are far more precise than what can be achieved
using older recombinant DNA technologies. However, the analysis becomes
more complex relative to the use of DNA-free genome editing articulated in
Section VI.A.
Furthermore, the hypothetical in Section VI.A specifically relied on the
Nonhomologous End Joining (“NHEJ”) pathway for DNA double-stranded
break (“DSB”) repair. “NHEJ is an error-prone DSB repair mechanism that can
efficiently introduce small, random nucleotide mutations . . . .” Enríquez, supra
note 1, at 620. Another DSB repair mechanism called Homology-Directed
Repair (“HDR”) is significantly more precise than NHEJ, “ . . . but requires the
presence of an undamaged, homologous, donor template for repair.” Id.
Although HDR-mediated DSB repair is less efficient than NHEJ-mediated DSB
repair, the potential need for a donor DNA template—either synthetic or created
via recombinant DNA techniques—raises the likelihood that it may be subject to
the type of traditional GM crop regulations that the DNA-free method is able to
circumvent more easily.

